GLP-1 Market
LLY $1381.18 ▼ -2.4% NVO $39.49 ▼ -3.0% PFE $28.07 ▼ -1.4% VKTX $26.19 ▼ -2.6% KLRA $11.89 ▼ -2.5% GPCR $17.36 ▼ -4.5% RHHBY $59.55 ▼ -1.2%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Transdermal estrogen

Company
Johns Hopkins University
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
110 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

110 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Nov 18, 2026

Find a Clinical Trial Near Me

See recruiting studies for Transdermal estrogen and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02081924

    Reproductive Hormones During Sustained Administration of Kisspeptin

    Not yet reported Imperial College London 76 participants Est. completion 2027-11-30 1 site
    Other conditions: Fertility Disorders, Hypothalamic Dysfunction
    View official trial listing →
  • Recruiting NCT NCT03401047

    Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome

    Not yet reported University of Virginia 37 participants Est. completion 2025-12-01 1 site Stand-alone
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Recruiting NCT NCT03424005

    A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

    Not yet reported, Not yet reported Hoffmann-La Roche 1132 participants Est. completion 2030-09-30 55 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT03507673

    Clinical Cohort Study on the Endocrinology and Vaginal/Endometrial Microbiome of the Luteal Phase in Assisted Reproduction

    University of Luebeck 1200 participants Est. completion 2028-06-30 5 sites
    Other conditions: Infertility
    View official trial listing →
  • Recruiting NCT NCT04043520

    Bioenergetic Effects of Aging and Menopause (BEAM)

    Not yet reported University of Colorado, Denver 57 participants Est. completion 2024-08-31 1 site
    Other conditions: Menopause, Obesity, Abdominal, Aging, Weight Gain
    View official trial listing →
  • Recruiting NCT NCT04263298

    Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer

    Not yet reported Herui Yao 210 participants Est. completion 2030-05-01 13 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04312399

    Hormone Replacement Trial Against ALzheimers' Disease

    Not yet reported University Hospital, Ghent 600 participants Est. completion 2028-12-31 1 site
    Other conditions: Postmenopausal Symptoms, Alzheimer Disease
    View official trial listing →
  • Recruiting NCT NCT04596592

    Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth

    University of Colorado, Denver 90 participants Est. completion 2026-07-31 1 site
    Other conditions: Transgenderism, Gender Dysphoria, Insulin Sensitivity
    View official trial listing →
  • Recruiting NCT NCT04606446

    Study of PF-07248144 in Advanced or Metastatic Solid Tumors

    Not yet reported Pfizer 320 participants Est. completion 2029-08-27 43 sites
    Other conditions: Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT04685148

    Maternal Mental Health Trial

    Not yet reported, Not yet reported Vibe G Frøkjær, MD, PhD 220 participants Est. completion 2030-12-31 1 site
    Other conditions: Major Depressive Disorder, Postpartum Depression
    View official trial listing →
  • Recruiting NCT NCT05113368

    Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer

    Not yet reported Sarah K. Lynam MD 31 participants Est. completion 2027-02 1 site
    Other conditions: Ovarian Cancer, Serous Ovarian Cancer
    View official trial listing →
  • Recruiting NCT NCT05181033

    Lenvatinib+Letrozole Versus Fulvestrant in Metastatic ER+/HER2- Breast Cancer, Post Progression on Al + CDK4/6 Inhibitor

    Not yet reported National University Hospital, Singapore 120 participants Est. completion 2027-08 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05216432

    First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

    Not yet reported Relay Therapeutics, Inc. 930 participants Est. completion 2027-04-30 37 sites
    Other conditions: PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer, Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer, Unresectable Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT05282277

    Examining the Effects of Estradiol on Neural and Molecular Response to Reward

    Not yet reported University of North Carolina, Chapel Hill 103 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Depression, Psychosis, Anhedonia
    View official trial listing →
  • Recruiting NCT NCT05283421

    Improving Diagnostics in Cervical Dysplasia

    Not yet reported University of Aarhus 150 participants Est. completion 2026-08-16 1 site
    Other conditions: Cervical Cancer
    View official trial listing →
  • Recruiting NCT NCT05362760

    Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management

    Not yet reported Prof. Wolfgang Janni 300 participants Est. completion 2029-04 54 sites
    Other conditions: Hormone Receptor-positive Metastatic Breast Cancer, HER2-negative Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05394103

    Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors

    Not yet reported, Not yet reported Qurient Co., Ltd. 130 participants Est. completion 2029-08-31 14 sites
    Other conditions: Advanced Cancer, Metastatic Cancer
    View official trial listing →
  • Recruiting NCT NCT05472792

    Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy

    Not yet reported UNC Lineberger Comprehensive Cancer Center 90 participants Est. completion 2032-04-15 1 site
    Other conditions: Breast Cancer, Quality of Life
    View official trial listing →
  • Recruiting NCT NCT05473273

    Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle.

    ART Fertility Clinics LLC 40 participants Est. completion 2026-12-30 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Recruiting NCT NCT05524584

    Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer

    Not yet reported University of California, Irvine 20 participants Est. completion 2031-12-31 1 site
    Other conditions: Breast Cancer, Metastatic Breast Cancer, Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05536128

    Evaluating the Efficacy and Safety of Fulvestrant Plus DNA Damage Repair Inhibitors After a CDK4/6 Inhibitor

    Not yet reported Seoul National University Hospital 64 participants Est. completion 2025-12-31 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05573126

    Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer

    Not yet reported, Not yet reported Ellipses Pharma 95 participants Est. completion 2028-02 14 sites
    Other conditions: Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05586724

    Micronized Progesterone Versus Norethisterone Acetate in Combination With Estrogen as Menopausal Hormone Therapy

    Not yet reported Angelica Lindén Hirschberg 520 participants Est. completion 2027-12 1 site
    Other conditions: Menopausal Symptoms
    View official trial listing →
  • Recruiting NCT NCT05586802

    Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome

    Not yet reported Georgios Papadakis 150 participants Est. completion 2027-04-30 1 site
    Other conditions: Klinefelter Syndrome
    View official trial listing →
  • Recruiting NCT NCT05594095

    SNF Platform Study of HR+/ HER2-advanced Breast Cancer

    Not yet reported Fudan University 620 participants Est. completion 2026-12-01 1 site
    Other conditions: Breast Neoplasm, Breast Cancer, Hormone Receptor Positive Tumor, HER2-negative Breast Cancer, Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05601440

    Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

    Not yet reported Canadian Cancer Trials Group 484 participants Est. completion 2028-06-30 10 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05608252

    VS-6766+Abema+Fulv in Met HR+/HER- BC

    Not yet reported, Not yet reported Adrienne G. Waks 63 participants Est. completion 2028-12-31 3 sites
    Other conditions: Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05672901

    Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause

    Not yet reported Stratpharma AG 100 participants Est. completion 2026-09 3 sites
    Other conditions: Genitourinary Syndrome of Menopause
    View official trial listing →
  • Recruiting NCT NCT05683418

    A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

    Not yet reported Totus Medicines 241 participants Est. completion 2027-12 25 sites
    Other conditions: HR+/HER2-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05704036

    Estrogen Supplementation and Bone Health in Women With CF

    Not yet reported Johns Hopkins University 75 participants Est. completion 2029-01 1 site Stand-alone
    Other conditions: Cystic Fibrosis, Hypoestrogenism
    View official trial listing →
  • Recruiting NCT NCT05716516

    STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)

    Not yet reported Dartmouth-Hitchcock Medical Center 36 participants Est. completion 2027-05 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05735080

    Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

    Not yet reported, Not yet reported Incyclix Bio 150 participants Est. completion 2027-09 18 sites
    Other conditions: Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Ovarian Cancer, CCNE1 Amplification, Solid Tumor, Advanced Cancer, Metastatic Cancer
    View official trial listing →
  • Recruiting NCT NCT05816655

    Comparison of Clinical Efficacy Between Letrozole + Ribociclib and Fulvestrant + Letrozole + Ribociclib in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer

    Not yet reported Korea University Guro Hospital 202 participants Est. completion 2029-06-30 2 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05899010

    MIcronized PROgesterone in Frozen Embryo Transfer Cycles

    Not yet reported Fundación Santiago Dexeus Font 1020 participants Est. completion 2028-04 1 site
    Other conditions: Infertility
    View official trial listing →
  • Recruiting NCT NCT05900895

    Estradiol Plus Olaparib for Breast Cancer (PHOEBE)

    Not yet reported Mary D Chamberlin 6 participants Est. completion 2028-12 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05982496

    18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer

    Not yet reported Università Vita-Salute San Raffaele 119 participants Est. completion 2029-12-01 1 site
    Other conditions: Breast Cancer Female, Lobular Breast Carcinoma, PET/MRI, Axillary Lymphadenopathy, Luminal A Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06028555

    International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study

    Center for Epidemiology and Health Research, Germany 101000 participants Est. completion 2028-10-31 1 site
    Other conditions: Contraception, Birth Control
    View official trial listing →
  • Recruiting NCT NCT06101303

    Endometriosis Pain

    Washington University School of Medicine 120 participants Est. completion 2029-09-01 1 site
    Other conditions: Pelvic Pain, Endometriosis
    View official trial listing →
  • Recruiting NCT NCT06145308

    Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing

    Not yet reported Peking Union Medical College 39 participants Est. completion 2028-07-10 2 sites
    Other conditions: Salivary Gland Carcinoma, Precision Therapy
    View official trial listing →
  • Recruiting NCT NCT06208410

    A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors

    Not yet reported, Not yet reported Risen (Suzhou) Pharma Tech Co., Ltd. 306 participants Est. completion 2027-02-26 1 site
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT06239376

    Artificial Cycle With or Without GnRH Agonist Pre-treatment for Frozen Embryo Transfer in Adenomyosis Patients

    Not yet reported Mỹ Đức Hospital 222 participants Est. completion 2027-05-30 1 site
    Other conditions: Adenomyosis, IVF, Frozen Embryo Transfer
    View official trial listing →
  • Recruiting NCT NCT06280560

    Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation

    Fundación IVI 60 participants Est. completion 2026-12-30 1 site
    Other conditions: Endometrial Receptivity
    View official trial listing →
  • Recruiting NCT NCT06307184

    Assessing the Convenience of Natural Proliferative Phase Frozen Embryo Transfer

    Instituto Valenciano de Infertilidade de Lisboa 530 participants Est. completion 2026-12 1 site
    Other conditions: Frozen Embryo Transfer
    View official trial listing →
  • Recruiting NCT NCT06409390

    Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 15 participants Est. completion 2027-04 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06439524

    The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled Trial

    Not yet reported Main Line Health 110 participants Est. completion 2028-12-01 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Recruiting NCT NCT06515470

    Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer

    Not yet reported Biotheryx, Inc. 82 participants Est. completion 2027-12-31 6 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06525155

    Effect GnRH Agonist Administration in Endometriosis Cyst Patients

    Not yet reported Rumah Sakit Pusat Angkatan Darat Gatot Soebroto 32 participants Est. completion 2025-02 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Recruiting NCT NCT06533865

    Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea

    Not yet reported Massachusetts General Hospital 114 participants Est. completion 2029-04 2 sites Stand-alone
    Other conditions: FHA (Functional Hypothalamic Amenorrhea)
    View official trial listing →
  • Recruiting NCT NCT06544473

    Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome

    Not yet reported Aarhus University Hospital 50 participants Est. completion 2026-12-31 1 site
    Other conditions: Turner Syndrome, Hypogonadism; Ovarian, Hormone Replacement Therapy, Estrogen Replacement Therapy, Estrogen Deficiency
    View official trial listing →
  • Recruiting NCT NCT06570460

    Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome

    Not yet reported Aarhus University Hospital 50 participants Est. completion 2026-12-31 1 site
    Other conditions: Turner Syndrome, Hypogonadism; Ovarian, Hormone Replacement Therapy, Estrogen Replacement Therapy, Estrogen Deficiency
    View official trial listing →
  • Recruiting NCT NCT06572930

    Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation

    ART Fertility Clinics LLC 150 participants Est. completion 2026-12-01 1 site
    Other conditions: Ovarian Stimulation
    View official trial listing →
  • Recruiting NCT NCT06607757

    Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer

    Not yet reported GBG Forschungs GmbH 120 participants Est. completion 2026-08-31 25 sites
    Other conditions: CCCA Assessed by Ki67 Drop Below <2.7% From Baseline
    View official trial listing →
  • Recruiting NCT NCT06610305

    Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression

    Not yet reported University of North Carolina, Chapel Hill 75 participants Est. completion 2028-06-01 1 site Stand-alone
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Recruiting NCT NCT06618703

    Brain Irradiation for Childhood Cancer - Endocrine Monitoring During the First Years

    Not yet reported University Hospital, Angers 230 participants Est. completion 2030-10 3 sites
    Other conditions: Endocrine; Deficiency, Hypothalamo-Pituitary Disorder, Radiotherapy Side Effect
    View official trial listing →
  • Recruiting NCT NCT06625775

    Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

    Not yet reported TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) 392 participants Est. completion 2028-11 44 sites
    Other conditions: Solid Tumor, Adult, Metastatic Breast Cancer, Advanced Breast Cancer, HER2 Mutation-Related Tumors, HER2-positive Metastatic Breast Cancer, KRAS Mutant Metastatic Colorectal Cancer, Metastatic Lung Cancer, Metastatic Colorectal Cancer, Advanced Lung Cancer, HR-positive, HER2-negative Advanced Breast Cancer, HER2-positive Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06663072

    Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors

    Not yet reported University of Chicago 25 participants Est. completion 2026-11 1 site
    Other conditions: Metastatic Pancreatic Neuroendocrine Tumor
    View official trial listing →
  • Recruiting NCT NCT06726148

    Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

    Not yet reported, Not yet reported Novartis Pharmaceuticals 280 participants Est. completion 2028-09-25 33 sites
    Other conditions: Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT06757634

    Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

    Not yet reported Celcuity Inc 1180 participants Est. completion 2033-07-30 239 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06798571

    Role of Menopause in Thermoregulation

    Not yet reported Penn State University 24 participants Est. completion 2026-12-01 1 site Stand-alone
    Other conditions: Menopause, Aging
    View official trial listing →
  • Recruiting NCT NCT06806501

    Muscle Mass, Quality, and the Menopause: Sex-specific Strategies to Mitigate Sarcopenia in Ageing Populations

    University of Nottingham 18 participants Est. completion 2026-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Recruiting NCT NCT06851754

    Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 185 participants Est. completion 2031-12-31 1 site
    Other conditions: Premature Ovarian Insufficiency
    View official trial listing →
  • Recruiting NCT NCT06852365

    Combined Oral Contraceptive Pill and Resistance Starch

    Not yet reported University of Pennsylvania 100 participants Est. completion 2028-04 1 site
    Metabolic syndrome Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Recruiting NCT NCT06856200

    A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer

    Not yet reported Fudan University 36 participants Est. completion 2026-06 1 site
    Other conditions: Advanced HR - Positive, HER2 - Negative Breast Cancer, Resistant to (Neo)Adjuvant Endocrine Therapy
    View official trial listing →
  • Recruiting NCT NCT06873971

    Er:YAG Laser Combined With Vaginal Estriol for Genitourinary Syndrome of Menopause

    Not yet reported University of Nove de Julho 60 participants Est. completion 2026-12-31 1 site
    Other conditions: Genitourinary Syndrome of Menopause
    View official trial listing →
  • Recruiting NCT NCT06896617

    Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET)

    Not yet reported Fundacion Clinic per a la Recerca Biomédica 334 participants Est. completion 2026-12-20 1 site
    Other conditions: Infertilities, Embryo Transfer
    View official trial listing →
  • Recruiting NCT NCT06905210

    Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris

    Not yet reported Eurofarma Laboratorios S.A. 531 participants Est. completion 2027-03 18 sites
    Other conditions: Acne Vulgaris, Acne Vulgaris on the Face
    View official trial listing →
  • Recruiting NCT NCT06936930

    Reproductive and Mental Health of Patients With Aplastic Anemia

    Institute of Hematology & Blood Diseases Hospital, China 600 participants Est. completion 2027-12-31 1 site
    Other conditions: Aplastic Anemia, Reproductive Health
    View official trial listing →
  • Recruiting NCT NCT06953076

    Ultrasound Transformation of Myomas During Relugolix-Estradiol-Norethisterone Treatment: The MySaturn Study

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS 111 participants Est. completion 2027-05-02 1 site
    Other conditions: Uterine Bleeding, Uterine Leiomyomas, Uterine Hemorrhage, Uterine Neoplasms
    View official trial listing →
  • Recruiting NCT NCT06969326

    Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy

    Not yet reported Women and Infants Hospital of Rhode Island 48 participants Est. completion 2026-12-01 1 site
    Other conditions: Postoperative Bleeding, Gender Dysphoria, Hysterectomy
    View official trial listing →
  • Recruiting NCT NCT06979596

    A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

    Not yet reported Merck Sharp & Dohme LLC 250 participants Est. completion 2027-11-04 60 sites
    Other conditions: Malignant Neoplasm
    View official trial listing →
  • Recruiting NCT NCT06982521

    Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

    Not yet reported Relay Therapeutics, Inc. 540 participants Est. completion 2031-12-31 254 sites
    Other conditions: PIK3CA Mutation, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor, Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06993844

    Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

    Not yet reported, Not yet reported Ensem Therapeutics 233 participants Est. completion 2027-12-30 15 sites
    Other conditions: Advanced Solid Tumors, Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06995482

    Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers

    Not yet reported Kashiv BioSciences, LLC 40 participants Est. completion 2026-06 2 sites
    Other conditions: Healthy Postmenopausal Women
    View official trial listing →
  • Recruiting NCT NCT06997029

    A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

    Not yet reported Bristol-Myers Squibb 234 participants Est. completion 2028-12-14 21 sites
    Other conditions: Advanced Solid Tumor, Advanced Breast Cancer, Advanced Ovarian Cancer
    View official trial listing →
  • Recruiting NCT NCT06998108

    Study of BEBT-209 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Patients With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Who Have Progressed After Prior Endocrine Therapy

    Not yet reported BeBetter Med Inc 330 participants Est. completion 2026-06-30 1 site
    Other conditions: HR+/HER2- Locally Advanced, Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06998407

    ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors

    Not yet reported, Not yet reported Avenzo Therapeutics, Inc. 380 participants Est. completion 2030-08 16 sites
    Other conditions: HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07015476

    Retrospective Observational Evaluation of the Bone Mineral Density Outcome in Young Women With Amenorrhea

    IRCCS Azienda Ospedaliero-Universitaria di Bologna 180 participants Est. completion 2026-11 1 site
    Other conditions: Amenorrhea
    View official trial listing →
  • Recruiting NCT NCT07024173

    A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer

    Not yet reported Shandong Suncadia Medicine Co., Ltd. 240 participants Est. completion 2027-12 2 sites
    Other conditions: Locally Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07037082

    Understanding Cycles to Improve Women's Health

    University Hospital, Montpellier 320 participants Est. completion 2029-07-01 1 site
    Other conditions: Woman of Reproductive Age, Socioeconomic Factors
    View official trial listing →
  • Recruiting NCT NCT07109726

    A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

    Not yet reported, Not yet reported Terremoto Biosciences Inc. 248 participants Est. completion 2029-02-28 25 sites
    Other conditions: Breast Cancer, Endometrial Cancer, Ovarian Cancer, Lung Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma, Solid Tumor, Cervical Cancer
    View official trial listing →
  • Recruiting NCT NCT07115082

    Clinical Study on the Safety and Efficacy of Human Amniotic Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency

    Not yet reported, Not yet reported Yan Hongli 50 participants Est. completion 2026-03-30 1 site
    Other conditions: Premature Ovarian Insufficiency
    View official trial listing →
  • Recruiting NCT NCT07117630

    An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy

    Not yet reported Fudan University 60 participants Est. completion 2027-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07148921

    Perception of Pain During Gender Affirming Hormone Therapy

    Medical University of Vienna 40 participants Est. completion 2026-03 1 site
    Other conditions: Transgender Persons, Pain Threshold, Perception of Pain, Sex Hormones
    View official trial listing →
  • Recruiting NCT NCT07180160

    Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast Cancer

    Not yet reported Wenjin Yin 123 participants Est. completion 2028-03 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07187947

    Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway

    IRCCS Azienda Ospedaliero-Universitaria di Bologna 500 participants Est. completion 2035-12-31 1 site
    Cardiovascular disease Other conditions: Gender Incongruence, Cardiovascular (CV) Risk, Cardiovascular Health Status
    View official trial listing →
  • Recruiting NCT NCT07254429

    COMPASS - COpenhagen MenoPAuSe Study

    Not yet reported Martin Blomberg Jensen 192 participants Est. completion 2028-05 1 site
    Other conditions: Menopausal Osteoporosis, Bone Markers
    View official trial listing →
  • Recruiting NCT NCT07287917

    Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

    Not yet reported, Not yet reported Aminex Therapeutics, Inc. 92 participants Est. completion 2028-12-29 20 sites
    Other conditions: Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07330544

    A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of Hormone Receptor (HR) -Positive, Human Epidermal Growth Factor Receptor-2 (HER-2) -Negative Advanced Breast Cancer That Relapsed or Progressed After Endocrine Therapy

    Not yet reported Zhejiang Cancer Hospital 118 participants Est. completion 2028-11-26 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07339722

    A Study of LY4515100 in Healthy Participants

    Not yet reported Eli Lilly and Company 209 participants Est. completion 2027-03 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Recruiting NCT NCT07340190

    A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies

    Not yet reported Novartis Pharmaceuticals 24 participants Est. completion 2028-04-07 6 sites
    Other conditions: Advanced Malignancies
    View official trial listing →
  • Recruiting NCT NCT07347600

    A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

    Hoffmann-La Roche 500 participants Est. completion 2029-12-31 32 sites
    Other conditions: Locally Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07358468

    Association Between Peri-Transfer Endometrial Peristalsis And Live Birth In Modified Natural Cycle Frozen Embryo Transfer: A Prospective Cohort Study

    Mỹ Đức Hospital 384 participants Est. completion 2027-12-01 2 sites
    Other conditions: Infertility, Endometrial Peristalsis, Uterine Contraction, Endometrial Waves, Frozen Embryo Transfer (FET), Uterine Peristalsis
    View official trial listing →
  • Recruiting NCT NCT07368998

    To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

    Not yet reported Hoffmann-La Roche 80 participants Est. completion 2031-10-31 34 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07389733

    A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer

    Not yet reported, Not yet reported Shandong Suncadia Medicine Co., Ltd. 180 participants Est. completion 2028-12 2 sites
    Other conditions: Advanced Unresectable or Metastatic Breast Cancer of Adults
    View official trial listing →
  • Recruiting NCT NCT07405801

    A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer

    Not yet reported Hoffmann-La Roche 80 participants Est. completion 2030-02-26 59 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07421895

    A Prospective Multicenter Observational Real-world Study of Retained Products of Conception

    The Third Xiangya Hospital of Central South University 600 participants Est. completion 2032-12-31 1 site
    Other conditions: Retained Products of Conception, RPOC
    View official trial listing →
  • Recruiting NCT NCT07422506

    A Real-World Study Comparing the Efficacy of Different Treatment Regimens for Early Missed Abortion

    Not yet reported The Third Xiangya Hospital of Central South University 580 participants Est. completion 2035-01-01 1 site
    Other conditions: Missed Abortion, Early Pregnancy Failure
    View official trial listing →
  • Recruiting NCT NCT07426822

    Rash & Diarrhea Prophylaxis With Capivasertib

    Not yet reported Maryam Lustberg 108 participants Est. completion 2029-04 1 site
    Other conditions: Metastatic HR+/HER2- Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07499804

    Effect of Tadalafil on Endometrial Thickness and Frozen Embryo Transfer Outcomes

    Not yet reported Beni-Suef University 100 participants Est. completion 2026-04-30 1 site
    Other conditions: IVF, Infertility, Female
    View official trial listing →
  • Recruiting NCT NCT07540572

    A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

    Not yet reported IDEAYA Biosciences 155 participants Est. completion 2030-01-31 23 sites
    Other conditions: Cancer
    View official trial listing →
  • Recruiting NCT NCT07558733

    Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

    Not yet reported, Not yet reported Faeth Therapeutics 32 participants Est. completion 2033-05 9 sites
    Other conditions: HR+ HER2- Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07580950

    The Research of Integrated Traditional Chinese and Western Medicine on Hypothalamic Amenorrhea

    Not yet reported Peking Union Medical College Hospital 210 participants Est. completion 2028-06-30 1 site
    Other conditions: Functional Hypothalamic Amenorrhea
    View official trial listing →
  • Recruiting NCT NCT07666555

    A Phase II Clinical Study of the Efficacy and Safety of Culmerciclib Rechallenge in HR-positive, HER2-negative Breast Cancer Patients With Resistance to First-line Endocrine Therapy.

    Not yet reported Fudan University 98 participants Est. completion 2029-12-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07675213

    Endometrial Peristalsis and Pregnancy Outcomes in Hormone Replacement Therapy (HRT) - Frozen Embryo Transfer (FET) Cycles

    Mỹ Đức Hospital 442 participants Est. completion 2027-12-01 1 site
    Other conditions: Infertility, Endometrial Peristalsis, Uterine Contraction, Endometrial Waves, Frozen Embryo Transfer (FET), Uterine Peristalsis, Hormone Replacement Therapy (HRT)
    View official trial listing →
  • Recruiting NCT NCT07704658

    Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors

    Not yet reported Rigel Pharmaceuticals 12 participants Est. completion 2027-08-30 2 sites
    Other conditions: NSCLC (Non-small Cell Lung Cancer), Thyroid Cancer, Solid Tumor Malignancies, Advanced Malignancies
    View official trial listing →
  • Recruiting NCT NCT07792408

    Effects of VX-407 on the Pharmacokinetics of Combined Oral Contraceptives

    Not yet reported Vertex Pharmaceuticals Incorporated 148 participants Est. completion 2027-03-20 1 site
    Other conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
    View official trial listing →
  • Recruiting NCT NCT07794150

    A Study to Assess the Skin Irritation and Sensitization of Estradiol/Levonorgestrel TDS in Healthy Postmenopausal Subjects

    Not yet reported Corium Innovations, Inc. 250 participants Est. completion 2027-05-31 2 sites
    Other conditions: Menopause, Healthy Female Participants
    View official trial listing →
  • Recruiting NCT NCT07808060

    A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight

    Not yet reported Eli Lilly and Company 34 participants Est. completion 2027-06 2 sites
    Other conditions: Obesity, Overweight
    View official trial listing →
  • Recruiting NCT NCT07831499

    Cyclic vs. Constant Estradiol: Regimens' Effects on Brain Health

    Not yet reported University of Colorado, Denver 40 participants Est. completion 2028-07-15 1 site Stand-alone
    Other conditions: Menopause, Healthy Adult, Brain, Postmenopausal
    View official trial listing →
  • Recruiting NCT NCT07923214

    A Phase I Dose Escalation Study of CG-7321 Monotherapy or Combination Therapy in Advanced Solid Tumors

    Not yet reported Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. 66 participants Est. completion 2027-12 4 sites
    Other conditions: Advanced Solid Tumors, Breast Cancer, Ovarian Cancer, Gastric Cancer, Other Solid Tumors
    View official trial listing →
  • Completed NCT NCT00000466

    Postmenopausal Estrogen/Progestin Interventions (PEPI)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2000-10
    Cardiovascular disease Other conditions: Bone Diseases, Coronary Disease, Diabetes Mellitus, Heart Diseases, Hypercholesterolemia, Hypertension, Myocardial Ischemia, Osteoporosis, Thrombosis, Postmenopause
    View official trial listing →
  • Completed NCT NCT00000555

    Women's Angiographic Vitamin and Estrogen Trial (WAVE)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2003-05
    Cardiovascular disease Other conditions: Coronary Arteriosclerosis, Coronary Disease, Heart Diseases, Myocardial Ischemia, Postmenopause
    View official trial listing →
  • Completed NCT NCT00000559

    Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2001-08
    Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Myocardial Ischemia, Postmenopause
    View official trial listing →
  • Completed NCT NCT00000897

    A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and Women

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 42 participants 6 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00001221

    Effect of Biosynthetic Growth Hormone and/or Ethinyl Estradiol on Adult Height in Patients With Turner Syndrome

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 160 participants Est. completion 2003-09 1 site
    Other conditions: Gonadal Dysgenesis, Turner's Syndrome
    View official trial listing →
  • Completed NCT NCT00001259

    A Treatment Study for Premenstrual Syndrome (PMS)

    Not yet reported National Institute of Mental Health (NIMH) 60 participants Est. completion 2020-02-06 1 site Stand-alone
    Other conditions: Premenstrual Syndrome, Menstruation Disturbances
    View official trial listing →
  • Completed NCT NCT00002721

    Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

    Not yet reported University of New Mexico 18 participants Est. completion 2013-06 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00003066

    Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer

    Not yet reported Herbert Irving Comprehensive Cancer Center 40 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003084

    Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer

    Not yet reported M.D. Anderson Cancer Center 75 participants Est. completion 2002-11 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00003394

    Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 18 participants Est. completion 2003-04 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00003584

    Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer

    Not yet reported University of New Mexico 35 participants Est. completion 2000-12 1 site
    Other conditions: Kidney Cancer
    View official trial listing →
  • Status unknown NCT NCT00003633

    Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer

    Not yet reported Herbert Irving Comprehensive Cancer Center 12 participants 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00003717

    Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

    Not yet reported St. Barnabas Medical Center 17 participants 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00004054

    Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer

    Not yet reported Radiation Therapy Oncology Group 397 participants Est. completion 2013-11 54 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00005048

    Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported NYU Langone Health 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00005108

    Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 25 participants Est. completion 2002-01 1 site
    Other conditions: Atherosclerosis, Healthy, Vascular Disease
    View official trial listing →
  • Completed NCT NCT00005627

    Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Dana-Farber Cancer Institute Est. completion 2003-04 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00005810

    Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Alliance for Clinical Trials in Oncology 40 participants Est. completion 2006-06 7 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00005847

    Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Eastern Cooperative Oncology Group 19 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00006133

    Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus

    Not yet reported National Center for Research Resources (NCRR) 970 participants 17 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Terminated NCT NCT00010153

    ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00014352

    Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 1 site
    Other conditions: Prostate Cancer, Thromboembolism
    View official trial listing →
  • Completed NCT NCT00016107

    Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer

    Not yet reported National Cancer Institute (NCI) 72 participants 1 site
    Other conditions: Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00024167

    Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

    Not yet reported M.D. Anderson Cancer Center 265 participants 40 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00028769

    S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer

    Not yet reported SWOG Cancer Research Network 41 participants Est. completion 2011-07 91 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00029159

    The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome

    Not yet reported Thomas Jefferson University 200 participants Est. completion 2012-06 2 sites
    Other conditions: Turner Syndrome
    View official trial listing →
  • Completed NCT NCT00029757

    Buccal Estrogen in Toothpaste Study: Systemic Absorption of Estradiol When Administered Mixed With Toothpaste in Postmenopausal or Surgically Menopausal Women

    Not yet reported National Center for Research Resources (NCRR) 15 participants 1 site
    Other conditions: Menopause, Postmenopause
    View official trial listing →
  • Completed NCT NCT00030095

    2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors

    Not yet reported National Cancer Institute (NCI) 2 sites
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00030147

    Raloxifene and Rimostil for Perimenopause-Related Depression

    Not yet reported National Institute of Mental Health (NIMH) 65 participants Est. completion 2015-06 1 site
    Other conditions: Perimenopausal Depression, Depression
    View official trial listing →
  • Completed NCT NCT00033358

    Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer

    Not yet reported National Cancer Institute (NCI) 52 participants 1 site
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT00038246

    Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 40 participants Est. completion 2004-12 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00056901

    Screening Evaluation for Women With Postpartum Depression

    National Institute of Mental Health (NIMH) 68 participants Est. completion 2017-12-24 1 site
    Other conditions: Postpartum Depression, Depression
    View official trial listing →
  • Completed NCT NCT00057941

    Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer

    Not yet reported National Cancer Institute (NCI) 148 participants Est. completion 2012-06 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT00060736

    The Effects of Estrogen Withdrawal on Mood Symptoms in Women

    National Institute of Mental Health (NIMH) 60 participants Est. completion 2016-04-27 1 site
    Other conditions: Perimenopausal Depression, Post Menopausal, Healthy, Depression
    View official trial listing →
  • Completed NCT NCT00065325

    The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer

    Not yet reported AstraZeneca 694 participants Est. completion 2014-09 117 sites
    Other conditions: Locally Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00066157

    Alzheimer's Disease: Therapeutic Potential of Estrogen

    Not yet reported, Not yet reported University of Wisconsin, Madison 42 participants Est. completion 2007-12 1 site Stand-alone
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT00075764

    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer

    Not yet reported SWOG Cancer Research Network 695 participants Est. completion 2018-10-01 426 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00079248

    Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer

    Not yet reported Institute of Cancer Research, United Kingdom 1 site
    Other conditions: Breast Cancer, Hot Flashes, Menopausal Symptoms, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00082810

    Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer

    Not yet reported National Cancer Institute (NCI) 33 participants Est. completion 2008-09 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT00083824

    Estrogen, HDL, and Coronary Heart Disease in Women

    Not yet reported, Not yet reported Tufts University 309 participants Est. completion 2007-02 1 site
    Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Coronary Arteriosclerosis
    View official trial listing →
  • Terminated NCT NCT00089414

    Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives

    Not yet reported National Institute of Mental Health (NIMH) 5 participants Est. completion 2010-06 1 site
    Other conditions: Premenstrual Syndrome, PMS, Premenstrual Dysphoric Disorder, PMDD, Depression
    View official trial listing →
  • Completed NCT NCT00090857

    Letrozole in Preventing Breast Cancer in Postmenopausal Women

    Not yet reported Dana-Farber Cancer Institute 49 participants Est. completion 2013-03 5 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00093002

    Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

    Not yet reported AstraZeneca 179 participants Est. completion 2007-07 31 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00100854

    Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

    Not yet reported Translational Oncology Research International 108 participants Est. completion 2018-09-05 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT00108238

    Estrogen Alternatives Study

    Not yet reported US Department of Veterans Affairs Est. completion 2006-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00108849

    Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms

    Not yet reported Novo Nordisk A/S 309 participants Est. completion 2007-05 57 sites
    Other conditions: Menopause, Postmenopausal Vaginal Atrophy
    View official trial listing →
  • Completed NCT NCT00113100

    Mechanisms of Skin Repair by Topical Estrogen

    Not yet reported University of Michigan 152 participants Est. completion 2007-06 1 site
    Other conditions: Skin Wrinkling
    View official trial listing →
  • Withdrawn NCT NCT00117260

    Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral Density

    Not yet reported Duramed Research Est. completion 2007-08
    Other conditions: Osteopenia
    View official trial listing →
  • Terminated NCT NCT00123539

    Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 334 participants Est. completion 2005-08 1 site
    Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Neurologic Manifestations
    View official trial listing →
  • Terminated NCT NCT00131924

    High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy

    Not yet reported Northwestern University 1 participants Est. completion 2006-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00138125

    Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer

    Not yet reported Translational Oncology Research International 2 participants Est. completion 2009-12 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00141544

    The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women

    Not yet reported Solvay Pharmaceuticals 28 participants Est. completion 2008-03 78 sites
    Other conditions: Menopause
    View official trial listing →
  • Terminated NCT NCT00141557

    The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women

    Not yet reported Solvay Pharmaceuticals 133 participants Est. completion 2008-03 78 sites
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00145522

    Study to Compare the Effect of Hormone Replacement Therapy (HRT) on Breast and Cardiovascular Metabolic Markers in Postmenopausal Women

    Not yet reported Solvay Pharmaceuticals 135 participants Est. completion 2009-03 11 sites
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00151060

    Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate

    Not yet reported University of Michigan Rogel Cancer Center 28 participants Est. completion 2006-06 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00151073

    Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate

    Not yet reported University of Michigan Rogel Cancer Center 28 participants Est. completion 2007-09 1 site
    Other conditions: Hormone-Refractory Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00151086

    Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer

    Not yet reported, Not yet reported University of Michigan Rogel Cancer Center 33 participants Est. completion 2006-08 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00152282

    A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women

    Not yet reported Abbott 105 participants Est. completion 2001-08
    Other conditions: Amenorrhea, Postmenopause
    View official trial listing →
  • Completed NCT NCT00160316

    Endometrial Safety Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination

    Not yet reported Solvay Pharmaceuticals 454 participants Est. completion 2007-12 22 sites
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00160342

    Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes

    Not yet reported Solvay Pharmaceuticals 1251 participants Est. completion 2007-09 125 sites
    Other conditions: Hot Flushes, Menopause, Postmenopause
    View official trial listing →
  • Completed NCT NCT00161681

    Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 200 participants Est. completion 2006-08 48 sites
    Other conditions: Premenstrual Syndrome
    View official trial listing →
  • Completed NCT NCT00163033

    Study to Evaluate 3 Dosages of Estetrol After 28 Days Administration in Healthy Postmenopausal Women

    Not yet reported Pantarhei Bioscience 49 participants Est. completion 2007-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00165399

    Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment

    Not yet reported Dana-Farber Cancer Institute 62 participants Est. completion 2005-12-31 5 sites
    Other conditions: Adenocarcinoma of the Prostate, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00167921

    Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 24 participants 2 sites
    Other conditions: Atrophic Vaginitis
    View official trial listing →
  • Terminated NCT NCT00176527

    Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

    Not yet reported University of Medicine and Dentistry of New Jersey 40 participants Est. completion 2007-08 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00176644

    Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer

    Not yet reported University of Medicine and Dentistry of New Jersey 23 participants Est. completion 2008-12 6 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00179426

    Effect of Antiseizure Medication on Hormone Levels and Sexual Function in Men With Epilepsy

    Beth Israel Deaconess Medical Center 175 participants Est. completion 2006-06 1 site
    Other conditions: Seizure Disorder, Epilepsy
    View official trial listing →
  • Completed NCT NCT00183924

    Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.

    Not yet reported University of Southern California 20 participants Est. completion 2008-12 1 site
    Other conditions: Prostate Adenocarcinoma
    View official trial listing →
  • Terminated NCT NCT00183963

    A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)

    Not yet reported University of Southern California 4 participants Est. completion 2008-06 1 site
    Other conditions: Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT00184795

    Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations

    Not yet reported Novo Nordisk A/S 576 participants Est. completion 2005-05-04 91 sites
    Other conditions: Menopause, Menopausal Vasomotor Symptoms
    View official trial listing →
  • Completed NCT NCT00185224

    Metabolism Study to Investigate the Impact of a Sequential Oral Contraceptive

    Not yet reported Bayer 58 participants Est. completion 2006-03 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00185237

    Treatment of Hot Flushes in Asian Women With Ultra-low Dose Estradiol Patch

    Not yet reported Bayer 165 participants Est. completion 2006-11
    Other conditions: Hot Flashes
    View official trial listing →
  • Completed NCT NCT00185328

    Efficacy and Tolerability of Angeliq in Thai Women

    Not yet reported Bayer 55 participants Est. completion 2006-12
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00191113

    Somatropin Treatment to Final Height in Turner Syndrome

    Not yet reported Eli Lilly and Company 154 participants Est. completion 2007-12 14 sites
    Other conditions: Turner Syndrome
    View official trial listing →
  • Completed NCT NCT00193193

    Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma

    Not yet reported SCRI Development Innovations, LLC 100 participants Est. completion 2007-02
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00193271

    Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer

    Not yet reported SCRI Development Innovations, LLC 30 participants Est. completion 2007-05 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00193726

    Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast Cancer

    Not yet reported Sudeep Gupta 273 participants Est. completion 2012-03-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00195455

    Study Evaluating Estradiol/Trimegestone in Vasomotor Symptoms (VMS) in Post-Menopausal Women.

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 133 participants Est. completion 2007-03 6 sites
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00195559

    Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 526 participants Est. completion 2007-12 51 sites
    Other conditions: Premenstrual Syndrome, Menstruation Disturbances
    View official trial listing →
  • Completed NCT NCT00196326

    Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive

    Not yet reported Duramed Research 2235 participants Est. completion 2007-06 55 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00196365

    A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain

    Not yet reported Duramed Research 97 participants Est. completion 2007-07 18 sites
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Completed NCT NCT00201864

    Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer

    Not yet reported Ohio State University Comprehensive Cancer Center 40 participants Est. completion 2014-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00204074

    Treatment of Menstrual Migraine With Sequential, Transdermal, 17-Beta-Estradiol. A Double-Blind, Randomised, Cross-Over Trial.

    Not yet reported, Not yet reported University Hospital, Linkoeping Est. completion 2005-07 1 site
    Other conditions: Migraine
    View official trial listing →
  • Terminated NCT NCT00206414

    Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer

    Not yet reported Baylor Breast Care Center 15 participants Est. completion 2006-09 1 site
    Other conditions: BREAST CANCER
    View official trial listing →
  • Completed NCT NCT00206557

    The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study

    Not yet reported The Alfred 60 participants Est. completion 2007-04 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
    View official trial listing →
  • Completed NCT NCT00206570

    Clinical Estradiol Trial in Women With Schizophrenia

    Not yet reported Bayside Health 100 participants Est. completion 2004-12 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
    View official trial listing →
  • Completed NCT NCT00206622

    Efficacy and Safety Study in Postmenopausal Women to Determine the Lowest Effective Dose for Relief of Moderate to Severe Hot-Flushes

    Not yet reported Bayer 425 participants Est. completion 2006-02 45 sites
    Other conditions: Hot Flashes
    View official trial listing →
  • Completed NCT NCT00212277

    Efficacy and Safety,Long-term Study of Low-dose Oral Contraceptive Pill to Treat Dysmenorrhea.

    Not yet reported Nobelpharma Est. completion 2007-02
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Completed NCT NCT00213096

    Effects of Hormonal Contraceptives on Liver Proteins and Coagulation Factors: A Comparison of a Contraceptive Vaginal Ring and an Oral Contraceptive

    Not yet reported Population Council 50 participants Est. completion 2004-02 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00224094

    A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women

    Not yet reported Watson Pharmaceuticals 27 participants 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00227942

    Estrogen for Treating Depression in Menopausal Women With Hot Flashes and Insomnia

    Not yet reported Hadine Joffe, MD 86 participants Est. completion 2007-11 1 site
    Other conditions: Sleep Initiation and Maintenance Disorders, Depression
    View official trial listing →
  • Completed NCT NCT00230815

    A Phase 3b Study to Evaluate Subject Satisfaction With Follitropin Alfa Injection in Oligoanovulatory Infertile Women Undergoing Ovulation Induction

    Not yet reported EMD Serono 62 participants Est. completion 2005-11
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT00234819

    Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Symptoms Associated With Menopause

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 325 participants Est. completion 2007-02 7 sites
    Other conditions: Vasomotor Symptoms Associated With Menopause
    View official trial listing →
  • Terminated NCT NCT00236301

    Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers

    Not yet reported Assistance Publique - Hôpitaux de Paris 99 participants Est. completion 2007-01 1 site
    Other conditions: Healthy Symptomatic Menopausal Women
    View official trial listing →
  • Completed NCT NCT00236769

    A Study of Efficacy and Safety With the Transdermal Contraceptive System.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1751 participants Est. completion 1999-10
    Other conditions: Contraception, Female Contraception
    View official trial listing →
  • Completed NCT NCT00236782

    A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Mercilon.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1517 participants Est. completion 1999-03
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00236795

    A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1494 participants Est. completion 1999-03
    Other conditions: Contraception, Female Contraception
    View official trial listing →
  • Completed NCT NCT00241449

    A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer

    Not yet reported AstraZeneca 51 participants Est. completion 2012-01 139 sites
    Other conditions: Breast Cancer, Metastasis
    View official trial listing →
  • Completed NCT NCT00253422

    Study of Faslodex +/- Concomitant Arimidex v Exemestane Following Progression on Non-steroidal Aromatase Inhibitors

    Not yet reported Institute of Cancer Research, United Kingdom 698 participants Est. completion 2022-11-28 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00254189

    Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on Ovulation

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 60 participants Est. completion 2004-10
    Other conditions: Ovulation
    View official trial listing →
  • Completed NCT NCT00254800

    The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females

    Not yet reported AstraZeneca 38 participants Est. completion 2006-08 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00258063

    A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST (an Oral Contraceptive)

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 60 participants Est. completion 2004-09
    Other conditions: Contraception, Female Contraception
    View official trial listing →
  • Completed NCT NCT00258076

    A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch)

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 53 participants Est. completion 2004-09
    Other conditions: Contraception, Female Contraception
    View official trial listing →
  • Completed NCT NCT00259090

    Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer

    Not yet reported AstraZeneca 120 participants Est. completion 2008-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00264407

    Neural Changes in the Aging Auditory System

    University of Rochester 126 participants Est. completion 2005-02 2 sites
    Alcohol use disorder Other conditions: Progesterone, Estrogens, Hearing, Psychoacoustics
    View official trial listing →
  • Completed NCT NCT00272740

    SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer

    Not yet reported AstraZeneca 93 participants 8 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00274469

    A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer

    Not yet reported AstraZeneca 205 participants Est. completion 2017-01-13 41 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00283816

    Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy

    Not yet reported University of Rochester 36 participants Est. completion 2008-01 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT00293059

    Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

    Not yet reported Bayer 190 participants Est. completion 2008-05 46 sites
    Other conditions: Metrorrhagia
    View official trial listing →
  • Completed NCT NCT00298025

    A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation

    Not yet reported EMD Serono 185 participants Est. completion 2004-05
    Other conditions: Infertile Women Undergoing Assisted Reproductive Technology (ART)
    View official trial listing →
  • Terminated NCT NCT00302731

    Bioidentical 'Natural' Hormone Evaluation in Early Menopause

    Not yet reported Jeanne Drisko, MD, CNS, FACN 21 participants Est. completion 2014-09 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00303524

    Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients

    Not yet reported AstraZeneca 170 participants Est. completion 2009-02 22 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00305448

    A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg

    Not yet reported AstraZeneca 143 participants Est. completion 2012-02 35 sites
    Other conditions: Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00307775

    Vaginal Estrogen for the Treatment of Faecal Incontinence in Women

    Not yet reported London North West Healthcare NHS Trust 43 participants Est. completion 2011-10 1 site
    Other conditions: Fecal Incontinence
    View official trial listing →
  • Completed NCT NCT00307801

    Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

    Not yet reported Bayer 231 participants Est. completion 2008-05 36 sites
    Other conditions: Metrorrhagia
    View official trial listing →
  • Completed NCT NCT00310531

    3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal Women

    Not yet reported Bayer 500 participants Est. completion 2007-06
    Other conditions: Osteopenia
    View official trial listing →
  • Completed NCT NCT00318318

    Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 20 participants Est. completion 2007-02 1 site
    Other conditions: Healthy, Estrogen Replacement Therapy
    View official trial listing →
  • Completed NCT NCT00319163

    Study Comparing Two Manufacturing Processes for Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg (LNG/EE) in Healthy, Cycling Women

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 26 participants Est. completion 2006-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00320567

    The Effect of Norgestimate/Ethinyl Estradiol on Bone Density in Pediatric Subjects With Anorexia Nervosa

    Not yet reported McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. 123 participants Est. completion 2004-04
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00320580

    An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen

    Not yet reported McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. 239 participants Est. completion 2003-03
    Other conditions: Metrorrhagia
    View official trial listing →
  • Completed NCT NCT00324259

    Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer

    Not yet reported Washington University School of Medicine 66 participants Est. completion 2014-08 7 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00327769

    Faslodex Advanced Breast Cancer Local Chinese Study

    Not yet reported AstraZeneca 234 participants Est. completion 2007-09 12 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT00328120

    Faslodex 500mg Multiple Dose Tolerability Study in BC Patients

    Not yet reported AstraZeneca 20 participants Est. completion 2010-06 5 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT00328497

    A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors

    Not yet reported CASI pharmaceuticals, Inc. 31 participants Est. completion 2009-12 1 site
    Other conditions: Carcinoid Tumor
    View official trial listing →
  • Completed NCT NCT00331071

    Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks

    Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 334 participants Est. completion 2006-03
    Other conditions: Contraception, Female Contraception
    View official trial listing →
  • Completed NCT NCT00334295

    Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.

    Not yet reported AstraZeneca 35 participants Est. completion 2011-01 9 sites
    Other conditions: Endometrial Carcinoma
    View official trial listing →
  • Status unknown NCT NCT00334971

    Aromatase Activity and Ovarian Growth Factors in African-American Versus Caucasian Women

    Not yet reported Massachusetts General Hospital 116 participants Est. completion 2018-01 1 site
    Other conditions: Healthy, Fragile X Syndrome
    View official trial listing →
  • Completed NCT NCT00335218

    Fat Distribution in Healthy Early Postmenopausal Women

    Not yet reported Bayer 67 participants Est. completion 2004-08 3 sites
    Other conditions: Healthy, Postmenopause
    View official trial listing →
  • Completed NCT NCT00338052

    Study of Bleeding With Extended Administration of an Oral Contraceptive

    Not yet reported Warner Chilcott 207 participants Est. completion 2007-05 23 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00344383

    An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen

    Not yet reported McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. 61 participants Est. completion 2004-07
    Other conditions: Metrorrhagia
    View official trial listing →
  • Completed NCT NCT00356447

    Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.

    Not yet reported Bayer 249 participants Est. completion 2007-10 9 sites
    Other conditions: Vasomotor Symptoms
    View official trial listing →
  • Completed NCT NCT00357006

    A Definitive Estrogen Patch Study (ADEPT)

    Not yet reported The Alfred 180 participants Est. completion 2013-12 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder(Not in Manic Phase)
    View official trial listing →
  • Completed NCT NCT00357110

    Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer

    Not yet reported AstraZeneca 13 participants Est. completion 2008-10 25 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00361075

    Midlife Cholesterol Study

    Not yet reported Northwestern University 120 participants Est. completion 2005-05 2 sites
    Cardiovascular disease Other conditions: Menopause, Postmenopause, Premenopause
    View official trial listing →
  • Withdrawn NCT NCT00370019

    Effects of an Estrogen Replacement Therapy Skin Patch on Ovulation in Women With Premature Ovarian Failure

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Est. completion 2011-12-12 1 site
    Other conditions: Premature Ovarian Failure
    View official trial listing →
  • Terminated NCT NCT00372996

    Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer

    Not yet reported Pfizer 219 participants Est. completion 2014-06 62 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00377988

    A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control

    Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 423 participants Est. completion 2008-10
    Other conditions: Contraception, Female Contraception
    View official trial listing →
  • Completed NCT NCT00380887

    Study Comparing Four New Formulations for Premarin in Healthy Postmenopausal Women

    Wyeth is now a wholly owned subsidiary of Pfizer 54 participants
    Other conditions: Postmenopause
    View official trial listing →
  • Terminated NCT NCT00387829

    DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery

    Not yet reported Integra LifeSciences Corporation 347 participants Est. completion 2011-12 36 sites
    Other conditions: Spinal Injuries, Adhesions
    View official trial listing →
  • Completed NCT NCT00390455

    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

    Not yet reported National Cancer Institute (NCI) 295 participants Est. completion 2014-07-02 368 sites
    Other conditions: Estrogen Receptor Positive, HER2 Positive Breast Carcinoma, HER2/Neu Negative, Progesterone Receptor Positive, Recurrent Breast Carcinoma, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT00391417

    Efficacy and Safety of a Topical Estradiol Gel for Treatment of Postmenopausal Symptoms

    Not yet reported BioSante Pharmaceuticals 431 participants Est. completion 2005-04
    Other conditions: Hot Flashes
    View official trial listing →
  • Completed NCT NCT00391807

    Study of Safety and Efficacy of an Oral Contraceptive

    Not yet reported Warner Chilcott 1683 participants Est. completion 2008-09 66 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00396799

    Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2006-11
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00399685

    Drug Interaction - Oral Contraceptive

    Not yet reported Bristol-Myers Squibb 28 participants Est. completion 2007-08 2 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00401219

    Study Comparing Bioavailability of 3 New Formulations of Premarin/MPA With Premarin/MPA (PREMPRO) Reference Formulation

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2007-02
    Other conditions: Estrogen Replacement Therapy
    View official trial listing →
  • Completed NCT NCT00402636

    Rapamycin+Estradiol- vs. Rapamycin-Eluting Stents to Reduce Restenosis (ISAR-PEACE)

    Not yet reported Deutsches Herzzentrum Muenchen 502 participants Est. completion 2006-10 2 sites
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Withdrawn NCT NCT00402935

    Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer

    Case Comprehensive Cancer Center Est. completion 2007-05 1 site
    Other conditions: Leukemia, Long-term Effects Secondary to Cancer Therapy in Adults, Long-term Effects Secondary to Cancer Therapy in Children, Lymphoma, Sexual Dysfunction and Infertility, Sexuality and Reproductive Issues, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00413764

    Efficacy of Tibolone Versus Transdermal E2/NETA on Sexual Function in Naturally Postmenopausal Women (P06089)

    Not yet reported Organon and Co 358 participants Est. completion 2005-11-15
    Other conditions: Sexual Dysfunction
    View official trial listing →
  • Completed NCT NCT00423917

    Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 36 participants Est. completion 2017-01-15 205 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00425776

    Treatment of Hot Flushes in Breast Cancer Patients With Acupuncture

    Not yet reported Vejle Hospital 94 participants Est. completion 2010-01 1 site
    Other conditions: Breast Cancer, Postmenopause
    View official trial listing →
  • Completed NCT NCT00426972

    Trial of Zesteem (Estradiol) in Healing of Split Thickness Skin Graft Donor Sites

    Not yet reported Renovo 148 participants Est. completion 2008-10 30 sites
    Other conditions: Burn, Trauma, Varicose Ulcer
    View official trial listing →
  • Completed NCT NCT00431093

    Trial to Compare the Effects of Tibolone (Livial®) and Continuous Combined Low-Dose Estradiol/Noresterone (Activelle®)

    Not yet reported Organon and Co 570 participants Est. completion 2005-03
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00442689

    Metabolic Syndrome in PCOS: Precursors and Interventions

    Not yet reported Northwestern University 97 participants Est. completion 2012-11 1 site
    Metabolic syndrome Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Withdrawn NCT NCT00447863

    Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling Women

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2007-08
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00451555

    Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer

    Not yet reported Eli Lilly and Company 156 participants Est. completion 2018-10-18 21 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00455156

    Study of the Safety, Efficacy and Cycle Control of a Contraceptive Vaginal Ring

    Not yet reported Premier Research 1200 participants Est. completion 2011-09 15 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00455962

    Effect of Race on Gonadotropin Responses

    Not yet reported, Not yet reported Massachusetts General Hospital 23 participants Est. completion 2011-12 1 site
    Other conditions: Premenopause, Healthy
    View official trial listing →
  • Completed NCT NCT00464789

    Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Healthy Postmenopausal Women

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2007-05
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00465192

    Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis

    Not yet reported Novo Nordisk A/S 230 participants Est. completion 1995-11-30
    Other conditions: Menopause, Postmenopausal Vaginal Atrophy
    View official trial listing →
  • Completed NCT NCT00471991

    Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition

    Not yet reported Bayer 60 participants Est. completion 2007-12 1 site
    Other conditions: Oral Contraceptive
    View official trial listing →
  • Completed NCT NCT00472004

    Study Comparing 17B Estradiol/TMG CC 1mg Vs. Tibolone In Postmenopausal Women

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 204 participants Est. completion 2009-12 1 site
    Other conditions: Vasomotor Symptoms
    View official trial listing →
  • Completed NCT NCT00475553

    Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing®

    Not yet reported Scott and White Hospital & Clinic 75 participants Est. completion 2008-05 1 site
    Other conditions: Breakthrough Bleeding, Breakthrough Spotting
    View official trial listing →
  • Completed NCT NCT00477633

    Study of Safety and Efficacy of an Oral Contraceptive

    Not yet reported Warner Chilcott 1700 participants Est. completion 2009-02 63 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00479778

    Study Of Pharmacokinetic (PK) Profile of Bazedoxifene (BZA) in 2 BZA/Conjugated Estrogen Forms

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 72 participants Est. completion 2007-07 1 site
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00480532

    A Study of Continuous Oral Contraceptives and Doxycycline

    Not yet reported Oregon Health and Science University 131 participants Est. completion 2011-05 2 sites
    Other conditions: Contraceptives, Oral
    View official trial listing →
  • Completed NCT NCT00481455

    Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)

    Not yet reported CASI pharmaceuticals, Inc. 15 participants Est. completion 2008-10 1 site
    Other conditions: Recurrent Glioblastoma Multiforme
    View official trial listing →
  • Completed NCT NCT00484107

    Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women

    Wyeth is now a wholly owned subsidiary of Pfizer 200 participants Est. completion 2006-10
    Other conditions: Postmenopause
    View official trial listing →
  • Status unknown NCT NCT00490308

    The Influence of Estradiol Supplementation During the Luteal in Patients Undergoing IVF Treatment

    Not yet reported Assaf-Harofeh Medical Center 120 participants Est. completion 2008-08 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT00504816

    A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers

    Not yet reported GlaxoSmithKline 22 participants Est. completion 2008-04 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00511199

    Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724)

    Not yet reported Organon and Co 2152 participants Est. completion 2008-04-01
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00511342

    Effects on Bone Mineral Density (BMD) of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG/EE (292005)(P05765)(COMPLETED)

    Not yet reported Organon and Co 110 participants Est. completion 2009-06
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00511355

    Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764)

    Not yet reported Organon and Co 121 participants Est. completion 2008-01
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00511433

    Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)

    Not yet reported Organon and Co 48 participants Est. completion 2008-01
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00534417

    Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer

    Not yet reported Accelerated Community Oncology Research Network 41 participants Est. completion 2011-09 10 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00541281

    Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer

    Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 150 participants Est. completion 2006-02 19 sites
    Other conditions: Hormone Resistant Prostate Cancer, Metastatic Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00543127

    Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole

    Not yet reported Spanish Breast Cancer Research Group 870 participants Est. completion 2016-07 53 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00549666

    A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects

    Not yet reported Sumitomo Pharma America, Inc. 23 participants Est. completion 2007-12 1 site
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Terminated NCT NCT00551733

    Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

    Not yet reported CTI BioPharma 450 participants Est. completion 2007-12-25 41 sites
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT00554632

    Birth Control Pill vs Birth Control Patch Study

    Not yet reported University of Vermont 24 participants Est. completion 2005-08
    Other conditions: Venous Thrombosis
    View official trial listing →
  • Completed NCT NCT00563576

    Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation

    Not yet reported Columbia University 71 participants Est. completion 2009-02 1 site
    Other conditions: Metrorrhagia
    View official trial listing →
  • Terminated NCT NCT00565916

    Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism

    Not yet reported Washington University School of Medicine 22 participants Est. completion 2008-01 1 site
    Other conditions: Postmenopausal Syndrome
    View official trial listing →
  • Completed NCT NCT00569244

    SH T00186 in the Treatment of Primary Dysmenorrhea

    Not yet reported Bayer 223 participants Est. completion 2009-12 27 sites
    Other conditions: Primary Dysmenorrhea
    View official trial listing →
  • Terminated NCT NCT00570258

    Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy

    Not yet reported University of Arkansas 27 participants Est. completion 2017-12 6 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00570921

    Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure

    Not yet reported Mara Chambers 33 participants Est. completion 2015-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT00576225

    CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL

    Not yet reported CTI BioPharma Est. completion 2010-04-05 44 sites
    Other conditions: NSCLC
    View official trial listing →
  • Completed NCT NCT00586898

    Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle

    Not yet reported Memorial Sloan Kettering Cancer Center 36 participants Est. completion 2009-03 1 site
    Other conditions: Prostate, Cancer, Hormonal Cycling
    View official trial listing →
  • Completed NCT NCT00589134

    The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium Concentration

    Not yet reported Yale University 26 participants Est. completion 2009-12 1 site
    Other conditions: Exercise Induced Hyponatremia
    View official trial listing →
  • Terminated NCT NCT00592007

    Study Evaluating the Addition of Fulvestrant to Erlotinib in Stage IIIB/IV Non-Small Cell Lung Cancer

    Not yet reported Lyudmila Bazhenova, M.D. 7 participants Est. completion 2012-04 1 site
    Other conditions: Non Small Cell Lung Carcinoma
    View official trial listing →
  • Completed NCT NCT00604825

    Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)

    Not yet reported GlaxoSmithKline 356 participants Est. completion 2008-07-23 87 sites
    Other conditions: Menopausal and Female Climacteric States
    View official trial listing →
  • Status unknown NCT NCT00617500

    Climacteric Clinical Trial : the Use of Complementary Therapy and Hormonal Replacement

    Not yet reported Sociedade Hospital Samaritano 278 participants Est. completion 2009-11 2 sites
    Other conditions: Climacteric
    View official trial listing →
  • Completed NCT NCT00619866

    An Efficacy and Safety Study of Elagolix (NBI-56418) in Women With Endometriosis

    Not yet reported AbbVie 155 participants Est. completion 2009-08-28
    Other conditions: Endometriosis, Pain
    View official trial listing →
  • Status unknown NCT NCT00623116

    A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland

    Not yet reported Hospital for Children and Adolescents, Finland 50 participants Est. completion 2025-12 1 site
    Other conditions: Kallmann Syndrome
    View official trial listing →
  • Completed NCT NCT00629616

    Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer

    Not yet reported UNICANCER 116 participants Est. completion 2018-04 6 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00631124

    A Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a Period of 3 Treatment Cycles

    Not yet reported Bayer 103 participants Est. completion 2008-12 2 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00635713

    Second Line Breast Cancer Trial

    Not yet reported AstraZeneca 588 participants Est. completion 2004-09
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT00640224

    Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study

    Not yet reported Silva Arslanian 65 participants Est. completion 2015-07 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT00649896

    Evaluation of Adhesion Quality of a New Formulation of the Mylan Estradiol Transdermal System 0.025 mg/Day and Climara® Transdermal System 0.025 mg/Day

    Not yet reported Mylan Pharmaceuticals Inc 76 participants Est. completion 2003-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00651469

    Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.

    Not yet reported Bayer 534 participants Est. completion 2004-07 27 sites
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Completed NCT NCT00651599

    Treatment of Vasomotor Symptoms in Korean Post Menopausal Women

    Not yet reported Bayer 90 participants Est. completion 2005-05 4 sites
    Other conditions: Vasomotor Symptoms
    View official trial listing →
  • Completed NCT NCT00653016

    An Open-label, Multicentre Study on Preference and Satisfaction of Canadian Women for the Transdermal Contraceptive Patch vs. Previous Primary Contraceptive Method

    Not yet reported Janssen-Ortho Inc., Canada 405 participants Est. completion 2003-08
    Other conditions: Female Contraception
    View official trial listing →
  • Completed NCT NCT00653614

    Cycle Control and Safety of E2-DRSP

    Not yet reported Bayer 635 participants Est. completion 2009-06 25 sites
    Other conditions: Contraceptive, Oral, Hormonal
    View official trial listing →
  • Completed NCT NCT00660803

    Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer

    AstraZeneca 200 participants Est. completion 2009-04 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00661531

    Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy

    Not yet reported Georgetown University 11 participants Est. completion 2015-06 3 sites
    Other conditions: Breast Cancer, Cancer of the Breast, Neoplasms, Breast
    View official trial listing →
  • Completed NCT NCT00662454

    Oral Contraceptive Efficacy and Body Weight

    Not yet reported Oregon Health and Science University 120 participants Est. completion 2006-05 1 site
    Other conditions: Contraception, Body Weight
    View official trial listing →
  • Completed NCT NCT00668603

    Comparison of Vascular Findings Between Symptomatic and Asymptomatic Postmenopausal Women Before and During Hormone Therapy (HRT)

    Not yet reported University of Helsinki 160 participants Est. completion 2008-03 1 site
    Cardiovascular disease Other conditions: Postmenopausal Vasomotor Symptoms
    View official trial listing →
  • Completed NCT NCT00685009

    The Women's Health Initiative Memory Study (The WHIMS Study)

    National Heart, Lung, and Blood Institute (NHLBI) 7525 participants Est. completion 2008-03 1 site
    Other conditions: Dementia Syndromes
    View official trial listing →
  • Status unknown NCT NCT00688194

    Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy

    Not yet reported Gruppo Italiano Mammella (GIM) 396 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00697307

    Bioequivalence Study of Patches With Different Release Profiles

    Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 43 participants Est. completion 2003-07
    Other conditions: Female Contraception
    View official trial listing →
  • Completed NCT NCT00698035

    Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients

    Not yet reported University of California, San Francisco 76 participants Est. completion 2012-12 1 site
    Other conditions: Sexual Dysfunction, Physiological
    View official trial listing →
  • Terminated NCT NCT00705822

    Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer

    Not yet reported Sanofi 54 participants Est. completion 2009-07 1 site
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Completed NCT NCT00706225

    Study Evaluating Potential Drug Interaction Of Bazedoxifene & Premarin In Healthy Postmenopausal Women

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 30 participants Est. completion 2008-07 1 site
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00709189

    Bioequivalence Study of the Oral Contraceptive Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 53 participants Est. completion 2005-08
    Other conditions: Female Contraception, Contraception, Therapeutic Equivalency, Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT00709644

    Bioequivalence Study of the Oral Contraceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 54 participants Est. completion 2005-08
    Other conditions: Pharmacokinetics, Therapeutic Equivalency, Contraceptives, Oral
    View official trial listing →
  • Completed NCT NCT00709982

    A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM) /Ethinyl Estradiol (EE) in Healthy Women.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47 participants Est. completion 2005-07
    Other conditions: Drug Interactions, Healthy, Pharmacokinetics
    View official trial listing →
  • Terminated NCT NCT00722072

    Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy

    Not yet reported OHSU Knight Cancer Institute 12 participants Est. completion 2012-07 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00722761

    Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne

    Not yet reported Massachusetts General Hospital 30 participants Est. completion 2012-04 1 site
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Terminated NCT NCT00722800

    A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS

    Not yet reported Massachusetts General Hospital 4 participants Est. completion 2011-12 1 site
    Other conditions: Hidradenitis Suppurativa
    View official trial listing →
  • Completed NCT NCT00728949

    A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer

    Not yet reported Eli Lilly and Company 93 participants Est. completion 2015-02 9 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00729404

    Inhibition of Ovulation, Patch, Ethinylestradiol and Gestodene

    Not yet reported Bayer 17 participants Est. completion 2009-02 3 sites
    Other conditions: Contraception, Ovulation Inhibition
    View official trial listing →
  • Completed NCT NCT00740025

    Once Daily vs Twice Daily Administration of Gonadotropins in Assisted Reproductive Technologies (ART)

    Virginia Center for Reproductive Medicine 200 participants Est. completion 2010-01 1 site
    Other conditions: Pregnancy
    View official trial listing →
  • Completed NCT NCT00741858

    Duragen Versus Duraguard in Chiari Surgery

    Not yet reported University of Illinois Chicago 34 participants Est. completion 2010-04 1 site
    Other conditions: Chiari Malformation
    View official trial listing →
  • Terminated NCT NCT00744328

    Postpartum Depression: Transdermal Estradiol Versus Sertraline

    Not yet reported Northwestern University 85 participants Est. completion 2013-09 1 site Stand-alone
    Other conditions: Postpartum Depression
    View official trial listing →
  • Completed NCT NCT00745108

    Tibolone Endometrium Study (Study 32972)(P06470)

    Not yet reported Organon and Co 32 participants Est. completion 2005-07-21
    Other conditions: Postmenopausal Women
    View official trial listing →
  • Completed NCT NCT00745173

    Study Evaluating Premarin and Bazedoxifene Potential Interaction

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 30 participants Est. completion 2008-10 1 site
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00746096

    Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary Dysmenorrhea

    Not yet reported Nobelpharma 115 participants Est. completion 2009-09
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Completed NCT NCT00752635

    Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris

    Not yet reported Johnson & Johnson Taiwan Ltd 48 participants Est. completion 2005-09
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Terminated NCT NCT00752986

    ZACtima FASlodex Trial in Postmenopausal Advance Breast Cancer Patients Instead of ZACtima FASlodex Trial

    Not yet reported Genzyme, a Sanofi Company 39 participants Est. completion 2013-09 11 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00754065

    To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)

    Not yet reported Bayer 409 participants Est. completion 2011-05-10 59 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00755963

    Effects of Hormone Replacement Therapy on the Serotonergic System and Mood in Postmenopausal Women

    Not yet reported Medical University of Vienna 30 participants Est. completion 2011-07 1 site
    Other conditions: Hormone Replacement
    View official trial listing →
  • Completed NCT NCT00775086

    Bioequivalence Study of Patches With Different Equilibration Profiles

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 42 participants Est. completion 2004-08
    Other conditions: Female Contraception
    View official trial listing →
  • Completed NCT NCT00778609

    Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache

    Not yet reported Bayer 449 participants Est. completion 2010-12 63 sites
    Other conditions: Oral Contraceptive, Headache, Pelvic Pain
    View official trial listing →
  • Completed NCT NCT00796133

    A Phase 2, Dose-finding, Cross-over Study to Evaluate the Effect of a NES/E2 Transdermal Gel Delivery on Ovulation Suppression in Normal Ovulating Women

    Not yet reported Population Council 18 participants Est. completion 2014-01 3 sites
    Other conditions: Ovulation
    View official trial listing →
  • Completed NCT NCT00799708

    A Study of the Effect of Estrogen on Estrogen Receptor Biomarkers in Healthy Postmenopausal Women (0000-094)(COMPLETED)

    Not yet reported Merck Sharp & Dohme LLC 27 participants Est. completion 2008-10
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00803335

    The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse

    Not yet reported TriHealth Inc. 54 participants Est. completion 2011-05 1 site
    Other conditions: Pelvic Organ Prolapse, Vaginal Atrophy
    View official trial listing →
  • Withdrawn NCT NCT00804960

    Does Letrozole Improve the Outcomes and/or Reduce the Cost of IVF-ET Cycles?

    Not yet reported Center for Human Reproduction Est. completion 2010-04 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT00805415

    Ovulation Inhibition of Two 4-phasic Oral Contraceptive Regimens

    Not yet reported Bayer 209 participants Est. completion 2004-02 2 sites
    Other conditions: Ovulation Inhibition
    View official trial listing →
  • Completed NCT NCT00808132

    Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis

    Not yet reported Pfizer 1886 participants Est. completion 2011-02 178 sites
    Other conditions: Menopause, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00819312

    YAZ, Oral Contraceptive Registration in China

    Not yet reported Bayer 675 participants Est. completion 2011-01 17 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00821496

    Evaluate the Effect of VI-0521 on the Pharmacokinetics of Oral Contraceptive in Healthy Female Subjects

    Not yet reported VIVUS LLC 20 participants Est. completion 2009-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00825617

    Quantitative Liver Functions in Turner Syndrome With and Without Hormone Replacement Therapy

    Not yet reported University of Aarhus 16 participants Est. completion 2000-06 1 site
    Other conditions: Turner Syndrome
    View official trial listing →
  • Withdrawn NCT NCT00826839

    Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients

    Not yet reported Weill Medical College of Cornell University Est. completion 2012-01 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT00827632

    Obesity, Oral Contraception, and Ovarian Suppression

    Not yet reported Columbia University 226 participants Est. completion 2008-12 1 site
    Other conditions: Ovarian Suppression
    View official trial listing →
  • Completed NCT NCT00830492

    Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist

    Not yet reported Yazd Research & Clinical Center for Infertility 200 participants Est. completion 2008-12 1 site
    Other conditions: Ovarian Stimulation
    View official trial listing →
  • Completed NCT NCT00842751

    Oral T7 Oral Testosterone in Man

    Not yet reported University of Washington 11 participants Est. completion 2009-12 1 site
    Other conditions: Healthy Males, Male Contraceptive
    View official trial listing →
  • Completed NCT NCT00843570

    Natural Versus HRT Cycles in Frozen Embryo Replacement Treatment

    Not yet reported University of Oxford 159 participants Est. completion 2013-05 2 sites
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT00844012

    Continuous Postoperative Use of Low-Dose Combined Oral Contraceptivesfor for Endometriosis-Related Chronic Pelvic Pain

    Not yet reported University Magna Graecia 60 participants Est. completion 2010-07 1 site
    Other conditions: Endometriosis, Chronic Pelvic Pain
    View official trial listing →
  • Completed NCT NCT00848276

    Sex Hormones and Blood PCSK9 Levels

    Ottawa Hospital Research Institute 61 participants Est. completion 2010-09 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00860964

    A Study of Prevention and Treatment of Postmenopausal Osteoporosis in Chinese Women

    Not yet reported Peking Union Medical College 221 participants Est. completion 2006-12
    Other conditions: Osteoporosis
    View official trial listing →
  • Status unknown NCT NCT00866437

    Evaluation of Efficacy/Safety of EVE-PMS Skin Test Panel

    Not yet reported EVE Medical Systems Ltd. 40 participants Est. completion 2010-11 1 site
    Other conditions: Premenstrual Syndrome
    View official trial listing →
  • Terminated NCT NCT00870220

    Initiating Transdermal Estradiol Therapy in Turner's Syndrome

    Not yet reported University of Chicago 1 participants Est. completion 2011-03 3 sites
    Other conditions: Turner's Syndrome
    View official trial listing →
  • Completed NCT NCT00871858

    Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer

    Not yet reported Institut Bergonié 120 participants Est. completion 2018-07-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00877097

    Effects of Continuous Combined Hormone Replacement Therapy and Clodronate on Bone Mineral Density (BMD) in Osteoporotic Women

    Not yet reported Kuopio University Hospital 167 participants Est. completion 2009-02
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00896571

    Transdermal Contraceptive Patch - Endometrial Effects Study

    Not yet reported Bayer 92 participants Est. completion 2011-08 1 site
    Other conditions: Contraception
    View official trial listing →
  • Status unknown NCT NCT00896636

    Study of Breast Tissue in Women Not Previously Diagnosed With Breast Cancer Who Are Undergoing Fine Needle Aspiration

    Northwestern University 385 participants Est. completion 2022-01 1 site
    Other conditions: Breast Cancer, Healthy, no Evidence of Disease
    View official trial listing →
  • Suspended NCT NCT00901290

    Determine the Effects of C-administration of AZD7325 and an Oral Contraceptive in Healthy Female Subjects

    Not yet reported AstraZeneca 56 participants Est. completion 2009-09 1 site
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Terminated NCT NCT00903006

    Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 11 participants Est. completion 2013-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00905684

    Effects of Counseling on the Continuation Rates and Compliance for Newly Prescribed Oral Contraceptives (Yasmin® or Any Other Oral Contraceptives (OC)

    Bayer 5446 participants Est. completion 2011-12 13 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00908570

    Topical Estriol for Vaginal Health

    Not yet reported Gynuity Health Projects 104 participants Est. completion 2011-03 2 sites
    Other conditions: Vaginal Health
    View official trial listing →
  • Completed NCT NCT00914693

    EU/LA Pearl Index Study - Transdermal Contraceptive Patch

    Not yet reported Bayer 1694 participants Est. completion 2011-09 66 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00915174

    Study to Evaluate the Effects of Neramexane on the Pharmacokinetics of a Combined Drospirenone/Ethinyl Estradiol Oral Contraceptive in Healthy Female Subjects

    Not yet reported Merz Pharmaceuticals GmbH 36 participants Est. completion 2009-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00915915

    Inhibition of Ovulation and Pharmacokinetics of Transdermal Ethinylestradiol (EE) and Gestodene (GSD)

    Not yet reported Bayer 108 participants Est. completion 2010-04 2 sites
    Other conditions: Contraception, Ovulation Inhibition
    View official trial listing →
  • Completed NCT NCT00918476

    Investigation Of The Effect Of Steady State Filibuvir On The Pharmacokinetics Of Oral Contraceptives (Levonorgestrel And Ethinyl Estradiol)

    Not yet reported Pfizer 14 participants Est. completion 2011-02 1 site
    Other conditions: Hepatitis C
    View official trial listing →
  • Status unknown NCT NCT00919919

    Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen

    Not yet reported Rabin Medical Center 60 participants Est. completion 2010-11 1 site
    Other conditions: Endometrial Hyperplasia, Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT00920985

    US Cycle Control and Blood Pressure Study

    Not yet reported Bayer 346 participants Est. completion 2010-09 28 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00921115

    Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.

    Not yet reported University of Kansas Medical Center 42 participants Est. completion 2023-03-20 1 site
    Other conditions: Invasive Breast Cancer
    View official trial listing →
  • Completed NCT NCT00923572

    Yasmin Post Marketing Surveillance

    Bayer 777 participants Est. completion 2013-08 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00924560

    A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females

    Not yet reported Duramed Research 1361 participants Est. completion 2012-08 46 sites
    Other conditions: Bone Mineral Density
    View official trial listing →
  • Terminated NCT NCT00932152

    Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer

    Not yet reported University of Pittsburgh 3 participants Est. completion 2013-01 1 site
    Other conditions: Non-small Cell Lung Cancer, Postmenopausal Women
    View official trial listing →
  • Completed NCT NCT00932321

    Study of Safety and Efficacy of an Oral Contraceptive

    Not yet reported Warner Chilcott 938 participants Est. completion 2004-11 34 sites
    Other conditions: Prevention of Pregnancy
    View official trial listing →
  • Completed NCT NCT00941057

    Bioequivalence Study: 2 mg Estradiol Valerate (EV) and 3 mg Dienogest (DNG) Without and With Levomefolate Calcium

    Not yet reported Bayer 43 participants Est. completion 2010-01 1 site
    Other conditions: Pharmacology, Clinical
    View official trial listing →
  • Completed NCT NCT00944918

    Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI)

    Not yet reported AstraZeneca 25 participants Est. completion 2011-06 2 sites
    Other conditions: Progression-free Survival
    View official trial listing →
  • Completed NCT NCT00946192

    Fat Mediated Modulation of Reproductive and Endocrine Function in Young Athletes

    Not yet reported Massachusetts General Hospital 121 participants Est. completion 2021-04 1 site
    Other conditions: Exercise-related Amenorrhea
    View official trial listing →
  • Completed NCT NCT00983957

    Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects

    Not yet reported Bristol-Myers Squibb 47 participants Est. completion 2010-02 3 sites
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT00984399

    Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen

    Not yet reported Memorial Sloan Kettering Cancer Center 31 participants Est. completion 2024-05-13 5 sites
    Other conditions: Atrophic Vaginitis, Breast Cancer
    View official trial listing →
  • Completed NCT NCT00984789

    Birth Control Patch Study

    Not yet reported Bayer 393 participants Est. completion 2010-09 23 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00997893

    Research Investigation of Soy and Estrogen

    Not yet reported University of Illinois Chicago 96 participants Est. completion 2015-05 1 site
    Other conditions: Menopause, Hot Flashes
    View official trial listing →
  • Completed NCT NCT00998257

    Regulatory Post Marketing Surveillance Study on YAZ

    Bayer 770 participants Est. completion 2011-11 1 site
    Other conditions: Contraception, Premenstrual Syndrome, Acne
    View official trial listing →
  • Withdrawn NCT NCT01004419

    Trial of ZD6474 and Faslodex in Non-Small Cell Lung Cancer

    Not yet reported University of Wisconsin, Madison Est. completion 2011-05
    Other conditions: Carcinoma, Non Small Cell Lung
    View official trial listing →
  • Terminated NCT NCT01015677

    A Study of MK-6913 for the Treatment of Hot Flashes in Postmenopausal Women (6913-004)

    Not yet reported Merck Sharp & Dohme LLC 99 participants Est. completion 2010-07-30
    Other conditions: Moderate to Severe Vasomotor Symptoms in Postmenopausal, Women
    View official trial listing →
  • Completed NCT NCT01040845

    A Pharmacokinetic Study of Colchicine With an Oral Contraceptive

    Not yet reported Mutual Pharmaceutical Company, Inc. 30 participants Est. completion 2008-02 1 site
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT01056042

    Efficacy of Injectable Contraceptive and Oral Contraceptive Administered After Surgical Treatment of Endometriosis With Pain

    Not yet reported Prince of Songkla University 112 participants Est. completion 2011-10 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT01063023

    Drug Interaction Oral Contraceptive Pill (OCP)

    Not yet reported Bristol-Myers Squibb 20 participants Est. completion 2010-06 1 site
    Other conditions: Hepatitis C Virus
    View official trial listing →
  • Completed NCT NCT01064453

    Angeliq Regulatory Post Marketing Surveillance

    Bayer 4078 participants Est. completion 2012-12 1 site
    Other conditions: Postmenopausal Period, Osteoporosis, Postmenopausal
    View official trial listing →
  • Completed NCT NCT01065220

    Sex Steroids and the Serotonin Transporter

    Not yet reported Medical University of Vienna 32 participants Est. completion 2014-01 1 site
    Other conditions: Transsexualism
    View official trial listing →
  • Completed NCT NCT01076621

    Observational Study to Investigate the Occurrence of Bleeding in Postmenopausal Women Treated With Estradiol/NETA for 12 Months

    Novo Nordisk A/S 176 participants Est. completion 2013-06 2 sites
    Other conditions: Menopause, Postmenopausal Bleeding
    View official trial listing →
  • Terminated NCT NCT01079949

    A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age

    Not yet reported Merck KGaA, Darmstadt, Germany 93 participants Est. completion 2010-10 1 site
    Other conditions: Infertility, Ovulation Induction
    View official trial listing →
  • Terminated NCT NCT01083641

    Estrogen for Triple Negative Breast Cancer

    Not yet reported University of Wisconsin, Madison 17 participants Est. completion 2015-03 1 site
    Other conditions: Female Breast Cancer
    View official trial listing →
  • Completed NCT NCT01085877

    Comparison of Two Vaginal Tablets, Produced at Different Sites, in Postmenopausal Women With Atrophic Vaginitis

    Not yet reported Novo Nordisk A/S 70 participants Est. completion 2010-05 1 site
    Other conditions: Menopause, Postmenopausal Vaginal Atrophy
    View official trial listing →
  • Terminated NCT NCT01087593

    Estrogens Effect on Pain in Postmenopausal Women Suffering of Fibromyalgia

    Not yet reported Ostergotland County Council, Sweden 29 participants Est. completion 2007-10 1 site
    Other conditions: Fibromyalgia
    View official trial listing →
  • Completed NCT NCT01088477

    Imaging of ER Density to Guide and Improve Tailored Therapy for Acquired Anti-hormonal Resistant Breast Cancer

    University Medical Center Groningen 21 participants Est. completion 2014-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01103518

    Ethinyl Estradiol and Cyproterone Acetate in Irregular Menstruation

    Not yet reported Fundação Educacional Serra dos Órgãos 100 participants Est. completion 2011-01 1 site
    Other conditions: Amenorrhea, Dysmenorrhea, Menstruation Disturbances, Hyperandrogenism
    View official trial listing →
  • Completed NCT NCT01109979

    Effect of Estradiol+Drospirenone Versus Estradiol+MPA on Endothelial Function

    Not yet reported Brigham and Women's Hospital 24 participants Est. completion 2016-06 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01112358

    Lutropin Alfa in Women at Risk of Poor Response

    Not yet reported Merck KGaA, Darmstadt, Germany 58 participants Est. completion 2007-01-30 1 site
    Other conditions: Ovarian Stimulation
    View official trial listing →
  • Completed NCT NCT01120665

    Isolated and Associated Effects of Physical Exercise and Estrogen Therapy on Climactercs Women

    Not yet reported University of Sao Paulo General Hospital 62 participants Est. completion 2009-02
    Other conditions: Women's Health
    View official trial listing →
  • Completed NCT NCT01129102

    Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea

    Not yet reported Nobelpharma 215 participants Est. completion 2011-04
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Completed NCT NCT01137708

    CP-690,550 And Oral Contraception Drug-Drug Interaction Study

    Not yet reported Pfizer 20 participants Est. completion 2010-07 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01142401

    Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer

    Not yet reported National Cancer Institute (NCI) 118 participants Est. completion 2021-01-08 21 sites
    Other conditions: Metastatic Breast Carcinoma, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT01160718

    Fulvestrant With or Without AZD6244 in Treating Patients With Advanced Breast Cancer That Progressed After Aromatase Inhibitor Therapy

    Not yet reported Swiss Cancer Institute 46 participants Est. completion 2016-09 17 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01174524

    Improvement of Quality of Life in Patients Using Low-dose Pills in the Different Phases of Menacme

    Not yet reported Hospital Geral de Fortaleza 100 participants Est. completion 2008-11 1 site
    Other conditions: Quality of Life, Menopause, Contraception
    View official trial listing →
  • Status unknown NCT NCT01175759

    Role of Hypersensitivity to Female Sex Hormones in Women With Unexplained Recurrent Pregnancy Loss

    Not yet reported EVE Medical Systems Ltd. 40 participants Est. completion 2011-12 1 site
    Other conditions: Abortion, Recurrent
    View official trial listing →
  • Completed NCT NCT01182207

    Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Non-Fasting Conditions

    Not yet reported Teva Pharmaceuticals USA 33 participants Est. completion 2006-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01185678

    Data on Oral Contraceptives Compliance in Non Stop Regimen

    Bayer 8416 participants Est. completion 2010-11 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01185704

    Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)

    Not yet reported Merck KGaA, Darmstadt, Germany 136 participants Est. completion 2012-02 1 site
    Other conditions: Polycystic Ovarian Syndrome
    View official trial listing →
  • Completed NCT NCT01186796

    Role of Endogenous Estrogen in Growth-Hormone Regulation in Postmenopausal Women

    Not yet reported Mayo Clinic 30 participants Est. completion 2013-06 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT01195974

    A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.

    Not yet reported ViiV Healthcare 13 participants Est. completion 2011-02-09 1 site
    Other conditions: Infection, Human Immunodeficiency Virus, HIV Infections
    View official trial listing →
  • Completed NCT NCT01204840

    Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)

    Not yet reported Ottawa Fertility Centre 38 participants Est. completion 2015-05 1 site
    Other conditions: Infertility, Poor Ovarian Reserve
    View official trial listing →
  • Completed NCT NCT01208324

    Estrogen and Serotonin on Changing Brain Chemistry

    Not yet reported University of Colorado, Denver 47 participants Est. completion 2018-11 1 site
    Other conditions: Menopause
    View official trial listing →
  • Terminated NCT NCT01210144

    EXpression PRofile Endometrium Samples Study

    Not yet reported Merck KGaA, Darmstadt, Germany 27 participants Est. completion 2010-08 1 site
    Other conditions: In Vitro Fertilization
    View official trial listing →
  • Completed NCT NCT01218386

    Pretreatment With Estradiol Valerate

    Not yet reported Universitair Ziekenhuis Brussel 80 participants Est. completion 2012-01 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01219101

    The Effect of Ethinyl Estradiol on Polycystic Ovary Syndrome Women Undergoing Intrauterine Insemination

    Not yet reported Royan Institute 95 participants Est. completion 2013-02 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01219153

    Extended High Dose Letrozole Regimen Versus Short Low Dose Letrozole Regimen as an Adjuvant to GnRH Antagonist Protocol in the Management of Poor Responders Undergoing IVF-ET

    Not yet reported Cairo University 136 participants Est. completion 2010-12 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01219699

    A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene

    Not yet reported Novartis Pharmaceuticals 221 participants Est. completion 2020-04-16 11 sites
    Other conditions: Advanced Solid Tumors With an Alteration of the PIK3CA Gene, Estrogen Receptor Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT01232075

    Extended Letrozole Regimen Versus Clomiphene Citrate for Superovulation in Patients With Unexplained Infertility Undergoing Intrauterine Insemination

    Not yet reported Cairo University 214 participants Est. completion 2010-12 2 sites
    Other conditions: Infertility
    View official trial listing →
  • Terminated NCT NCT01233947

    Study of AFP464 +/- Faslodex in ER + Breast Cancer

    Not yet reported Tigris Pharmaceuticals 7 participants Est. completion 2012-08 1 site
    Other conditions: Breast Neoplasm
    View official trial listing →
  • Completed NCT NCT01236768

    Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm

    Not yet reported Agile Therapeutics 407 participants Est. completion 2011-06 21 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01246791

    Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female Volunteers

    Not yet reported Nobelpharma 12 participants Est. completion 2011-05
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01252186

    A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women

    Not yet reported Teva Women's Health 265 participants Est. completion 2011-12 24 sites
    Other conditions: Hemostasis, Oral Contraceptive
    View official trial listing →
  • Completed NCT NCT01253187

    Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: YAZ and YAZ + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) and YAZ + Levomefolate Calcium (Metafolin)

    Not yet reported Bayer 44 participants Est. completion 2007-09 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01253824

    Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female Volunteers

    Not yet reported Nobelpharma 14 participants Est. completion 2011-07
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01257984

    Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function

    Not yet reported Bayer 508 participants Est. completion 2012-09 43 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01258660

    Assessment of the Pharmacodynamic Effect on Plasma Folate and Red Blood Cell Folate and Comparison of the Folate Metabolites During the 24 Weeks of Treatment (Yasmin + Metafolin Versus Yasmin + Folic Acid) Followed by a 20 Week Elimination Phase of Folate

    Not yet reported Bayer 172 participants Est. completion 2008-01 1 site
    Other conditions: Contraception
    View official trial listing →
  • Status unknown NCT NCT01266213

    Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women

    Not yet reported Samsung Medical Center 147 participants Est. completion 2019-12 1 site
    Other conditions: Metastatic Breast Cancer, Estrogen Receptor Positive Tumor, Breast Cancer Nos Premenopausal
    View official trial listing →
  • Completed NCT NCT01277211

    A Study to Evaluate the Effectiveness of NuvaRing® to Prevent Pregnancies in Chinese Women (P06450)

    Not yet reported Organon and Co 983 participants Est. completion 2013-09-18
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01284244

    A Randomized Controlled Trial of the Uresta Continence Pessary

    Not yet reported Mount Sinai Hospital, Canada 36 participants Est. completion 2014-05 1 site
    Other conditions: Stress Urinary Incontinence
    View official trial listing →
  • Completed NCT NCT01291004

    A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives

    Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 206 participants Est. completion 2012-03-31 2 sites
    Other conditions: Follicle Development, Ovarian Follicle, Follicle Count, Follicle Size, Oral Contraceptive
    View official trial listing →
  • Completed NCT NCT01292785

    Effects of Sex Steroid Hormones on Human Brain Function, Structure and Connectivity

    Medical University of Vienna 80 participants Est. completion 2015-04 1 site
    Other conditions: Gender Identity Disorder
    View official trial listing →
  • Completed NCT NCT01293747

    Pharmacokinetics of Injectable Estradiol and Progesterone Microspheres Suspension

    Not yet reported Productos Científicos S. A. de C. V. 30 participants Est. completion 2011-10 1 site
    Other conditions: Menopause
    View official trial listing →
  • Terminated NCT NCT01296555

    A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer

    Not yet reported Genentech, Inc. 674 participants Est. completion 2021-06-25 31 sites
    Other conditions: Solid Cancers, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT01297348

    Study Of Lybrel In Relation To Venous Thromboembolism

    Pfizer 598682 participants Est. completion 2012-04
    Other conditions: Venous Thrombosis, Pulmonary Embolism, Sinus Thrombosis, Intracranial
    View official trial listing →
  • Completed NCT NCT01300351

    Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Advanced Breast Cancer Women

    Not yet reported AstraZeneca 249 participants Est. completion 2014-03 15 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01300676

    The Effects of Tualang Honey on Postmenopausal Women

    Not yet reported, Not yet reported Universiti Sains Malaysia 79 participants Est. completion 2010-06 1 site
    Other conditions: Postmenopausal Syndrome
    View official trial listing →
  • Completed NCT NCT01310647

    Antral Follicle Priming Prior to ICSI (Intracytoplasmic Sperm Injection) in Previously Diagnosed Low Responders

    Not yet reported Instituto de Investigacion Sanitaria La Fe 66 participants Est. completion 2014-02 1 site Stand-alone
    Other conditions: Ovarian Diseases
    View official trial listing →
  • Completed NCT NCT01319968

    Postpartum Dyspareunia Resulting From Vaginal Atrophy

    Meir Medical Center 117 participants Est. completion 2013-09 2 sites
    Other conditions: Vulvovaginal Atrophy, Dyspareunia Among Puerperal Women
    View official trial listing →
  • Completed NCT NCT01339442

    BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer

    Not yet reported Washington University School of Medicine 31 participants Est. completion 2016-12-28 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT01344031

    MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer

    Not yet reported National Cancer Institute (NCI) 31 participants 1 site
    Other conditions: Estrogen Receptor Positive, Invasive Breast Carcinoma, Recurrent Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT01344369

    Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions

    Not yet reported Teva Pharmaceuticals USA 36 participants Est. completion 2008-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01345786

    Bioequivalence of Nomegestrol Acetate (NOMAC) and Estradiol (E2) in Commercial Versus Phase 3 Pivotal Clinical Batches of NOMAC-E2 Tablets (P06328)

    Not yet reported Organon and Co 158 participants Est. completion 2010-06
    Other conditions: Healthy Postmenopausal Females
    View official trial listing →
  • Completed NCT NCT01360996

    Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism

    Not yet reported Woman's 64 participants Est. completion 2015-02 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT01361958

    Minimal Effective Dose of Nomegestrol Acetate Inhibiting the Ovulation in Women Receiving Estradiol

    Not yet reported Theramex 38 participants Est. completion 1998-09
    Other conditions: Suppression of Ovulation
    View official trial listing →
  • Completed NCT NCT01367912

    Timing of Estrogen Support During the Luteal Phase of in Vitro Fertilization (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycle

    Not yet reported Zekai Tahir Burak Women's Health Research and Education Hospital 301 participants Est. completion 2008-11 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01370551

    Clinical Study of Vaginal Lactobacilli and Estriol (Gynoflor®) for Atrophic Vaginitis in Breast Cancer Patients

    Not yet reported Medinova AG 16 participants Est. completion 2012-07 2 sites
    Other conditions: Atrophic Vaginitis
    View official trial listing →
  • Completed NCT NCT01370798

    Local Oestrogen Versus Placebo as Preoperative Treatment in Patients With Severe Hypospadias: Effects on Post-operative Complications

    Not yet reported Hospices Civils de Lyon 244 participants Est. completion 2017-09-18 4 sites
    Other conditions: Hypospadias
    View official trial listing →
  • Completed NCT NCT01372293

    71A/G HSD17B5 SNP and Effects of Oral Contraceptive Pill in PCOS Women

    Not yet reported Federal University of Rio Grande do Sul 49 participants Est. completion 2010-12
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT01373931

    A Study of LY2216684 in Healthy Females

    Not yet reported Eli Lilly and Company 20 participants Est. completion 2011-12 1 site
    Other conditions: Depressive Disorder, Major
    View official trial listing →
  • Status unknown NCT NCT01384331

    New Treatments for Troublesome Bleeding in Implanon Users

    Not yet reported Family Planning Association New South Wales 200 participants Est. completion 2013-04 1 site
    Other conditions: Menstrual Problem
    View official trial listing →
  • Completed NCT NCT01385280

    Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer

    Not yet reported University of Arizona 13 participants Est. completion 2013-10 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT01385332

    A Comparative Study of Two Patterns of Controlled Ovarian Hyperstimulation in Mid Follicular Phase or Early Luteal Phase for Egg Donors

    Not yet reported Parc de Salut Mar 10 participants Est. completion 2012-09 1 site
    Other conditions: Stimulation in the Ovary
    View official trial listing →
  • Completed NCT NCT01385618

    Gene-polymorphisms Relating to Human Subfertility

    Infertility Treatment Center Dortmund 150 participants Est. completion 2015-03 1 site
    Other conditions: Estradiol Receptor Polymorphism, Progesterone Receptor Polymorphism, IVF, Subfertility
    View official trial listing →
  • Completed NCT NCT01394016

    A Phase 1 Study of LY2835219 In Participants With Advanced Cancer

    Not yet reported Eli Lilly and Company 225 participants Est. completion 2022-04-12 3 sites
    Other conditions: Advanced Cancer
    View official trial listing →
  • Completed NCT NCT01418924

    Sex Hormones & Serum Sclerostin Level

    Bagcilar Training and Research Hospital 45 participants Est. completion 2011-10 1 site
    Other conditions: Bony Sclerosis, Testicular; Hormone, C
    View official trial listing →
  • Terminated NCT NCT01428245

    Assessment of Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition

    Not yet reported University of Virginia 3 participants Est. completion 2013-05-14 1 site
    Other conditions: Hyperandrogenemia, Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT01441947

    Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer

    Not yet reported Massachusetts General Hospital 68 participants Est. completion 2019-08-09 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01455597

    Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)

    Not yet reported Warner Chilcott 309 participants Est. completion 2012-12-03 64 sites
    Other conditions: Vulvovaginal Atrophy
    View official trial listing →
  • Status unknown NCT NCT01459445

    Metformin+ Drospirenone/ethinylestradiol30µg and Flow-mediated Dilation in Polycystic Ovary Syndrome

    Not yet reported Iuliu Hatieganu University of Medicine and Pharmacy 26 participants Est. completion 2012-01 1 site
    Other conditions: Polycystic Ovary Syndrome, Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT01465022

    Breastfeeding and Oral Contraceptives: a Randomized, Controlled Trial

    Not yet reported University of New Mexico 197 participants Est. completion 2008-06
    Other conditions: Breast Feeding, Contraception
    View official trial listing →
  • Completed NCT NCT01466673

    An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne Treatment

    Not yet reported Janssen-Cilag Ltd.,Thailand 201 participants Est. completion 2010-03 3 sites
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Completed NCT NCT01475513

    Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women

    Not yet reported Virginia Commonwealth University 47 participants Est. completion 2014-05-28 1 site
    Other conditions: Insulin Sensitivity, Cardiovascular Risk, Perimenopausal Disorder
    View official trial listing →
  • Completed NCT NCT01477632

    Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2005-06 1 site
    Other conditions: Menopause, Healthy
    View official trial listing →
  • Completed NCT NCT01480778

    Evaluation of Ciclo 21® Effect (Levonorgestrel + Ethinyl Estradiol) Compared to Nordette®.

    Not yet reported Azidus Brasil 62 participants Est. completion 2015-06 1 site
    Other conditions: Irregular Periods
    View official trial listing →
  • Completed NCT NCT01482338

    Premenstrual Symptoms Treatment Comparing Between Oral Contraceptives Containing Desogestrel and Drospirenone

    Not yet reported Chulalongkorn University 90 participants Est. completion 2012-03 1 site
    Other conditions: Premenstrual Syndrome
    View official trial listing →
  • Completed NCT NCT01482416

    Vascular Effect of Estrogens Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery

    Not yet reported Federal University of Minas Gerais 60 participants Est. completion 2014-08 1 site
    Other conditions: Unspecified Injury of Brachial Artery, Left Side, Initial Encounter
    View official trial listing →
  • Completed NCT NCT01485419

    Characterization of the Early Sex Hormone Milieu Post Injury and Relationship With Resuscitation Requirements and Coagulopathy

    University of Pittsburgh 292 participants Est. completion 2012-12 1 site
    Other conditions: Traumatic Injury
    View official trial listing →
  • Completed NCT NCT01486979

    Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis

    Not yet reported Novo Nordisk A/S 58 participants Est. completion 2007-05 1 site
    Other conditions: Menopause, Postmenopausal Vaginal Atrophy
    View official trial listing →
  • Completed NCT NCT01489852

    Estrogen Pretreatment Prior to GnRH Antagonist Protocol

    Not yet reported Gemer 472 participants Est. completion 2011-05 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01490190

    Study of the Use of a Contraceptive Vaginal Ring (NuvaRing) in Normal Daily Practice in Indian Women (P07733)

    Not yet reported Organon and Co 252 participants Est. completion 2012-12-05
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01498861

    Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol

    Not yet reported ViiV Healthcare 16 participants Est. completion 2012-03 1 site
    Other conditions: Infection, Human Immunodeficiency Virus
    View official trial listing →
  • Terminated NCT NCT01500473

    Therapeutic Effect of Desogestrel on Ventilatory Control in Patients With Congenital Central Hypoventilation Syndrome

    Not yet reported Children's Hospital Los Angeles 1 participants Est. completion 2016-05-11 1 site
    Other conditions: Congenital Central Hypoventilation Syndrome
    View official trial listing →
  • Completed NCT NCT01508858

    Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women

    Not yet reported Novo Nordisk A/S 21 participants Est. completion 2007-04 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01509625

    Retrospective Study Assessment Treatment Response Faslodex®( 500 mg)

    Isabel Blancas 272 participants Est. completion 2014-03 7 sites
    Other conditions: Malignant Neoplasm of Breast Stage IV
    View official trial listing →
  • Completed NCT NCT01511822

    Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance

    Not yet reported AGUNCO Obstetrics and Gynecology Centre 1 site
    Other conditions: PCOS, Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT01519401

    Effect of Two Different Dosages of Ethinyl-estradiol in Association With Drospirenone in Women With Polycystic Ovary Syndrome.

    Not yet reported Catholic University of the Sacred Heart 50 participants Est. completion 2011-07 1 site
    Other conditions: Polycystic Ovary Syndrome, Estro-progestin Drugs
    View official trial listing →
  • Completed NCT NCT01535820

    The Effect of an Adhesive Overlay on the Delivery of Contraceptive Hormones From ORTHO EVRA® in Healthy Women

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 54 participants Est. completion 2011-07 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01553773

    Postmenopausal Facial Skin After Estradiol and Genistein Topical Treatment

    Not yet reported Federal University of São Paulo 30 participants Est. completion 2005-03 1 site
    Other conditions: Atrophy
    View official trial listing →
  • Completed NCT NCT01556191

    Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR

    Not yet reported Intergroupe Francophone de Cancerologie Thoracique 379 participants Est. completion 2020-06-17 61 sites
    Other conditions: Stage IV Lung Cancer
    View official trial listing →
  • Completed NCT NCT01560416

    Fulvestrant With or Without Ganetespib in HR+ Breast Cancer

    Not yet reported Dana-Farber Cancer Institute 50 participants Est. completion 2016-06-26 5 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01569113

    Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo.

    Not yet reported HRA Pharma 76 participants Est. completion 2012-08 3 sites
    Other conditions: Emergency Contraception
    View official trial listing →
  • Withdrawn NCT NCT01577199

    RCT of Low-dose Clomiphene vs. High Dose Gonadotropin Protocol for IVF Poor Responders

    Not yet reported Weill Medical College of Cornell University Est. completion 2012-12
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01581814

    Effects of Drospirenone-ethinylestradiol and/or Metformin on Cardiovascular Risk in Hyperinsulinemic Women With Polycystic Ovary Syndrome

    Not yet reported Catholic University of the Sacred Heart 99 participants Est. completion 2012-03 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT01586000

    A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycle Control, Ovulation Inhibition, and Pharmacokinetics in Normal Cycling Women

    Not yet reported Kimberly Myer 197 participants Est. completion 2015-05 8 sites
    Other conditions: Suppression of Ovulation
    View official trial listing →
  • Status unknown NCT NCT01588873

    Contraceptive Pill and Hormonal Vaginal Ring in Women With Polycystic Ovary Syndrome

    Not yet reported University of Oulu 42 participants Est. completion 2019-12 1 site
    Other conditions: Adverse Effect of Oral Contraceptives, Sequela
    View official trial listing →
  • Status unknown NCT NCT01590849

    Assessment of Autonomic Tone in Normotensive Women Using Combined Hormonal Oral Contraceptive Containing Drospirenone

    Not yet reported Instituto do Coracao 69 participants 1 site
    Other conditions: Contraceptive Affecting the Autonomic Nervous System, Contraceptive Affecting Blood Pressure
    View official trial listing →
  • Completed NCT NCT01597193

    Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

    Not yet reported Pfizer 101 participants Est. completion 2018-01-22 17 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01600274

    Bioavailability Study With Oral Single Dose Administration of Ethinylestradiol and Dienogest

    Not yet reported Pharbil Waltrop GmbH 20 participants Est. completion 2010-02 1 site
    Other conditions: Focus: Bioequivalence
    View official trial listing →
  • Status unknown NCT NCT01603745

    Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary Syndrome

    Not yet reported Catholic University of the Sacred Heart 10 participants Est. completion 2012-10 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT01605071

    Timing Estrogen After MenoPaUSe

    Not yet reported University of Colorado, Denver 53 participants Est. completion 2017-01 1 site
    Other conditions: Insulin Resistance
    View official trial listing →
  • Status unknown NCT NCT01608698

    Comparison of Body Weight Change During Contraception With Belara and Yasmin

    Not yet reported Mahidol University 100 participants Est. completion 2016-02 1 site
    Other conditions: Body Weight Changes
    View official trial listing →
  • Completed NCT NCT01615354

    A Study of Aleglitazar in Combination With Oral Contraceptive Healthy Volunteers

    Not yet reported Hoffmann-La Roche 18 participants Est. completion 2013-01 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Terminated NCT NCT01633060

    A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi

    Not yet reported Novartis Pharmaceuticals 432 participants Est. completion 2017-09-21 197 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01633814

    Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women

    Not yet reported University of Missouri-Columbia 4 participants Est. completion 2015-08 1 site Stand-alone
    Other conditions: Menopause, Aging, Blood Pressure
    View official trial listing →
  • Terminated NCT NCT01634789

    A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women

    Not yet reported Pfizer 2 participants Est. completion 2012-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01638910

    Efficacy and Safety of a Combined Oral Contraceptive of Estradiol Valerate and Dienogest in Healthy Female Subjects

    Not yet reported Bayer 955 participants Est. completion 2014-11 39 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01650168

    Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg)

    Center for Epidemiology and Health Research, Germany 101498 participants Est. completion 2020-12 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01653743

    Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women

    Not yet reported Merck KGaA, Darmstadt, Germany 81 participants Est. completion 2014-12 6 sites
    Other conditions: Anovulation, Oligo-ovulation, Hypothalamic-pituitary Dysfunction, Polycystic Ovarian Syndrome
    View official trial listing →
  • Completed NCT NCT01655225

    A Study of LY3023414 in Participants With Advanced Cancer

    Not yet reported Eli Lilly and Company 156 participants Est. completion 2022-02-02 8 sites
    Other conditions: Advanced Cancer, Metastatic Cancer, Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, Malignant Mesothelioma, Non-small Cell Lung Cancer
    View official trial listing →
  • Status unknown NCT NCT01659008

    Estradiol vs Lysteda in Treatment of Heavy Menstrual Bleeding

    Not yet reported Kay I Waud MD PhD 100 participants Est. completion 2016-03 2 sites
    Other conditions: Menstrual Cycle and Uterine Bleeding Disorders
    View official trial listing →
  • Status unknown NCT NCT01668056

    Synchronization of Ovarian Stimulation for in Vitro Fertilization With Follicular Wave Emergence

    Not yet reported University of Sao Paulo General Hospital 30 participants Est. completion 2014-12 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01669291

    Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation

    Not yet reported Main Line Fertility Center 43 participants Est. completion 2014-05 1 site
    Other conditions: Fertility
    View official trial listing →
  • Completed NCT NCT01670656

    A Study to Evaluate the Effect of Contraceptive Vaginal Rings on Primary Dysmenorrhea (P08257/MK-8175A/MK-8342B-057)

    Not yet reported Organon and Co 439 participants Est. completion 2013-09-12
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Completed NCT NCT01670877

    Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer

    Not yet reported Washington University School of Medicine 56 participants Est. completion 2021-03-11 17 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT01698164

    Multi-centre Clinical Trial on Hormone Replacement Treatment in China

    Not yet reported Peking Union Medical College Hospital 1200 participants 1 site
    Cardiovascular disease Other conditions: Menopausal Syndrome, Osteoporosis, Breast Cancer
    View official trial listing →
  • Completed NCT NCT01705249

    Bleeding Profile With Continuous Hormone Replacement Therapy of Activelle® in Postmenopausal Women

    Not yet reported Novo Nordisk A/S 191 participants Est. completion 2003-06-06 19 sites
    Other conditions: Menopause, Healthy
    View official trial listing →
  • Completed NCT NCT01710696

    Induction of Puberty With 17-beta Estradiol in Girls With Turner Syndrome

    Not yet reported Novo Nordisk A/S 50 participants Est. completion 2004-07-26 28 sites
    Other conditions: Genetic Disorder, Turner Syndrome
    View official trial listing →
  • Completed NCT NCT01746732

    A Study of Evacetrapib in Healthy Female Participants

    Not yet reported Eli Lilly and Company 23 participants Est. completion 2013-05 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT01768247

    HCG (Human Chorionic Gonadotropin) Priming for Thin Endometrium in IVF (in Vitro Fertilization)

    Not yet reported Universitair Ziekenhuis Brussel 15 participants Est. completion 2014-01 1 site
    Other conditions: Endometrial Thickness, Pregnancy Outcome
    View official trial listing →
  • Status unknown NCT NCT01780558

    A Study:the Different Outcomes Between Natural Cycle and Hormone Replacement Cycle in FET

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 600 participants Est. completion 2015-01 1 site
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT01780610

    The Effects of Two Endometrium Preparation Protocols in Frozen-thawed Embryo Transfer in Women With Irregular Cycles

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 670 participants Est. completion 2015-01 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01790282

    Is Adding E2 to P4 Luteal Support In High Responder Long Gn-RH Agonist ICSI Cycles Detrimental to Outcome? RCT

    Not yet reported Mansoura Integrated Fertility Center 220 participants Est. completion 2015-03 1 site
    Other conditions: IVF, Infertility
    View official trial listing →
  • Completed NCT NCT01797120

    Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI

    Not yet reported PrECOG, LLC. 131 participants Est. completion 2017-09-12 25 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01798836

    Oestradiol Pre-treatment in an Ultrashort Flare GnRH Agonist/GnRH Antagonist Protocol in Poor Responders Undergoing IVF

    Not yet reported, Not yet reported National and Kapodistrian University of Athens 17 participants Est. completion 2015-02 1 site
    Other conditions: Infertility
    View official trial listing →
  • Withdrawn NCT NCT01805817

    Comparison of Levonorgestrel Intrauterine System, Copper T Intrauterine Device and Oral Contraceptives on Life Quality

    Not yet reported Istanbul Training and Research Hospital 1 site
    Other conditions: Contraceptive Methods Comparison
    View official trial listing →
  • Completed NCT NCT01813162

    In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products

    Not yet reported CONRAD 101 participants Est. completion 2014-12 2 sites
    Other conditions: HIV Prevention
    View official trial listing →
  • Completed NCT NCT01817400

    Mediators of Abnormal Reproductive Function in Obesity (MARO)

    Not yet reported University of Colorado, Denver 10 participants Est. completion 2014-12 1 site
    Other conditions: Infertility, Female, Obesity
    View official trial listing →
  • Completed NCT NCT01817530

    Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)

    Not yet reported AbbVie 571 participants Est. completion 2015-12
    Other conditions: Heavy Uterine Bleeding, Uterine Fibroids
    View official trial listing →
  • Completed NCT NCT01822288

    The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder

    Not yet reported Far Eastern Memorial Hospital 125 participants Est. completion 2021-08-26 1 site
    Other conditions: Menopausal Syndromes
    View official trial listing →
  • Completed NCT NCT01845649

    Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia

    Not yet reported Warner Chilcott 550 participants Est. completion 2013-11-20 57 sites
    Other conditions: Vulvovaginal Atrophy
    View official trial listing →
  • Status unknown NCT NCT01850095

    The Influence of Peripheral Androgen Conversion at Women Adult Acne

    Not yet reported Marco Alexandre Dias da Rocha 60 participants Est. completion 2015-01 1 site
    Other conditions: Acne, Quality of Life
    View official trial listing →
  • Terminated NCT NCT01886794

    Hormonal Status on Blood Flow and Tissue in Pelvic Organ Prolapse

    Not yet reported The University of Texas Medical Branch, Galveston 7 participants Est. completion 2023-12-11 1 site
    Other conditions: Pelvic Floor Disorders
    View official trial listing →
  • Withdrawn NCT NCT01895881

    Estrogen Therapy as Prevention in the Progression of Aneurysm (EPPA) Trial

    Not yet reported Rush University Medical Center Est. completion 2018-12 1 site
    Other conditions: Cerebral Aneurysm, Menopause, Treatment
    View official trial listing →
  • Completed NCT NCT01896726

    A Study of Baricitinib and Birth Control Pills in Healthy Females

    Not yet reported Eli Lilly and Company 20 participants Est. completion 2013-10 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01902264

    Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception

    Not yet reported Bayer 34 participants Est. completion 2015-02 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT01903031

    Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART

    Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 84 participants Est. completion 2016-10-10 21 sites
    Other conditions: HIV-1 Infection
    View official trial listing →
  • Completed NCT NCT01909141

    Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS

    Not yet reported Cairo University 100 participants Est. completion 2014-04 1 site
    Other conditions: Polycystic Ovary Syndrome, Infertility
    View official trial listing →
  • Completed NCT NCT01921374

    Mother-caregivers of Children With Duchenne Muscular Dystrophy

    Not yet reported Monica Levy Andersen 60 participants Est. completion 2014-07 1 site
    Other conditions: Other Diseases or Conditions
    View official trial listing →
  • Status unknown NCT NCT01926210

    Comparison of Ovarian Mild Stimulation and Controlled Ovarian Stimulation in Poor Ovarian Responders

    Not yet reported Huang Rui 500 participants Est. completion 2016-09 1 site
    Other conditions: Infertility
    View official trial listing →
  • Terminated NCT NCT01928082

    The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass

    Not yet reported University of Chicago 1 participants Est. completion 2014-08-01 1 site Stand-alone
    Other conditions: Hypercalciuria, Hypercalciuria, Familial Idiopathic, Osteopenia, Osteoporosis
    View official trial listing →
  • Completed NCT NCT01933204

    Acupuncture for Relieving Perimenopausal Symptoms

    Not yet reported, Not yet reported Chengdu University of Traditional Chinese Medicine 220 participants Est. completion 2015-08 2 sites
    Other conditions: Perimenopause
    View official trial listing →
  • Completed NCT NCT01942135

    Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)

    Not yet reported Pfizer 521 participants Est. completion 2022-09-28 247 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01953211

    Oral Contraceptive Hormone-free Interval Pituitary/ Ovarian Activity

    University of Southern California 64 participants 1 site
    Other conditions: Hypothalamic-pituitary-ovarian Axis, Gonadotropins, Ethinyl Estradiol, Contraceptive Efficacy
    View official trial listing →
  • Withdrawn NCT NCT01953809

    A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women

    Not yet reported GlaxoSmithKline Est. completion 2015-03
    Other conditions: Infections, Bacterial
    View official trial listing →
  • Completed NCT NCT01958073

    Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women

    Not yet reported University of California, San Diego 35 participants Est. completion 2017-12 2 sites
    Other conditions: Recurrent Urinary Tract Infection
    View official trial listing →
  • Terminated NCT NCT01963403

    Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive

    Not yet reported University of California, Davis 26 participants Est. completion 2015-09 2 sites
    Other conditions: Abnormal Uterine Bleeding, Unspecified, Uterine Bleeding Heavy
    View official trial listing →
  • Completed NCT NCT01973816

    MEdical Versus SUrgical Treatments of Rectal Endometriosis

    Not yet reported University Hospital, Rouen 78 participants Est. completion 2022-10-11 11 sites
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT01980680

    The Exogenous Progesterone Free Luteal Phase After GnRHa Trigger - a Pilot Study in Normo-responder IVF Patients

    Not yet reported Peter Humaidan 50 participants Est. completion 2020-05 1 site
    Other conditions: Infertility
    View official trial listing →
  • Active, not recruiting NCT NCT01984138

    REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy

    Not yet reported Polly A. Niravath, MD 33 participants Est. completion 2026-06 1 site
    Other conditions: Estrogen Receptor Positive Breast Cancer, Breast Cancer
    View official trial listing →
  • Completed NCT NCT01984320

    Cabergoline and Coasting to Prevent OHSS

    Not yet reported Cairo University 300 participants Est. completion 2015-07 1 site
    Other conditions: OHSS
    View official trial listing →
  • Withdrawn NCT NCT01986764

    E2 and LDX for the Treatment of Cognitive Complaints After Oophorectomy

    Not yet reported University of Pennsylvania Est. completion 2013-07-01 1 site
    Other conditions: Planned RRSO
    View official trial listing →
  • Completed NCT NCT01989780

    Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer

    Not yet reported Japan Breast Cancer Research Group 160 participants Est. completion 2019-06 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02000193

    Maintenance Hormone Therapy for Postmenopausal HR Positive Advanced Breast Cancer

    Not yet reported Sun Yat-sen University 58 participants Est. completion 2018-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02021097

    Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception

    Not yet reported Regenex Pharmaceutical, China 1008 participants Est. completion 2016-02 21 sites
    Other conditions: Oral Contraceptive
    View official trial listing →
  • Completed NCT NCT02026973

    Impact of Endogenous E2 on SSI and GH Rebound

    Not yet reported Mayo Clinic 62 participants Est. completion 2015-11 1 site
    Other conditions: Normal Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02028507

    Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors

    Not yet reported Spanish Breast Cancer Research Group 693 participants Est. completion 2021-01-11 37 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02036879

    Gender Disparity and Hormones in Cystic Fibrosis

    Not yet reported University of Texas Southwestern Medical Center 55 participants Est. completion 2018-08 2 sites
    Other conditions: Cystic Fibrosis (CF)
    View official trial listing →
  • Completed NCT NCT02038335

    HIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHIC

    University of Pittsburgh 451 participants Est. completion 2020-12 1 site
    Obstructive sleep apnea Other conditions: Contraception, HIV, Microbiota
    View official trial listing →
  • Completed NCT NCT02042196

    Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women

    Not yet reported University of Colorado, Denver 100 participants Est. completion 2016-05-02 1 site Stand-alone
    Other conditions: Menopause, Aging
    View official trial listing →
  • Completed NCT NCT02049957

    Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer

    Not yet reported Calithera Biosciences, Inc 118 participants Est. completion 2018-06-29 40 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02057133

    A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread

    Not yet reported Eli Lilly and Company 198 participants Est. completion 2026-12 13 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT02072512

    The Study of Goserelin Plus Fulvestrant Comparing With Goserelin Plus Anastrozole for Advanced Breast Cancer

    Not yet reported Hospital Affiliated to Military Medical Science, Beijing 180 participants Est. completion 2016-12 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02086032

    The Effect of Different Types of Progestin on Sleeping of Menopausal Women

    Not yet reported Chiang Mai University 100 participants Est. completion 2015-07 1 site
    Other conditions: Menopausal and Postmenopausal Disorders
    View official trial listing →
  • Status unknown NCT NCT02086318

    A New Algorithm to Predict Ovarian Age

    University Magna Graecia 720 participants Est. completion 2018-06 1 site
    Other conditions: Infertility, Polycystic Ovary Syndrome, Premature Ovarian Failure (POF), Ovarian Cysts, Endometriosis
    View official trial listing →
  • Completed NCT NCT02088684

    Study of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast Cancer

    Not yet reported Novartis Pharmaceuticals 70 participants Est. completion 2018-04-17 11 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02089620

    Comparison Between Oral Contraceptive Pills and Calcium Supplements in Treatment of Premenstrual Syndrome

    Not yet reported Beni-Suef University 210 participants Est. completion 2015-06 1 site
    Other conditions: Premenstrual Syndrome
    View official trial listing →
  • Completed NCT NCT02103569

    Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325

    Not yet reported Bristol-Myers Squibb 20 participants Est. completion 2014-07
    Other conditions: Hepatitis C
    View official trial listing →
  • Status unknown NCT NCT02114645

    The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes

    Not yet reported Zekai Tahir Burak Women's Health Research and Education Hospital 100 participants Est. completion 2015-04 1 site
    Other conditions: Infertility
    View official trial listing →
  • Withdrawn NCT NCT02115594

    Phase 2 Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With ER+ Advanced Breast Cancer

    Not yet reported Syndax Pharmaceuticals Est. completion 2016-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02116803

    An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective

    Not yet reported, Not yet reported Novartis Pharmaceuticals 12 participants Est. completion 2016-11-28 9 sites
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT02122198

    Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women

    Not yet reported University of Colorado, Denver 17 participants Est. completion 2017-09-15 2 sites
    Cardiovascular disease Other conditions: Cognitive Impairment, Executive Dysfunction, Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT02127593

    A Bioequivalence Study of Norgestimate /Ethinyl Estradiol (NGM/EE) Tablets Manufactured at 2 Different Facilities

    Not yet reported Janssen Research & Development, LLC 101 participants Est. completion 2014-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02137083

    A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer

    Not yet reported Fudan University 22 participants Est. completion 2017-07 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT02140437

    Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC

    Not yet reported Fudan University Est. completion 2016-06
    Other conditions: Carcinoma Breast Stage IV
    View official trial listing →
  • Terminated NCT NCT02144246

    Contraceptive Hormones and Women With Cystic Fibrosis

    Not yet reported University of Pennsylvania 5 participants 1 site
    Other conditions: Cystic Fibrosis Exacerbations While on and Off Hormonal Contraception
    View official trial listing →
  • Completed NCT NCT02148393

    Implantation Enhancement by Elective Cryopreservation of All Viable Embryos

    Not yet reported Universitair Ziekenhuis Brussel 212 participants Est. completion 2017-02-28 1 site
    Other conditions: Infertility, OHSS
    View official trial listing →
  • Completed NCT NCT02157467

    Study of Combined Oral Contraceptive Effects in Female Subjects

    Not yet reported ViiV Healthcare 46 participants Est. completion 2014-08-25
    Other conditions: Infection, Human Immunodeficiency Virus
    View official trial listing →
  • Completed NCT NCT02159131

    Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol When Co-administered With GSK1265744 in Healthy Adult Female Subjects

    Not yet reported ViiV Healthcare 20 participants Est. completion 2014-12 1 site
    Other conditions: Infections, Human Immunodeficiency Virus and Hepatitis
    View official trial listing →
  • Completed NCT NCT02159326

    Microgynon Riociguat Drug Interaction Study in Healthy Postmenopausal Women

    Not yet reported Bayer 31 participants Est. completion 2015-07 1 site
    Other conditions: Drug Interactions
    View official trial listing →
  • Completed NCT NCT02161614

    Vascular Effect of Estradiol Valerate Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery

    Not yet reported Federal University of Minas Gerais 60 participants Est. completion 2015-12 1 site
    Other conditions: Flow-mediated Dilation Evaluation of the Brachial Artery
    View official trial listing →
  • Completed NCT NCT02170038

    Clinical Study Investigating the Conversion of the Contraceptive Compound Norethisterone Within the Body Towards the Contraceptive Compound Ethinylestradiol

    Not yet reported Bayer 16 participants Est. completion 2015-03 1 site
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT02182791

    Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (VIRAMUNE) and Ethinyl Estradiol/Norethindrone in HIV-1 Infected Women

    Not yet reported Boehringer Ingelheim 14 participants
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT02184364

    Klimadynon® in Comparison to Conjugated Oestrogens in Women Suffering From Menopausal Complaints

    Not yet reported Boehringer Ingelheim 161 participants
    Other conditions: Menopause
    View official trial listing →
  • Status unknown NCT NCT02186782

    Concomitant CC and E2 Versus CC Alone in Ovulation Induction

    Not yet reported Maher elesawi kamel elesawi 600 participants Est. completion 2018-08 3 sites
    Other conditions: Infertility, Anovulation
    View official trial listing →
  • Completed NCT NCT02197208

    A RCT Comparing Spontaneous Natural Cycles and Human Chorionic Gonadotrophin-induced Natural Cycles in FET

    Not yet reported The University of Hong Kong 300 participants Est. completion 2015-12 2 sites
    Other conditions: Subfertility, Pregnancy
    View official trial listing →
  • Completed NCT NCT02200952

    Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS

    San Carlo Public Hospital, Potenza, Italy 16 participants Est. completion 2014-06-30 1 site
    Other conditions: Ovarian Hyperstimulation Syndrome
    View official trial listing →
  • Completed NCT NCT02206984

    Endocrine Response in Women With Invasive Lobular Breast Cancer

    Not yet reported Priscilla McAuliffe 201 participants Est. completion 2024-07-19 12 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02210702

    Oral Contraceptive Ethinyl Estradiol Dose Effect on Postpartum Depression and Sexual Functioning Scales

    Not yet reported The Jones Institute 33 participants 1 site
    Other conditions: Postpartum Depressive Mood, Postpartum Sexual Function
    View official trial listing →
  • Completed NCT NCT02215395

    An Open-label Study to Evaluate the Effects of Concurrent Administration of Vaginal Antimycotic Medication Miconazole Nitrate on the Pharmacokinetics of Nestorone and Ethinyl Estradiol Delivered by a Contraceptive Vaginal Ring in Normal Ovulating Women

    Not yet reported Population Council 45 participants Est. completion 2015-04 1 site
    Other conditions: Antifungal Drug Adverse Reaction
    View official trial listing →
  • Completed NCT NCT02216786

    A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer

    Not yet reported Queen Mary University of London 333 participants Est. completion 2021-12-31 79 sites
    Other conditions: Estrogen Receptor Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02225080

    Duragen® Secure Post Marketing Clinical Follow-up (PMCF)

    Integra LifeSciences Corporation 100 participants Est. completion 2016-06 5 sites
    Other conditions: Dura Mater Nick Cut or Tear, Surgery
    View official trial listing →
  • Terminated NCT NCT02233621

    Assessment of Performance of [18F]-FES for Endometriosis Diagnosis

    Not yet reported University Hospital, Angers 31 participants Est. completion 2016-04-06 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT02237079

    Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM)

    Not yet reported Tulane University Health Sciences Center 17 participants Est. completion 2018-04 1 site
    Other conditions: Obesity, Glucose Homeostasis, Postmenopausal Symptoms
    View official trial listing →
  • Status unknown NCT NCT02237131

    Continuous Versus Cyclic Oral Contraceptives for Endometriosis

    Not yet reported University of Athens 50 participants Est. completion 2015-12 1 site
    Other conditions: Dysmenorrhea, Pelvic Pain, Dyspareunia, Endometrioma
    View official trial listing →
  • Active, not recruiting NCT NCT02238808

    A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers

    Not yet reported AHS Cancer Control Alberta 19 participants Est. completion 2028-06 1 site
    Other conditions: Estrogen Receptor Positive Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02245438

    Effect of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Norethindrone-Ethinyl Estradiol in Healthy Female Adult Volunteers

    Not yet reported Boehringer Ingelheim 52 participants
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02251925

    Frozen Embryo Transfer in Natural and Hormonal Replacement Cycles

    Not yet reported Royan Institute 460 participants Est. completion 2015-11 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02253173

    Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women

    Not yet reported TherapeuticsMD 764 participants Est. completion 2015-10 105 sites
    Other conditions: Vulvovaginal Atrophy, Menopause, Dyspareunia, Painful Intercourse
    View official trial listing →
  • Completed NCT NCT02255175

    Perimenopausal Effects of Estradiol on Reward Responsiveness

    Not yet reported University of North Carolina, Chapel Hill 64 participants Est. completion 2018-10-17 1 site Stand-alone
    Other conditions: Perimenopausal Depression
    View official trial listing →
  • Status unknown NCT NCT02257671

    Oral Contraceptives and Economic Behaviour

    Not yet reported Karolinska University Hospital 400 participants Est. completion 2015-12 1 site
    Other conditions: Female Contraception
    View official trial listing →
  • Status unknown NCT NCT02264743

    Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy

    Not yet reported Royal Brompton & Harefield NHS Foundation Trust 60 participants Est. completion 2015-11 3 sites
    Other conditions: Venous Thrombosis, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT02272647

    Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women

    Not yet reported Mayo Clinic 47 participants Est. completion 2018-02 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02273791

    HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients

    Mansoura University 126 participants Est. completion 2016-04 2 sites
    Other conditions: Infertility, Polycystic Ovarian Syndrome
    View official trial listing →
  • Withdrawn NCT NCT02292732

    A Pharmacokinetics (PK) and Safety Study to Determine the Effect of Repeat Dosing of Trametinib on Combined Oral Contraceptive (Norethindrone Plus Ethinyl Estradiol) in Female Subjects With Solid Tumors

    Not yet reported GlaxoSmithKline Est. completion 2017-05
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT02308904

    Reproductive Capacity and Iron Burden in Thalassemia

    Not yet reported UCSF Benioff Children's Hospital Oakland 59 participants Est. completion 2020-09-01 1 site
    Other conditions: THALASSEMIA MAJOR
    View official trial listing →
  • Completed NCT NCT02313415

    Treatment of Infertility by Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchyma Stem Cells

    Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 26 participants Est. completion 2017-08-31 1 site
    Other conditions: Infertility, Intrauterine Adhesions
    View official trial listing →
  • Withdrawn NCT NCT02316249

    Vaginal Creams to Reduce Vaginal Erosion in Pessary Users

    Not yet reported Northwell Health Est. completion 2015-08 1 site
    Other conditions: Atrophy of Vagina, Vaginal Ulceration, Vaginitis
    View official trial listing →
  • Status unknown NCT NCT02330757

    HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients

    Not yet reported Mansoura University 150 participants Est. completion 2024-12-31 2 sites
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02333253

    Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase

    Not yet reported Cairo University 60 participants Est. completion 2016-01 1 site
    Other conditions: Other Complications Associated With Artificial Fertilization
    View official trial listing →
  • Status unknown NCT NCT02344472

    Detect V / CHEVENDO (Chemo vs. Endo)

    Not yet reported Prof. Wolfgang Janni 271 participants Est. completion 2025-01-31 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02345772

    Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy

    Not yet reported, Not yet reported Western Regional Medical Center 4 participants Est. completion 2015-11 1 site
    Other conditions: HER2-positive Breast Cancer, ER-positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02349399

    Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases

    Bayer 26065 participants Est. completion 2016-03-01 3 sites
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Completed NCT NCT02352597

    Phytoestrogens as an Alternative to Estradiol in Ovulation Induction in PCOS

    Not yet reported Cairo University 150 participants Est. completion 2015-01
    Other conditions: Polycystic Ovaries
    View official trial listing →
  • Completed NCT NCT02362711

    Efficacy and Safety, Long-Term Study of NPC-16 to Treat Dysmenorrhea

    Not yet reported Nobelpharma 248 participants Est. completion 2017-01-28
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Completed NCT NCT02384239

    A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer

    Not yet reported University of California, San Francisco 70 participants Est. completion 2021-01-31 9 sites
    Other conditions: Metastatic Breast Cancer, Hormone Receptor Positive
    View official trial listing →
  • Status unknown NCT NCT02385448

    Comparing the Use of Dienogest and Combined Oral Contraceptive Pills (Microgynon) to Reduce the Risk of Recurrence of Endometriotic Cyst After Conservative Surgery

    Not yet reported The University of Hong Kong 144 participants Est. completion 2019-02 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Status unknown NCT NCT02393482

    Psychological Impact of Amenorrhea in Women With Endometriosis

    Not yet reported University of Cagliari 50 participants Est. completion 2022-06 1 site
    Other conditions: Amenorrhea, Endometriosis, Quality of Life
    View official trial listing →
  • Status unknown NCT NCT02394496

    Overcoming Endocrine Resistance in Metastatic Breast Cancer

    Not yet reported Consorzio Oncotech 396 participants Est. completion 2017-01 69 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02404051

    Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer

    Not yet reported Consorzio Oncotech 745 participants Est. completion 2019-01 41 sites
    Other conditions: Metastatic Breast Cancer, Breast Cancer, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Locally Advanced Malignant Neoplasm
    View official trial listing →
  • Completed NCT NCT02406690

    Endometrial Receptivity Profile in Patients With Endometrial Proliferation Defects

    Reproductive Medicine Associates of New Jersey 1 participants Est. completion 2015-09-17 1 site
    Other conditions: Endometrial Dysfunction
    View official trial listing →
  • Completed NCT NCT02410031

    Risk Minimisation Study for Diane-35 and Its Generics

    Bayer 759 participants Est. completion 2016-03-04 5 sites
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Completed NCT NCT02413008

    A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting

    Not yet reported ITF Research Pharma, S.L.U. 61 participants Est. completion 2017-02-10 6 sites
    Other conditions: Vaginal Atrophy
    View official trial listing →
  • Completed NCT NCT02419729

    Evaluation of Fractional CO2 Laser Treatment Efficacy and Comparison to Vaginal Estrogen Therapy in Postmenopausal Women With Vulvovaginal Atrophy

    Not yet reported Faculdade de Medicina do ABC 45 participants Est. completion 2015-11 1 site
    Other conditions: Vulvovaginal Atrophy
    View official trial listing →
  • Completed NCT NCT02447328

    A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

    Not yet reported AstraZeneca 83 participants Est. completion 2020-09-16 9 sites
    Other conditions: Locally Advanced or, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02449902

    TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy

    Not yet reported TherapeuticsMD 50 participants Est. completion 2013-09 1 site
    Other conditions: Menopause, Vulvovaginal Atrophy, Painful Intercourse, Dyspareunia
    View official trial listing →
  • Completed NCT NCT02451228

    Indomethacin PK and PD Therapy in Pregnancy

    The University of Texas Medical Branch, Galveston 62 participants Est. completion 2018-12-31 6 sites
    Other conditions: Premature Labor, Pregnancy, Premature Birth
    View official trial listing →
  • Completed NCT NCT02455453

    Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography

    Not yet reported Washington University School of Medicine 47 participants Est. completion 2019-01-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02461875

    Cabergoline Versus GnRH Antagonist Rescue and Cabergoline in the Prevention of Ovarian Hyperstimulation Syndrome

    Not yet reported Aljazeera Hospital 236 participants Est. completion 2015-12 1 site
    Other conditions: OHSS
    View official trial listing →
  • Completed NCT NCT02475265

    Transdermal Estrogen in Older Premenopausal Women With Anorexia Nervosa

    Not yet reported Massachusetts General Hospital 11 participants Est. completion 2018-07-30 1 site
    Obstructive sleep apnea Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT02480881

    A Drug-drug Interaction Study Between BMS-663068 and Oral Contraceptives in Healthy Female Volunteers (DDI)

    Not yet reported ViiV Healthcare 26 participants Est. completion 2016-01-11 2 sites
    Other conditions: Infection, Human Immunodeficiency Virus
    View official trial listing →
  • Status unknown NCT NCT02480985

    The PIT-TBI Pilot Study

    Not yet reported CHU de Quebec-Universite Laval 70 participants Est. completion 2018-03 5 sites
    Other conditions: Pituitary Disorders, Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT02486757

    Investigation of Female Reproductive Hormone Dynamics During Adolescence

    Not yet reported Massachusetts General Hospital 9 participants Est. completion 2016-03-01 1 site Stand-alone
    Other conditions: Menstruation Disturbances
    View official trial listing →
  • Completed NCT NCT02494297

    DUS on the Prescribing Indications for CPA/EE in 5 European Countries

    Center for Epidemiology and Health Research, Germany 1597 participants Est. completion 2016-10-31 1 site
    Other conditions: Hirsutism, Androgenetic Alopecia, Severe Anemia, Seborrhea, PCOS
    View official trial listing →
  • Status unknown NCT NCT02494609

    Oral Contraceptive DDI Study

    Not yet reported Lexicon Pharmaceuticals 30 participants 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT02494713

    Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer

    Not yet reported The University of Texas Health Science Center, Houston 4 participants Est. completion 2017-09-14 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT02496052

    The Efficacy and Safety of the Dried Biological Amnion Graft in Patients With Intrauterine Adhesions

    Not yet reported Beijing Obstetrics and Gynecology Hospital 300 participants Est. completion 2017-06 1 site
    Other conditions: Intrauterine Adhesions
    View official trial listing →
  • No Longer Available NCT NCT02510079

    Emergent Expanded Access for ahSC Augmentation of Nerve Autografts After Severe Peripheral Nerve Injury.

    W. Dalton Dietrich 1 site
    Other conditions: Sciatic Nerve Injury
    View official trial listing →
  • Completed NCT NCT02516202

    The Vaginal Health Trial

    Not yet reported Fred Hutchinson Cancer Center 302 participants Est. completion 2017-07 2 sites
    Other conditions: Atrophy of Vagina, Menopause, Dyspareunia (Female)
    View official trial listing →
  • Completed NCT NCT02524561

    KEEPS Mammographic Density And Breast Health Ancillary Study

    Not yet reported Brigham and Women's Hospital 517 participants Est. completion 2013-12 1 site
    Other conditions: Mammographic Density, Abnormal Mammogram
    View official trial listing →
  • Completed NCT NCT02524769

    The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides

    Not yet reported Loyola University 27 participants Est. completion 2017-06 1 site
    Other conditions: Overactive Bladder
    View official trial listing →
  • Status unknown NCT NCT02525276

    Female Sex Hormones, Insulin Resistance and Effects of Exercise in a Human Experimental Model of Menopause

    Not yet reported Copenhagen University Hospital, Rigshospitalet 48 participants Est. completion 2018-08
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT02528383

    Trial of Vaginal Estrogen for Urogenital Symptom Relief in Women on Aromatase Inhibitors

    Not yet reported Susan Tannenbaum 3 participants Est. completion 2017-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02529683

    Study of Nuvaring Acceptability, Adherence and Biological Effects Among HIV-negative Women in Kenya

    Not yet reported Centers for Disease Control and Prevention 200 participants Est. completion 2015-08
    Other conditions: Hormonal Contraception
    View official trial listing →
  • Completed NCT NCT02533427

    Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol

    Not yet reported Gilead Sciences 15 participants Est. completion 2016-03-18 1 site
    Other conditions: HCV Infection
    View official trial listing →
  • Completed NCT NCT02549430

    To Reverse ENDocrine Resistance Trial - PD 0332991 Monotherapy vs PD 0332991 in Combination With the Endocrine Therapy

    Not yet reported Fondazione Sandro Pitigliani 115 participants Est. completion 2017-02-09 6 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02550977

    Russia/Ukraine Suppression of Ovarian Activity Study

    Not yet reported Bayer 91 participants Est. completion 2016-08-15 8 sites
    Other conditions: Contraception
    View official trial listing →
  • Terminated NCT NCT02577913

    European Active Surveillance Study Comparing Regimens of Administration in Combined Hormonal Contraception

    Center for Epidemiology and Health Research, Germany 2281 participants Est. completion 2019-05-22 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT02599714

    Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer

    Not yet reported AstraZeneca 54 participants Est. completion 2023-11-23 7 sites
    Other conditions: Advanced and Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02617108

    Intrauterine Balloon and Postoperative Estrogen Therapy in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis

    Not yet reported Fu Xing Hospital, Capital Medical University 310 participants Est. completion 2021-11
    Other conditions: Uterine Septum
    View official trial listing →
  • Completed NCT NCT02618148

    Hormone Estradiol Replacement Therapy Additional Herbals

    Not yet reported Trieu, Nguyen Thi, M.D. 60 participants Est. completion 2015-06 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT02636972

    The Progression From Dysmenorrhoea to Chronic Pelvic Pain

    University of Adelaide 56 participants Est. completion 2016-01 1 site
    Other conditions: Dysmenorrhoea, Pelvic Pain, Chronic Pain
    View official trial listing →
  • Status unknown NCT NCT02638922

    Evaluation and Treatment of Tall Statured Girls

    Copenhagen University Hospital, Rigshospitalet 304 participants Est. completion 2017-12
    Other conditions: Constitutional Tall Stature
    View official trial listing →
  • Completed NCT NCT02640755

    Absorption, Metabolism, Excretion and Pharmacokinetics of a Single Dose [14C]AZD2014 Followed by a Multiple Dose Phase

    Not yet reported AstraZeneca 4 participants Est. completion 2017-07-06 1 site
    Other conditions: Solid Malignancies
    View official trial listing →
  • Status unknown NCT NCT02646735

    Fulvestrant 500mg With Exemestane Endocrine Therapy for Postmenopausal Advanced Breast Cancer Patients

    Not yet reported Chinese Academy of Medical Sciences 148 participants Est. completion 2020-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02655146

    the Effects of GnRHa Add up to Routine Luteal Phase Support on Frozen Embryo Implantation in Frozen Embryo Transfer .

    Not yet reported Chong Qing Reproducive and Genetic Institute 700 participants Est. completion 2017-03 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02657343

    An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer.

    Not yet reported, Not yet reported Dana-Farber Cancer Institute 25 participants Est. completion 2022-06-30 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02660294

    Intrauterine Autologous PRP Infusion Compared to HRT for Enhancing Endometrial Thickness in Patients Undergoing ICSI

    Not yet reported, Not yet reported Ain Shams University 30 participants Est. completion 2017-04 1 site
    Other conditions: Infertility
    View official trial listing →
  • Terminated NCT NCT02668822

    Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in the Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)

    Not yet reported Organon and Co 18 participants Est. completion 2016-09-12
    Other conditions: Dysmenorrhea
    View official trial listing →
  • Terminated NCT NCT02669238

    Evaluation of a Subcutaneous Progestogen Implants in the Medical Management of Painful Endometriosis

    Not yet reported, Not yet reported Centre Hospitalier Universitaire de la Réunion 2 participants Est. completion 2019-10-10 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT02670785

    A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy

    Not yet reported Warner Chilcott 203 participants Est. completion 2016-11-14 20 sites
    Other conditions: Vulvovaginal Atrophy, Menopause, Dyspareunia
    View official trial listing →
  • Completed NCT NCT02673606

    Impact of Estrogen on Fear Extinction R61

    Not yet reported NYU Langone Health 136 participants Est. completion 2019-04-15 1 site
    Other conditions: Fear, Fear; Examination, Phobic
    View official trial listing →
  • Completed NCT NCT02675231

    A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer

    Not yet reported Eli Lilly and Company 237 participants Est. completion 2023-11-09 93 sites
    Other conditions: Hormone Receptor Positive Breast Cancer, HER-2 Positive Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02677259

    Luteal Phase Estradiol Support for In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles

    Not yet reported One Fertility 506 participants Est. completion 2018-06
    Other conditions: IVF
    View official trial listing →
  • Status unknown NCT NCT02681536

    Miniflare Versus Long Protocol in Poor Responders

    Not yet reported Woman's Health University Hospital, Egypt 200 participants Est. completion 2016-09 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02689843

    Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS

    Not yet reported Shiraz University of Medical Sciences 90 participants Est. completion 2018-12-30 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Status unknown NCT NCT02690480

    Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast Cancer

    Not yet reported Spanish Breast Cancer Research Group 189 participants Est. completion 2023-12 32 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT02691936

    Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy

    Not yet reported The Cleveland Clinic 69 participants Est. completion 2018-12 6 sites
    Other conditions: Atrophic Vaginitis, Menopause
    View official trial listing →
  • Terminated NCT NCT02693002

    Estrogen Diastolic Heart Failure

    Not yet reported Gretchen Wells 4 participants Est. completion 2016-11 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT02694809

    The PROMISE Study: Duavee in Women With DCIS

    Not yet reported Northwestern University 142 participants Est. completion 2024-06-19 10 sites
    Other conditions: Ductal Breast Carcinoma In Situ, Postmenopausal
    View official trial listing →
  • Terminated NCT NCT02701452

    Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response

    Not yet reported University Hospital, Lille 1 participants Est. completion 2019-01-01
    Other conditions: Ovarian Hyperstimulation Syndrome, Hypercoagulability
    View official trial listing →
  • Completed NCT NCT02705963

    A Drug-Drug Interaction Study to Assess the Effect of Trametinib on the Pharmacokinetics of an Oral Contraceptive in Female Patients With Solid Tumors

    Not yet reported Novartis Pharmaceuticals 19 participants Est. completion 2019-08-29 7 sites
    Other conditions: Solid Tumors
    View official trial listing →
  • Status unknown NCT NCT02715232

    Effects of Sex Steroids on the Serotonin System

    Not yet reported Medical University of Vienna 92 participants Est. completion 2020-12 1 site
    Other conditions: Gender Dysphoria
    View official trial listing →
  • Completed NCT NCT02718378

    Evaluation of Safety and Efficacy of Estetrol in Healthy Men

    Not yet reported Pantarhei Oncology B.V. 45 participants Est. completion 2017-02 1 site
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Completed NCT NCT02720224

    Study Conducted to Further Understand the Elimination Pathways, Metabolite Profile and PK Profile of 14C-estetrol

    Not yet reported Estetra 6 participants Est. completion 2016-04 1 site
    Other conditions: Contraception, Menopause
    View official trial listing →
  • Completed NCT NCT02726971

    Comparison of Different Doses of Oestrogen Therapy for Preventing Intrauterine Adhesion

    Not yet reported, Not yet reported Fu Xing Hospital, Capital Medical University 141 participants Est. completion 2016-08 1 site
    Other conditions: Asherman Syndrome
    View official trial listing →
  • Completed NCT NCT02729545

    The Efficacy and Safety Study of Tung's Acupuncture for Polycystic Ovarian Syndrome

    Not yet reported Beijing Hospital of Integrated Traditional Chinese and Western Medicine 60 participants Est. completion 2018-05 1 site
    Other conditions: Polycystic Ovarian Syndrome
    View official trial listing →
  • Status unknown NCT NCT02733731

    The Treatment Effect of Chinese Herbal Compound Ointment on Atrophic Vaginitis

    Not yet reported First Affiliated Hospital, Sun Yat-Sen University 80 participants Est. completion 2016-06 1 site
    Other conditions: Atrophic Vaginitis
    View official trial listing →
  • Completed NCT NCT02736032

    Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone Agonist

    Not yet reported Cairo University 310 participants Est. completion 2018-05 3 sites
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02737800

    Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma Patients

    Not yet reported Kasr El Aini Hospital 88 participants Est. completion 2017-08 1 site
    Other conditions: Endometrioma
    View official trial listing →
  • Status unknown NCT NCT02744131

    OCP vs Metformin for Improvement in Clinical Symptoms and Metabolic Markers in Indian PCOS Women

    Not yet reported Kar Clinic & Hospital Pvt. Ltd. 100 participants Est. completion 2019-12 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Terminated NCT NCT02751385

    Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer

    Not yet reported Boehringer Ingelheim 2 participants Est. completion 2017-11-28 1 site
    Other conditions: Carcinoma, Non-Small-Cell Lung
    View official trial listing →
  • Status unknown NCT NCT02752568

    Assisted Hatching Versus Endometrial Scratch in Recurrent Implantation Failure

    Not yet reported Kasr El Aini Hospital 300 participants Est. completion 2016-12
    Other conditions: Recurrent Implantation Failure
    View official trial listing →
  • Status unknown NCT NCT02755038

    Scalp Hair Estradiol and Progesterone Level Determination in Women (Proof of Concept Study)

    Bnai Zion Medical Center 40 participants Est. completion 2017-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02756364

    Sapanisertib in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor Therapy

    Not yet reported Calithera Biosciences, Inc 141 participants Est. completion 2019-11-25 53 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Withdrawn NCT NCT02757287

    Desogestrel (DSG) and Corifollitropin(FSH-CTP) Alfa for Ovarian Stimulation in Donors

    Not yet reported Fundacion Dexeus Est. completion 2018-12-01 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02760030

    Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery

    Not yet reported Ohio State University Comprehensive Cancer Center 14 participants Est. completion 2025-08-31 3 sites
    Other conditions: Estrogen Receptor and/or Progesterone Receptor Positive, HER2/Neu Negative, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02763566

    A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer

    Not yet reported Eli Lilly and Company 463 participants Est. completion 2028-03 45 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02770365

    Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy

    Not yet reported Padagis LLC 695 participants Est. completion 2016-11 1 site
    Other conditions: Atrophy
    View official trial listing →
  • Active, not recruiting NCT NCT02778685

    Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast Cancer

    Not yet reported City of Hope Medical Center 47 participants Est. completion 2026-03-30 7 sites
    Other conditions: Metastatic Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Terminated NCT NCT02780791

    Maturation of Follicles After Transplantation of Ovarian Tissue Into the Pelvic Wall and the Ovary

    Not yet reported Insel Gruppe AG, University Hospital Bern 1 participants Est. completion 2020-07-31 1 site
    Other conditions: Infertility, Ovarian Failure, Premature
    View official trial listing →
  • Withdrawn NCT NCT02792153

    Estradiol and Fear Extinction in Anorexia Nervosa (AN)

    Not yet reported Johns Hopkins University Est. completion 2018-08-22 1 site Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT02795039

    Bioequivalence Study of Fulvestrant Injection 50 mg/mL in Healthy Post-menopausal Female Subjects

    Not yet reported Fresenius Kabi 266 participants Est. completion 2017-03-03 3 sites
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02817828

    E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - EU/Russia Study

    Not yet reported Estetra 1577 participants Est. completion 2018-04-26 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT02828852

    Study of the Platelet Function During the Last Month of Pregnancy

    Not yet reported University Hospital, Toulouse 60 participants Est. completion 2016-07 1 site
    Other conditions: Pregnancy
    View official trial listing →
  • Completed NCT NCT02834312

    E4Relief (Response to Estetrol in Life Improvement for MEnopausal-associated Hot Flushes)

    Not yet reported Donesta Bioscience 260 participants Est. completion 2018-01-22 1 site
    Other conditions: Hot Flushes
    View official trial listing →
  • Status unknown NCT NCT02838576

    Effects of Hormone Replacement Therapy on Arthralgia in Postmenopausal Women

    Not yet reported Hospital de Clinicas de Porto Alegre 72 participants Est. completion 2020-12-31 1 site
    Other conditions: Arthralgia
    View official trial listing →
  • Completed NCT NCT02845219

    A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females

    Not yet reported Novo Nordisk A/S 25 participants Est. completion 2016-12 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02845388

    Sildenafil Citrate in Frozen Embryo Transfer

    Not yet reported Omar Ahmed El Sayed Saad 90 participants Est. completion 2016-06
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02846142

    Study to Assess the Safety, Tolerability, PK, ECG Effects, Food Effect, and Drug-drug Interaction (DDI) of Hormonal Contraceptives of PTI-428 in Healthy Female Volunteers

    Not yet reported Proteostasis Therapeutics, Inc. 94 participants Est. completion 2017-03 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT02847806

    Effects of Replacement Therapy With Sexual Steroid Hormones on the Insulin Sensitivity of Hypogonadal Man

    Not yet reported University Hospital, Caen 6 participants Est. completion 2016-08 1 site
    Other conditions: Hypogonadism
    View official trial listing →
  • Completed NCT NCT02855294

    The Effect of Oral Contraceptives on Women Balance

    Not yet reported Cairo University 100 participants Est. completion 2016-07 1 site
    Other conditions: Joint Stabilioty
    View official trial listing →
  • Completed NCT NCT02859285

    A Study Evaluating the Effects of Topical Clitoral Estradiol Cream in Post Menopausal Women

    Not yet reported ProHealth Care, Inc 30 participants Est. completion 2020-03-10 1 site
    Other conditions: Hypoactive Sexual Desire Disorder
    View official trial listing →
  • Completed NCT NCT02866786

    The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOS

    Not yet reported S.C.B. Medical College and Hospital 101 participants Est. completion 2017-08-01 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT02866955

    Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor.

    Not yet reported Institut de Cancérologie de Lorraine 100 participants Est. completion 2015-08-28 21 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02872818

    Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia

    Not yet reported Kayseri Education and Research Hospital 40 participants Est. completion 2015-03 1 site
    Other conditions: Apoptotic Signal Pathways in Endometrial Hyperplasia
    View official trial listing →
  • Completed NCT NCT02894398

    Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant

    Not yet reported iOMEDICO AG 388 participants Est. completion 2023-02-15 70 sites
    Other conditions: Breast Cancer, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
    View official trial listing →
  • Status unknown NCT NCT02909361

    Fulvestrant 500mg in Patients With Advanced Breast Cancer

    Fudan University 500 participants Est. completion 2022-10 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02911844

    Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension

    Not yet reported University of Pennsylvania 5 participants Est. completion 2018-12-05 1 site
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT02913430

    Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib

    Not yet reported Shannon Puhalla 7 participants Est. completion 2024-04-30 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT02922348

    Hormone Replacement for Premature Ovarian Insufficiency

    Not yet reported University of Pennsylvania Est. completion 2018-12-01 1 site Stand-alone
    Other conditions: Primary Ovarian Insufficiency
    View official trial listing →
  • Terminated NCT NCT02936206

    Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.

    Not yet reported Icahn School of Medicine at Mount Sinai 2 participants Est. completion 2020-05-01 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02955394

    Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer

    Not yet reported University of Colorado, Denver 61 participants Est. completion 2027-02 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02957630

    "E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"

    Not yet reported, Not yet reported Estetra 101 participants Est. completion 2017-10-09 1 site
    Other conditions: Contraception, Liver Metabolism, Hemostasis Parameter
    View official trial listing →
  • Completed NCT NCT02958852

    A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer

    Not yet reported Lund University Hospital 126 participants Est. completion 2025-01-15 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02967510

    Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel) for the Treatment of Vaginal Dryness in Postmenopausal Women With Vulvovaginal Atrophy

    Not yet reported ITF Research Pharma, S.L.U. 283 participants Est. completion 2018-05 23 sites
    Other conditions: Vaginal Atrophy
    View official trial listing →
  • Status unknown NCT NCT02983071

    G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer

    Not yet reported, Not yet reported G1 Therapeutics, Inc. 102 participants Est. completion 2023-10 8 sites
    Other conditions: Carcinoma, Ductal, Breast, Breast Cancer, Breast Neoplasm
    View official trial listing →
  • Terminated NCT NCT02983604

    GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer

    Not yet reported, Not yet reported Gilead Sciences 14 participants Est. completion 2018-07-19 6 sites
    Other conditions: Advanced Estrogen Receptor Positive HER2- Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02984696

    Total Antioxidant Capacity Before and After HRT in Hypotalamic Amenorrhea

    Not yet reported Catholic University of the Sacred Heart 20 participants Est. completion 2017-12 1 site Stand-alone
    Other conditions: Hypothalamic Amenorrhea
    View official trial listing →
  • Terminated NCT NCT03003949

    The Menopause Transition: Estrogen Variability, Stress Reactivity and Mood

    Not yet reported University of North Carolina, Chapel Hill 82 participants Est. completion 2020-05-10 2 sites
    Other conditions: Perimenopausal Disorder, Stress, Emotional
    View official trial listing →
  • Completed NCT NCT03007979

    Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer

    Not yet reported Washington University School of Medicine 55 participants Est. completion 2023-03-31 2 sites
    Other conditions: Breast Cancer, Breast Carcinoma, Cancer of Breast, Malignant Tumor of Breast
    View official trial listing →
  • Completed NCT NCT03018366

    Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women

    Not yet reported Cedars-Sinai Medical Center 29 participants Est. completion 2023-02-01 1 site
    Cardiovascular disease Other conditions: Estrogen Deficiency, Functional Hypothalamic Amenorrhea, Endothelial Dysfunction
    View official trial listing →
  • Status unknown NCT NCT03024580

    A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer

    Not yet reported Instituto Nacional de Cancer, Brazil 20 participants Est. completion 2020-09 1 site
    Other conditions: Breast Neoplasm
    View official trial listing →
  • Status unknown NCT NCT03033160

    Vaginal Estrogen for Asymptomatic Microscopic Hematuria

    Not yet reported Boston Urogynecology Associates 68 participants Est. completion 2020-12-30 1 site
    Other conditions: Asymptomatic Microscopic Hematuria
    View official trial listing →
  • Completed NCT NCT03041129

    Post-Prandial Liver Glucose Metabolism in PCOS

    University of Colorado, Denver 19 participants Est. completion 2018-09-29 1 site
    Other conditions: Polycystic Ovarian Syndrome, Obesity, Hepatic Steatosis
    View official trial listing →
  • Completed NCT NCT03043924

    Functional Study of the Hypothalamus in Magnetic Resonance Imaging (MRI) in Polycystic Ovary Syndrome (PCOS)

    Not yet reported University Hospital, Lille 52 participants Est. completion 2022-04-15 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT03047330

    Menopausal Sleep Fragmentation and Body Fat Gain

    Not yet reported Brigham and Women's Hospital 41 participants Est. completion 2022-08-01 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT03056755

    Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments

    Not yet reported Novartis Pharmaceuticals 383 participants Est. completion 2024-11-12 94 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03060304

    The Effect of Tamoxifen on Clinical Outcome in Women With Thin Endometrium Undergoing Frozen Thawed Cycle.

    Not yet reported Sun Yat-sen University 100 participants Est. completion 2020-06
    Other conditions: Endometrium
    View official trial listing →
  • Completed NCT NCT03075956

    Safety, Tolerability and Pharmacokinetics of Estetrol (E4) After Single and Multiple Oral Doses in Healthy Female Volunteers

    Not yet reported Estetra 31 participants Est. completion 2017-08-02 1 site
    Other conditions: Contraception, Menopause
    View official trial listing →
  • Status unknown NCT NCT03081130

    Intravenous Laser Irradiation Effect on Treatment Resistant Thin Endometrium

    Kaohsiung Veterans General Hospital. 60 participants Est. completion 2018-03-31 1 site
    Other conditions: Endometrium, Laser
    View official trial listing →
  • Completed NCT NCT03103087

    LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

    Not yet reported Myovant Sciences GmbH 382 participants Est. completion 2020-09-16 127 sites
    Other conditions: Heavy Menstrual Bleeding, Uterine Fibroid
    View official trial listing →
  • Completed NCT NCT03106454

    Ovulation Incidence in Oral Contraceptive Users

    Not yet reported University of Southern California 58 participants Est. completion 2024-01-01 1 site
    Other conditions: Contraception, Ovulation
    View official trial listing →
  • Completed NCT NCT03111511

    A Study in Healthy Female Participants to Investigate the Effect of JNJ-56136379 at Steady-state on the Single-dose Pharmacokinetics of Ethinylestradiol and Drospirenone (Oral Contraceptive) and on the Single-dose Pharmacokinetics of Midazolam (Probe Substrate for Cytochrome P450 3A4)

    Not yet reported Janssen Sciences Ireland UC 18 participants Est. completion 2017-08-23 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03112226

    Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function

    Not yet reported University of Colorado, Denver 19 participants Est. completion 2020-06-21 2 sites
    Other conditions: Cognitive Impairment, Estrogen Deficiency, Menopause, Endothelial Dysfunction, Vascular Stiffness
    View official trial listing →
  • Status unknown NCT NCT03120728

    Application for the Etonogestrel/Ethinyl Estradiol Ring

    Not yet reported University of Southern California 36 participants Est. completion 2018-07-01 2 sites
    Other conditions: Emergency Contraception, Healthy, Reproductive Age Women
    View official trial listing →
  • Completed NCT NCT03124524

    Treatment Choice in Primary Dysmenorrhea

    Not yet reported Adana Numune Training and Research Hospital 99 participants Est. completion 2016-10-10
    Other conditions: Primary Dysmenorrhea
    View official trial listing →
  • Terminated NCT NCT03134638

    A Study of SY-1365 in Adult Patients With Advanced Solid Tumors

    Not yet reported Syros Pharmaceuticals 107 participants Est. completion 2020-06-24 20 sites
    Other conditions: Advanced Solid Tumors, Ovarian Cancer, Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT03169777

    QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT03172533

    Estrogen Replacement in Anorexia Nervosa

    Not yet reported University of Erlangen-Nürnberg Medical School 11 participants Est. completion 2019-01-15 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT03174691

    Early Luteal Progesterone Profile in IVF Patients Triggered With hCG

    Not yet reported Vietnam National University 161 participants Est. completion 2017-08-08 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT03178695

    Inovium Ovarian Rejuvenation Trials

    Not yet reported Ascendance Biomedical 200 participants Est. completion 2018-05-01 1 site
    Other conditions: Perimenopausal Disorder, Menopause, Menopause, Premature, Menopause Related Conditions, Menopause Premature Symptomatic, Menopause Premature Asymptomatic, Premature Ovarian Failure, Premature Ovarian Failure, Familial, Premature Ovarian Failure 2A, Premature Ovarian Failure 3, Premature Ovarian Failure 4, Premature Ovarian Failure 1, Premature Ovarian Failure 5, Premature Ovarian Failure 6, Premature Ovarian Failure 7, Premature Ovarian Failure 9, Premature Ovarian Failure 8, Infertility, Infertility, Female, Infertility Unexplained
    View official trial listing →
  • Completed NCT NCT03179904

    TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer

    Not yet reported Mayo Clinic 17 participants Est. completion 2026-03-13 3 sites
    Other conditions: Advanced Breast Carcinoma, HER2-Positive Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, HER2-positive Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT03197571

    QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28
    Other conditions: Urothelial Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT03197584

    QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Status unknown NCT NCT03202862

    The Efficacy of Fulvestrant in ESR1(Estrogen Receptor 1) Mutated Metastatic Breast Cancer

    Not yet reported Fudan University 50 participants Est. completion 2019-08-01
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT03204318

    SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain

    Not yet reported Myovant Sciences GmbH 638 participants Est. completion 2021-04-08 123 sites
    Other conditions: Endometriosis Related Pain
    View official trial listing →
  • Completed NCT NCT03204331

    SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain

    Not yet reported Myovant Sciences GmbH 623 participants Est. completion 2021-05-31 91 sites
    Other conditions: Endometriosis Related Pain
    View official trial listing →
  • Completed NCT NCT03213457

    A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain

    Not yet reported AbbVie 681 participants Est. completion 2023-12-06 197 sites
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT03232281

    Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis

    Not yet reported Ipsen 300 participants Est. completion 2019-11-16 24 sites
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT03236740

    OCP vs Metformin on Ovarian Stromal Blood Flow in PCOS

    Not yet reported S.C.B. Medical College and Hospital 101 participants Est. completion 2018-03-15 1 site
    Other conditions: PCOS
    View official trial listing →
  • Status unknown NCT NCT03237117

    Effect of Growth Hormone on Uterine Receptivity in Women With RIF in an Oocyte Donation Program

    Not yet reported Competence Centre on Health Technologies 105 participants Est. completion 2017-12-31 1 site
    Other conditions: Female Infertility
    View official trial listing →
  • Completed NCT NCT03238196

    Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer

    Not yet reported Vanderbilt-Ingram Cancer Center 35 participants Est. completion 2024-03-20 6 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT03241810

    Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer

    Not yet reported Elevation Oncology 22 participants Est. completion 2018-11-30 59 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT03249402

    A Study to Evaluate the Effect of Multiple Oral Doses of JNJ-42847922 on the Steady-state Pharmacokinetics of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Adult Participants

    Not yet reported Janssen-Cilag International NV 24 participants Est. completion 2017-11-24 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03262740

    The Effect of BMS-986195 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients

    Not yet reported Bristol-Myers Squibb 58 participants Est. completion 2018-01-30 2 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT03264638

    A Clinical and Biological Research of Combined Chinese and Western Medicine in the Treatment of PCOS

    Not yet reported Aijun Sun 315 participants Est. completion 2018-08-31 1 site
    Other conditions: PCOS
    View official trial listing →
  • Completed NCT NCT03271489

    Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

    Not yet reported AbbVie 478 participants Est. completion 2024-06-28 157 sites
    Other conditions: Heavy Menstrual Bleeding, Uterine Fibroids
    View official trial listing →
  • Status unknown NCT NCT03274765

    Improved Medically Assisted Procreation Monitoring

    Rennes University Hospital 30 participants Est. completion 2018-12-15 1 site
    Other conditions: Infertility
    View official trial listing →
  • Terminated NCT NCT03289039

    Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer

    Not yet reported Dana-Farber Cancer Institute 21 participants Est. completion 2021-07-20 6 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03294538

    Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis

    Not yet reported Actavis Inc. 663 participants Est. completion 2017-02-15 44 sites
    Other conditions: Atrophic Vaginitis
    View official trial listing →
  • Terminated NCT NCT03294694

    Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer

    Not yet reported Dana-Farber Cancer Institute 33 participants Est. completion 2020-10-14 3 sites
    Other conditions: Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer, HER2-Negative Breast Cancer, Metastatic Epithelial Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT03300518

    Effectiveness of Estradiol Valerate Pretreatment in Antagonist Protocol for Poor Ovarian Response Patient

    Not yet reported Reproductive & Genetic Hospital of CITIC-Xiangya 552 participants Est. completion 2021-08-18 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT03301233

    Effect Sildenafil and Estradiiol Valerate on Endometrial Thickness in Infertile Women

    Not yet reported Ain Shams University 90 participants Est. completion 2018-07-30 1 site
    Other conditions: Endometrial Thickness
    View official trial listing →
  • Completed NCT NCT03321981

    MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer.

    Not yet reported Merus B.V. 105 participants Est. completion 2023-07-26 25 sites
    Other conditions: Breast Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT03322852

    Effect of Clomiphene Citrate on Uterine Blood Fow in Women With Unexplained Delayed Conception

    Cairo University 50 participants Est. completion 2016-10-30 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Completed NCT NCT03324685

    A Drug Interaction Study of BIIB074 and an Oral Contraceptive Regimen

    Not yet reported Biogen 36 participants Est. completion 2018-03-15 1 site
    Other conditions: Drug Interactions
    View official trial listing →
  • Status unknown NCT NCT03329898

    Comparing the Efficacy of Two Methods for the Therapy of Uterine Adhesion

    Not yet reported Beijing Obstetrics and Gynecology Hospital 200 participants Est. completion 2018-11-25 1 site
    Other conditions: Intrauterine Adhesion
    View official trial listing →
  • Completed NCT NCT03333564

    Effect of Vitamin D3 and Omega-3FA on Estradiol

    Not yet reported Applied Science Private University 116 participants Est. completion 2017-02
    Other conditions: Vitamin D Deficiency
    View official trial listing →
  • Terminated NCT NCT03343067

    A Study to Evaluate Safety and Efficacy of Elagolix in Participants With Endometriosis With Associated Moderate to Severe Pain

    Not yet reported AbbVie 11 participants Est. completion 2018-10-23 37 sites
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT03344536

    A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 10 participants Est. completion 2021-08-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03346317

    Comparing the Efficacy of Two Methods in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis

    Not yet reported Beijing Obstetrics and Gynecology Hospital 100 participants Est. completion 2018-05-20 1 site
    Other conditions: Intrauterine Adhesion
    View official trial listing →
  • Status unknown NCT NCT03351205

    The Efficacy of Estrogen Therapy Against Adhesion Reformation After Hysteroscopic Adhesiolysis

    Not yet reported Beijing Obstetrics and Gynecology Hospital 100 participants Est. completion 2018-11-22 1 site
    Other conditions: Intrauterine Adhesion
    View official trial listing →
  • Completed NCT NCT03353857

    Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam

    Not yet reported Bayer 68 participants Est. completion 2019-02-19 2 sites
    Other conditions: Biological Availability
    View official trial listing →
  • Completed NCT NCT03355651

    Efficacy and Tolerability of a Nutritional Supplement, Plactive Progen, in ACL Reconstruction

    Not yet reported OPKO Health, Inc. 80 participants Est. completion 2017-03-03
    Other conditions: ACL Reconstruction
    View official trial listing →
  • Completed NCT NCT03359057

    Trial Evaluating Folic Acid Supplementation by Concomitant Administration of Ethinyl Estradiol + Levonorgestrel

    Not yet reported Galeno Desenvolvimento de Pesquisas Clínicas 36 participants Est. completion 2013-09-17 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT03361969

    Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.

    Not yet reported Pantarhei Oncology B.V. 63 participants Est. completion 2020-05-15 6 sites
    Other conditions: Prostatic Neoplasm
    View official trial listing →
  • Completed NCT NCT03363828

    The Temporo-spatial Dynamics of Genital Tract Microbiota

    Peter Humaidan 27 participants Est. completion 2021-01-08 2 sites
    Other conditions: Infertility, Female
    View official trial listing →
  • Completed NCT NCT03363893

    Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies

    Not yet reported, Not yet reported Carrick Therapeutics Limited 124 participants Est. completion 2022-12-15 23 sites
    Other conditions: Advanced Solid Malignancies
    View official trial listing →
  • Status unknown NCT NCT03373149

    Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response

    Not yet reported Riyadh Fertility and Reproductive Health center 228 participants Est. completion 2020-11 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Completed NCT NCT03385551

    Study to Evaluate Estradiol Vaginal Tablets vs Promestriene Vaginal Cream

    Instituto Palacios 120 participants Est. completion 2020-09-30 2 sites
    Other conditions: Vulvovaginal Atrophy
    View official trial listing →
  • Active, not recruiting NCT NCT03393845

    Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients

    Not yet reported Nancy Chan, MD 47 participants Est. completion 2027-09-01 5 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03395665

    Estradiol, Progesterone and Endometrial Thickness in Frozen Euploid Embryo Transfer

    Fundacion Dexeus 299 participants Est. completion 2018-01 1 site
    Other conditions: Infertility, Preimplantation Genetic Diagnosis/Screening, Miscarriage
    View official trial listing →
  • Completed NCT NCT03395756

    Depot Medroxyprogesterone Acetate as Emergency Contraception

    Not yet reported University of Southern California 30 participants Est. completion 2020-10-30 1 site
    Other conditions: Emergency Contraception, Contraception
    View official trial listing →
  • Completed NCT NCT03412890

    LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

    Not yet reported Myovant Sciences GmbH 477 participants Est. completion 2021-01-13 150 sites
    Other conditions: Heavy Menstrual Bleeding, Uterine Fibroid
    View official trial listing →
  • Completed NCT NCT03418363

    How DHEA Supplements Affect Coagulation in Women Using Birth Control Pills

    Not yet reported Oregon Health and Science University 15 participants Est. completion 2019-12-11 1 site
    Other conditions: Contraceptive Usage, Coagulation
    View official trial listing →
  • Active, not recruiting NCT NCT03425838

    Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

    Not yet reported Borstkanker Onderzoek Groep 1050 participants Est. completion 2028-12 72 sites
    Other conditions: Breast Neoplasm Female
    View official trial listing →
  • Status unknown NCT NCT03442504

    Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer

    Not yet reported Institut Cancerologie de l'Ouest 57 participants Est. completion 2024-06 4 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT03443089

    Comparative Bioavailability of Two Injectable Suspension Formulations of Medroxyprogesterone Acetate+Estradiol Cypionate

    Not yet reported Galeno Desenvolvimento de Pesquisas Clínicas 24 participants Est. completion 2017-08-01 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT03451110

    Study to Assess the Pharmacokinetic Drug-Drug Interactions of Lemborexant When Coadministered With an Oral Contraceptive, Famotidine, or Fluconazole in Healthy Subjects

    Not yet reported Eisai Inc. 50 participants Est. completion 2018-03-23 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT03462251

    Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line

    Not yet reported iOMEDICO AG 41 participants Est. completion 2022-11-30 27 sites
    Other conditions: Breast Cancer, Hormone Receptor Positive Tumor, HER 2 Negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT03470610

    Administration of Vaginal and Rectal Progesterone During FET Cycles

    Thor Haahr 277 participants Est. completion 2019-09-01 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT03498313

    Unique Effects of Perimenstrual Estradiol or Progesterone Supplementation on Perimenstrual Suicidality

    Not yet reported University of Illinois Chicago 60 participants Est. completion 2021-05-09 1 site Stand-alone
    Other conditions: Suicidal Ideation
    View official trial listing →
  • Withdrawn NCT NCT03506399

    A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive

    Not yet reported Eli Lilly and Company Est. completion 2018-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT03531437

    Comparison of Coagulation Profiles Between Zoely and Minidoz: RCT

    Not yet reported Mahidol University 112 participants Est. completion 2018-04-18
    Other conditions: Contraception, Hypercoagulability
    View official trial listing →
  • Active, not recruiting NCT NCT03531645

    Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma

    Not yet reported M.D. Anderson Cancer Center 18 participants Est. completion 2027-09-30 1 site
    Other conditions: Malignant Neoplasms of Female Genital Organs
    View official trial listing →
  • Status unknown NCT NCT03544762

    Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation

    Not yet reported National Taiwan University Hospital 60 participants Est. completion 2020-12-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03554044

    T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer

    Not yet reported University of California, San Francisco 20 participants Est. completion 2023-12-31 1 site
    Other conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8, Recurrent Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT03555877

    Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer

    Not yet reported GBG Forschungs GmbH 56 participants Est. completion 2022-07-21 1 site
    Other conditions: Breast Cancer Metastatic
    View official trial listing →
  • Status unknown NCT NCT03556800

    Study to Investigate the Pharmacokinetics & Safety Following One Application of 3 Different Doses 0.5,0.75,& 1.25 gm,a Transdermal Estradiol Cream (VML-0203), in Comparison to a Single Dose of EstroGel 1.25 gm to Healthy Post-menopausal Women.

    Not yet reported Viramal Limited 20 participants Est. completion 2022-06-30 1 site
    Other conditions: Menopause
    View official trial listing →
  • Status unknown NCT NCT03557619

    A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies

    Not yet reported AbbVie 12 participants Est. completion 2026-03-21 4 sites
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Status unknown NCT NCT03560856

    A Biomarker Study of Palbociclib + Fulvestrant for Second, and Third Line of Postmenopausal Women With hr+/her2- Advanced Breast Cancer

    Not yet reported Assistance Publique - Hôpitaux de Paris 54 participants Est. completion 2022-06-01
    Other conditions: Breast Cancer, HR+/HER2-negative Breast Cancer, Metastasis
    View official trial listing →
  • Completed NCT NCT03578172

    HMG Stimulation Versus HRT for Endometrial Preparation Prior to Blastocyst Transfer in Moderate to Severe IUA Patients

    Not yet reported Reproductive & Genetic Hospital of CITIC-Xiangya 186 participants Est. completion 2019-11-20 1 site
    Other conditions: Infertility, Female, Intrauterine Adhesion
    View official trial listing →
  • Terminated NCT NCT03584009

    A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor Therapy

    Not yet reported Hoffmann-La Roche 103 participants Est. completion 2021-05-06 40 sites
    Other conditions: Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03584971

    Estrogen and Cooperation, Competitiveness, and Risk Preferences

    RWTH Aachen University 80 participants Est. completion 2021-12-30 1 site
    Other conditions: Behavioral Correlates of Estradiol
    View official trial listing →
  • Status unknown NCT NCT03591549

    Fulvestrant in Metastatic Breast Cancer

    Not yet reported Assiut University 30 participants Est. completion 2021-10-01
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT03620643

    Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours

    Not yet reported Royal Marsden NHS Foundation Trust 33 participants Est. completion 2024-08-30 5 sites
    Other conditions: Lobular Breast Carcinoma, Gastric Cancer, Triple Negative Breast Cancer, CDH1 Gene Mutation
    View official trial listing →
  • Status unknown NCT NCT03620929

    Estrogen in the Prevention of Adhesion Reformation

    Not yet reported Fu Xing Hospital, Capital Medical University 186 participants Est. completion 2022-12-01 1 site
    Other conditions: Asherman Syndrome
    View official trial listing →
  • Completed NCT NCT03633331

    Testing the Effects of Palbociclib and Fulvestrant or Letrozole for Patients 70 Years of Age of Older With Metastatic Breast Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 93 participants Est. completion 2026-02-27 447 sites
    Other conditions: Estrogen Receptor-positive Breast Cancer, HER2/Neu Negative, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Active, not recruiting NCT NCT03640624

    Multidisciplinary Treatment of Chronic Vulvar Pain

    Not yet reported Norwegian University of Science and Technology 106 participants Est. completion 2027-06 1 site
    Other conditions: Vulvodynia, Chronic Pain
    View official trial listing →
  • Completed NCT NCT03642665

    Natural Versus Artificial Cycle for Frozen-Thawed Embryo Transfer

    Not yet reported Universitaire Ziekenhuizen KU Leuven 554 participants Est. completion 2024-11-01 1 site
    Other conditions: Embryo Transfer
    View official trial listing →
  • Completed NCT NCT03643510

    Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 27 participants Est. completion 2026-03-12 7 sites
    Other conditions: Adenocarcinoma of Endometrium
    View official trial listing →
  • Completed NCT NCT03652623

    Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - PK Study

    Not yet reported, Not yet reported Hektoen Institute for Medical Research 49 participants Est. completion 2023-11-30 1 site
    Other conditions: HIV/AIDS, Gender, Behavior and Behavior Mechanisms
    View official trial listing →
  • Completed NCT NCT03662516

    A Study to Determine the Effects of PF-04965842 on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Subjects

    Not yet reported Pfizer 17 participants Est. completion 2019-01-19 1 site
    Other conditions: Healthy Females
    View official trial listing →
  • Completed NCT NCT03685331

    HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer

    Not yet reported Abramson Cancer Center at Penn Medicine 9 participants Est. completion 2025-12-01 1 site
    Other conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer, Advanced Breast Cancer, BRCA2 Mutation, BRCA1 Mutation
    View official trial listing →
  • Completed NCT NCT03689543

    Estrogen Receptor Beta and Mood

    Not yet reported National Institute of Mental Health (NIMH) 74 participants Est. completion 2024-09-09 1 site
    Other conditions: Perimenopause-Related Depression
    View official trial listing →
  • Completed NCT NCT03691493

    Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis

    Not yet reported Emory University 36 participants Est. completion 2022-10-13 10 sites
    Other conditions: Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Bone, Progesterone Receptor Positive, Prognostic Stage IV Breast Cancer AJCC v8
    View official trial listing →
  • Completed NCT NCT03720847

    Effect of Perimenstrual Ovarian Steroid Supplementation on Perimenstrual Suicidality

    Not yet reported University of North Carolina, Chapel Hill 30 participants Est. completion 2017-11 1 site
    Other conditions: Suicidal Ideation
    View official trial listing →
  • Withdrawn NCT NCT03724955

    Pilot E2 for Hypogonadal Women With CFBD

    Not yet reported Emory University Est. completion 2021-06 1 site
    Other conditions: Cystic Fibrosis Related Bone Disease
    View official trial listing →
  • Terminated NCT NCT03725696

    The Effect of Bariatric Surgery on Spermatogenesis

    The Cleveland Clinic 25 participants Est. completion 2020-12-31 1 site
    Other conditions: Bariatric Surgery Candidate, Sexual Function and Fertility Disorders
    View official trial listing →
  • Completed NCT NCT03726931

    FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET

    Not yet reported Amsterdam UMC, location VUmc 40 participants Est. completion 2023-01-29 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT03749733

    Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol Acetate

    Not yet reported Grünenthal GmbH Est. completion 2019-12 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT03751124

    Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

    Not yet reported Myovant Sciences GmbH 229 participants Est. completion 2021-10-20 104 sites
    Other conditions: Uterine Leiomyoma, Uterine Fibroids
    View official trial listing →
  • Completed NCT NCT03767335

    MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer

    Not yet reported Menarini Group 62 participants Est. completion 2024-02-23 27 sites
    Other conditions: Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03773263

    New Application of Sequential in Vitro Muturation System for Infertility Patients With Polycystic Ovary Syndrome

    Not yet reported Sun Yat-sen University 300 participants Est. completion 2020-03 5 sites
    Other conditions: Polycystic Ovary Syndrome, Infertility
    View official trial listing →
  • Completed NCT NCT03778931

    Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

    Not yet reported Stemline Therapeutics, Inc. 478 participants Est. completion 2024-08-22 244 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03779633

    Preoperative Oestrogen in Postmenopausal Women With Pelvic Organ Prolapse

    Not yet reported Medical University of Vienna 120 participants Est. completion 2020-08-27 2 sites
    Other conditions: Pelvic Organ Prolapse
    View official trial listing →
  • Completed NCT NCT03783897

    A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects

    Not yet reported Enanta Pharmaceuticals, Inc 43 participants Est. completion 2019-06-18 1 site
    MASH
    View official trial listing →
  • Status unknown NCT NCT03788681

    Luteal Phase Support With Estradiol In Poor Responders Undergoing In Vitro Fertilization

    Not yet reported Ain Shams University 170 participants Est. completion 2019-09-01 1 site
    Other conditions: ICSI
    View official trial listing →
  • Status unknown NCT NCT03789123

    Effects of Dienogest and Dienogest Plus Estradiol Valerate in Ovarian Endometrioma

    Not yet reported Bagcilar Training and Research Hospital 710 participants Est. completion 2019-12-01 1 site
    Other conditions: Ovarian Reserve
    View official trial listing →
  • Completed NCT NCT03809546

    Individual Differences in Drug Response

    Not yet reported University of Chicago 60 participants Est. completion 2021-06-01 1 site
    Other conditions: Differential Female Response to Δ9-tetrahydrocannabinol (THC)
    View official trial listing →
  • Completed NCT NCT03815929

    Oophorectomy, Estrogen Therapy and Cardiovascular Disease Risk in Young Women

    Not yet reported Mayo Clinic 35 participants Est. completion 2023-08-28 1 site
    Other conditions: Cardiovascular Risk Reduction
    View official trial listing →
  • Completed NCT NCT03819140

    Continuous Versus Cyclical OCP Use in PCOS

    Not yet reported University of California, San Francisco 51 participants Est. completion 2022-10-16 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Status unknown NCT NCT03832894

    Oestradiol Supplementation in Luteal Long Agonist Fresh In Vitro Fertilization/Intra Cytoplasmic Sperm Injection ( IVF/ICSI) Cycle .

    Not yet reported Cairo University 2 participants Est. completion 2020-01-01 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT03837223

    RESCUE PROTOCOL AND FRESH EMBRYO TRANSFER

    Istituto Clinico Humanitas 271 participants Est. completion 2016-12-31
    Other conditions: GnRH Trigger and Rescue Protocol
    View official trial listing →
  • Completed NCT NCT03848234

    Estradiol Patch as add-on to Antipsychotics in Patients With Schizophrenia, Schizoaffective or Schizophreniform Disorder

    Not yet reported Tangent Data 209 participants Est. completion 2016-07-29 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders
    View official trial listing →
  • Completed NCT NCT03854903

    WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor

    Not yet reported Georgetown University 19 participants Est. completion 2025-01-09 1 site
    Other conditions: Metastatic Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Hormone Receptor Positive Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT03856268

    Understanding the Roles of Hormones in Adipocyte Remodeling Following Menopause

    Pennington Biomedical Research Center Est. completion 2022-11-11 1 site
    Other conditions: Menopause Surgical, Estrogen Deficiency, Adiposity, Follicle-Stimulating Hormone Deficiency, Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT03876145

    The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome

    Not yet reported Royan Institute 120 participants Est. completion 2020-11-20 1 site
    Other conditions: Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome
    View official trial listing →
  • Completed NCT NCT03887728

    Comparison of Blood Flow in the Arteriae Uterinae in Ovarian Stimulation Cycles

    ART Fertility Clinics LLC 124 participants Est. completion 2020-12-14 1 site
    Other conditions: Endometrial Receptivity
    View official trial listing →
  • Completed NCT NCT03901131

    PROMES: A Clinical Study in Which Researchers Want to Learn More About the Safety Profile of MESIGYNA (Norethisterone Enantate 50 mg and Estradiol Valerate 5 mg) Used as a Medication to Prevent Pregnancy for Adult Women in Reproductive Age in the Peruvian Population at the Outpatient Clinic.

    Bayer 296 participants Est. completion 2022-02-17 1 site
    Other conditions: Contraceptive
    View official trial listing →
  • Completed NCT NCT03921710

    CAPA-IVM Versus STANDARD IVM

    Not yet reported Mỹ Đức Hospital 80 participants Est. completion 2018-10-10 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Status unknown NCT NCT03925233

    Breast Cancer Treatment Based on Organ-like Culture

    Xijing Hospital 300 participants Est. completion 2021-12-15 1 site
    Other conditions: Breast Cancer Organoids
    View official trial listing →
  • Completed NCT NCT03926936

    FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study

    Not yet reported Frederic Amant 17 participants Est. completion 2022-12-27 14 sites
    Obstructive sleep apnea Other conditions: Endometrial Stromal Sarcoma, Endometrial Cancer, Sex Cord Stromal Tumor, Serous Ovarian Tumor
    View official trial listing →
  • Status unknown NCT NCT03927456

    A Study of SHR6390 in Combination With Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 357 participants Est. completion 2022-12-30 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT03930706

    SHorter Treatment of Replacement Therapy for Frozen Embryo Transfer (FET)

    Not yet reported Universitair Ziekenhuis Brussel 150 participants Est. completion 2021-03-31 1 site
    Other conditions: Infertility
    View official trial listing →
  • Active, not recruiting NCT NCT03939897

    Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer

    Not yet reported National Cancer Institute (NCI) 24 participants Est. completion 2027-07-31 14 sites
    Other conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast Carcinoma, Recurrent Breast Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT03941730

    Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer

    Not yet reported Mayo Clinic 8 participants Est. completion 2026-12-31 9 sites
    Other conditions: Advanced Triple-Negative Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Recurrent Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT03945513

    A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles

    Not yet reported Insud Pharma 1034 participants Est. completion 2023-09-08 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT03945812

    Platelet-Rich Plasma vs. Granulocyte Colony-Stimulating Factor vs. Placebo and Outcomes in Frozen Embryo Transfer

    Not yet reported Wael Elbanna Clinic 665 participants Est. completion 2023-03-08 1 site
    Other conditions: Infertility, Frozen Embryo Transfer (FET)
    View official trial listing →
  • Terminated NCT NCT03976544

    Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT Patients

    Not yet reported CRG UZ Brussel 362 participants Est. completion 2025-01-01 1 site
    Other conditions: Miscarriage, Frozen Embryo Transfer, Natural Cycle, Hormone Replacement Therapy Cycle, Preimplantation Genetic Screening, Euploid Embryos
    View official trial listing →
  • Status unknown NCT NCT03981341

    Impact of Estrogen + Estradiol Receptor Alpha Modulator Therapy on Oxidative Stress in Post-menopausal Women With and Without Sleep Apnea

    Not yet reported Laval University 36 participants Est. completion 2023-12-01 1 site
    Other conditions: Sleep Apnea, Post Menopausal, Oxidative Stress
    View official trial listing →
  • Completed NCT NCT03998761

    Progesterone Versus Progesterone Plus Dydrogesterone in FET

    Not yet reported Mỹ Đức Hospital 1364 participants Est. completion 2021-01-31 1 site
    Other conditions: Infertility
    View official trial listing →
  • Withdrawn NCT NCT04002635

    Letrozole for Frozen Embryo Transfer (FET) in Patients With Polycystic Ovary Syndrome (PCOS)

    Not yet reported CRG UZ Brussel Est. completion 2022-04-01
    Other conditions: Infertility, Female, Polycystic Ovary Syndrome, IVF, Ovulation Disorder
    View official trial listing →
  • Completed NCT NCT04013438

    Luteal Phase Support During Frozen Embryo Transfer Cycle

    Not yet reported Royan Institute 60 participants Est. completion 2019-04-30 1 site
    Other conditions: Infertility, Female, Frozen Embryo Transfer
    View official trial listing →
  • Completed NCT NCT04018274

    Effect of PF-06651600 on the Pharmacokinetics of Oral Contraceptive Steroids

    Not yet reported Pfizer 29 participants Est. completion 2019-10-16 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT04021017

    PRE-GAiN Bone Health Pilot Study

    Not yet reported University of Saskatchewan Est. completion 2022-12-13 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Status unknown NCT NCT04034589

    Pyrotinib in Combination With Fulvestrant in Patients With HER2 Positive,HR-Positive Metastatic Breast Cancer

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 46 participants Est. completion 2022-07-06 2 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04050592

    Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life

    Not yet reported Hanna Savolainen-Peltonen 150 participants Est. completion 2022-12 1 site
    Cardiovascular disease Other conditions: Menopause, Atherosclerosis, Estrogen Replacement Therapy
    View official trial listing →
  • Completed NCT NCT04051320

    Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model

    Not yet reported University of North Carolina, Chapel Hill 23 participants Est. completion 2022-07-19 1 site
    Other conditions: Perinatal Depression, Post Partum Depression, Depression, Postpartum, Depression
    View official trial listing →
  • Completed NCT NCT04055129

    Hormone Induced Effects on Ligament Laxity and Lower Extremity Motor Control

    University of St. Augustine for Health Sciences 52 participants Est. completion 2023-08-01 1 site
    Other conditions: Hormone Influence on Ligament Laxity and Motor Control
    View official trial listing →
  • Terminated NCT NCT04059484

    Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer

    Not yet reported Sanofi 367 participants Est. completion 2025-01-02 109 sites
    Other conditions: Breast Cancer Metastatic
    View official trial listing →
  • Terminated NCT NCT04060862

    A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer

    Not yet reported Hoffmann-La Roche 20 participants Est. completion 2023-08-29 20 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04066283

    Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Women

    University of Colorado, Denver 29 participants Est. completion 2023-12-31 1 site
    Other conditions: Transgender, Gender Identity, Vascular Stiffness, Vascular Inflammation, Insulin Sensitivity, Blood Pressure, Lipid Disorder, Appetitive Behavior
    View official trial listing →
  • Completed NCT NCT04079218

    Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial

    Not yet reported Kerry Murphy 60 participants Est. completion 2023-08-09 1 site
    Other conditions: HIV Infection, Vaginal Atrophy, Menopause, Menopause Related Conditions, Aging, Premature Aging, Atrophic Vaginitis, Dysbiosis, Vaginitis
    View official trial listing →
  • Completed NCT NCT04090957

    Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II)

    Not yet reported Estetra 1015 participants Est. completion 2022-08-18 117 sites
    Other conditions: Vasomotor Symptoms, Menopausal Symptoms
    View official trial listing →
  • Status unknown NCT NCT04092673

    Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies

    Not yet reported, Not yet reported Effector Therapeutics 30 participants Est. completion 2025-03-31 14 sites
    Other conditions: Solid Tumor, Adult
    View official trial listing →
  • Terminated NCT NCT04092829

    Impact of Corpus Luteum Presence or Absence in the Incidence of Preeclampsia After Frozen Embryo Transfer

    Not yet reported Instituto Valenciano de Infertilidad, IVI VALENCIA 591 participants Est. completion 2022-12-31 1 site
    Other conditions: Pre-Eclampsia, Frozen Embryo Transfer
    View official trial listing →
  • Status unknown NCT NCT04100655

    The Effect of the GM-CSF Gel on the Endometrial Thickness in Infertile Women With Thin Endometrium

    Not yet reported Sir Run Run Shaw Hospital 96 participants Est. completion 2020-12 1 site
    Other conditions: Thin Endometrium
    View official trial listing →
  • Active, not recruiting NCT NCT04103476

    Advancing Postmenopausal Preventive Therapy

    Not yet reported University of Southern California 385 participants Est. completion 2026-12-31 1 site
    Other conditions: Atherosclerosis, Cognitive Decline
    View official trial listing →
  • Completed NCT NCT04107129

    Predicting Endometrial Receptivity for Optimal Reproductive Management

    Stanford University 76 participants Est. completion 2024-07-30 1 site
    Other conditions: Infertility, Female, Endometriosis
    View official trial listing →
  • Completed NCT NCT04112368

    Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach

    Not yet reported University of Illinois Chicago 124 participants Est. completion 2024-08-01 1 site Stand-alone
    Other conditions: Suicidal Ideation
    View official trial listing →
  • Terminated NCT NCT04131517

    A Study to Test the Interaction of Padsevonil With Oral Contraceptives in Healthy Female Participants

    Not yet reported UCB Biopharma SRL 14 participants Est. completion 2020-05-22 1 site
    Other conditions: Healthy Female Participants
    View official trial listing →
  • Completed NCT NCT04150731

    16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast Cancer

    Not yet reported, Not yet reported University of Aarhus 8 participants Est. completion 2023-06-28 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04172987

    A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female Participants

    Not yet reported Eli Lilly and Company 40 participants Est. completion 2021-02-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT04190927

    A New Hormone Replacement Paradigm: Physiologic Restoration Study

    Not yet reported Women's Hormone Network 100 participants Est. completion 2023-08-01
    Other conditions: Menopause, Perimenopausal Disorder, Menopause Related Conditions
    View official trial listing →
  • Completed NCT NCT04193852

    Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product

    Not yet reported Laboratorios Andromaco S.A. 10 participants Est. completion 2019-11-25 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT04194905

    Bioavailability of Levonorgestrel/Ethinyl Estradiol Tablets 0.1 mg/0.02 mg With Regards to Reference Product

    Not yet reported Laboratorios Andromaco S.A. 10 participants Est. completion 2020-12-15 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Enrolling by invitation NCT NCT04202094

    Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems

    Not yet reported Universitair Ziekenhuis Brussel 50 participants Est. completion 2030-12 1 site
    Other conditions: Childhood Cancer, Hematological Disorders
    View official trial listing →
  • Completed NCT NCT04209543

    Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)

    Not yet reported Estetra 1570 participants Est. completion 2024-02-08 224 sites
    Other conditions: Vasomotor Symptoms, Menopausal Symptoms
    View official trial listing →
  • Completed NCT NCT04209881

    Ovarian Reserve and Ankylosing Spondylitis

    Kanuni Sultan Suleyman Training and Research Hospital 50 participants Est. completion 2020-05-19 1 site
    Other conditions: Ovarian Diseases, Ankylosing Spondylitis, Anti-Mullerian Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT04230070

    Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product

    Not yet reported Laboratorios Andromaco S.A. 30 participants Est. completion 2020-11-17 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT04247126

    A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors

    Not yet reported Syros Pharmaceuticals 105 participants Est. completion 2023-03-30 16 sites
    Other conditions: Advanced Solid Tumor, Breast Cancer, Small-cell Lung Cancer, Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT04247204

    Assessment of Endometrial and Sub-endometrial Vascularity Before and After PRP Infusion in Frozen Embryo Transfer Cycles

    Not yet reported Hatem AbuHashim 30 participants Est. completion 2020-10-05
    Other conditions: Frozen Embryo Transfer
    View official trial listing →
  • Completed NCT NCT04258163

    Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 760 participants Est. completion 2019-07-01 3 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT04259996

    Impact of Serum Progesterone in Modified Natural Cycles and Stimulated Cycles on Ongoing Pregnancy Rate

    Instituto Valenciano de Infertilidad, IVI VALENCIA 488 participants Est. completion 2023-07-01 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Completed NCT NCT04267250

    Effect Of Multiple Dose PF-06700841 On The Pharmacokinetics Of Single Dose Oral Contraceptive Steroids

    Not yet reported Pfizer 18 participants Est. completion 2020-11-06 2 sites
    Other conditions: Healthy Female Volunteers
    View official trial listing →
  • Completed NCT NCT04272008

    The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol

    Not yet reported TherapeuticsMD 21 participants Est. completion 2021-06-08 2 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT04278053

    Evaluation of Sports Supplements on Blood Flow

    Not yet reported University of Arkansas, Fayetteville 24 participants Est. completion 2019-05-08 1 site
    Other conditions: Determine the Effects of Nitrosigine and Citrulline-malate on Flow-mediated Dilation Among Young Adults
    View official trial listing →
  • Terminated NCT NCT04278755

    Binge Eating & Birth Control

    Not yet reported University of North Carolina, Chapel Hill 8 participants Est. completion 2022-05-17 1 site
    Obstructive sleep apnea Other conditions: Binge Eating, Eating Disorders, Binge-Eating Disorder
    View official trial listing →
  • Withdrawn NCT NCT04280523

    TranspulmonarY Estrogen Gradient and Estrogen Receptors (TYEGER) in PAH

    Vanderbilt University Medical Center Est. completion 2023-12-31 1 site
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Status unknown NCT NCT04283435

    Endometrial Effects of Sildenafil in Frozen-Thawed Cycles in Women With Thin Endometrium

    Not yet reported Cairo University 100 participants Est. completion 2022-03-01 1 site
    Other conditions: IVF, Endometrial Receptivity
    View official trial listing →
  • Status unknown NCT NCT04289974

    Predicted Biomarkers of CDK4/6 Inhibitors (Palbociclib) in ER-positive Metastasis Breast Cancer

    Chinese Academy of Medical Sciences 100 participants Est. completion 2022-04 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04300790

    Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients

    Not yet reported MedSIR 69 participants Est. completion 2025-03-16 19 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT04305236

    Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast Cancer

    Not yet reported University of California, Irvine 1 participants Est. completion 2022-02-16 1 site
    Other conditions: Breast Neoplasm, Hormone Receptor Positive Breast Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT04305496

    Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer

    Not yet reported AstraZeneca 818 participants Est. completion 2026-06-22 215 sites
    Other conditions: Locally Advanced (Inoperable) or Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT04309643

    Drug-drug Interaction Study of CTP-543 and Oral Contraceptives in Healthy Female Subjects

    Not yet reported Concert Pharmaceuticals 21 participants Est. completion 2020-07-08 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04330677

    Dissecting the Role of Estradiol in Mediating Gender-specific Anxiolytic and Prosocial Effects of Oxytocin

    Not yet reported University Hospital, Bonn 487 participants Est. completion 2020-01-25 1 site
    Other conditions: Oxytocin, Estrogen, Fear Extinction, Emotion Processing, Memory
    View official trial listing →
  • Completed NCT NCT04352777

    Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer

    Not yet reported Duke University 18 participants Est. completion 2025-06-25 1 site
    Other conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer, Hormone Receptor Positive Tumor
    View official trial listing →
  • Status unknown NCT NCT04355520

    A Study of TQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer

    Not yet reported, Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 42 participants Est. completion 2021-09 4 sites
    Other conditions: HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer
    View official trial listing →
  • Terminated NCT NCT04359329

    Estrogen Patch for COVID-19 Symptoms

    Not yet reported Sharon Nachman 2 participants Est. completion 2020-07-30 1 site
    Other conditions: COVID
    View official trial listing →
  • Completed NCT NCT04418908

    Estrogen, Diabetes, and Endothelial Function

    Not yet reported University of Colorado, Denver 40 participants Est. completion 2018-10-22
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT04423068

    Inpatient Adolescent Contraception

    Not yet reported Children's Mercy Hospital Kansas City 25 participants Est. completion 2023-04-04 1 site
    Other conditions: Pregnancy Related, Contraception, Contraceptive Usage, Contraception Behavior, Pregnancy
    View official trial listing →
  • Status unknown NCT NCT04433897

    Effect of Hormonal Replacement Therapy on Nocturia in Postmenopausal Women

    University Hospital, Ghent 300 participants Est. completion 2025-12-31 1 site
    Other conditions: Nocturia
    View official trial listing →
  • Completed NCT NCT04445025

    Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With Endometriosis

    Not yet reported Colorado Center for Reproductive Medicine 30 participants Est. completion 2024-12-30 1 site
    Other conditions: Infertility, Endometriosis
    View official trial listing →
  • Status unknown NCT NCT04447872

    The LUTEAL Trial: Luteal Stimulation vs. Estrogen Priming Protocol

    Not yet reported Northwell Health 142 participants Est. completion 2025-06 1 site
    Other conditions: Infertility, Diminished Ovarian Reserve, IVF
    View official trial listing →
  • Status unknown NCT NCT04453332

    Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters

    Not yet reported Hospital de Clinicas de Porto Alegre 60 participants Est. completion 2021-12 1 site
    Other conditions: Menopause, Hormone Replacement Therapy
    View official trial listing →
  • Terminated NCT NCT04454749

    Endometrial Compaction and Its Influence on Pregnancy Rate in Frozen Embryo Cycle Regimes

    ART Fertility Clinics LLC 3 participants Est. completion 2021-03-04 1 site
    Other conditions: Endometrial Disorder, Infertility, Female, IVF, Pregnancy Early
    View official trial listing →
  • Completed NCT NCT04482920

    Effect of Hormone Therapy on Renal Function

    University of Colorado, Denver 22 participants Est. completion 2023-08-31 1 site
    Other conditions: Transgenderism, Kidney Diseases, Kidney Injury
    View official trial listing →
  • Completed NCT NCT04483505

    Rogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer.

    Not yet reported Fundacion CRIS de Investigación para Vencer el Cáncer 9 participants Est. completion 2023-04-04 8 sites
    Other conditions: Breast Cancer Metastatic, Hormone Receptor Positive Malignant Neoplasm of Breast
    View official trial listing →
  • Withdrawn NCT NCT04498520

    Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

    Not yet reported Pamela Munster Est. completion 2025-06-30
    Other conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Carcinoma, Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Metastatic Endometrioid Adenocarcinoma, Metastatic Fallopian Tube Carcinoma, Metastatic HER2 Negative Breast Carcinoma, Metastatic Malignant Solid Neoplasm, Metastatic Ovarian Carcinoma, Metastatic Primary Peritoneal Carcinoma, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma, Refractory Breast Carcinoma, Stage IV Fallopian Tube Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Primary Peritoneal Cancer AJCC v8, Stage IV Uterine Corpus Cancer AJCC v8, Stage IVA Fallopian Tube Cancer AJCC v8, Stage IVA Ovarian Cancer AJCC v8, Stage IVA Primary Peritoneal Cancer AJCC v8, Stage IVA Uterine Corpus Cancer AJCC v8, Stage IVB Fallopian Tube Cancer AJCC v8, Stage IVB Ovarian Cancer AJCC v8, Stage IVB Primary Peritoneal Cancer AJCC v8, Stage IVB Uterine Corpus Cancer AJCC v8
    View official trial listing →
  • Withdrawn NCT NCT04503161

    The Effect of an ASC-seeded Collagen Hydrogel on Cerebrospinal Fluid Leak Rates Following Skull Base Surgery

    Not yet reported Stanford University Est. completion 2022-09
    Other conditions: CSF Leak
    View official trial listing →
  • Status unknown NCT NCT04503915

    Estrogen Supplementation Mode in HRT-FET Cycle: a RCT

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 784 participants Est. completion 2023-12-01
    Other conditions: Hormone Replacement Therapy, Estrogen, Live Birth Rate
    View official trial listing →
  • Completed NCT NCT04508582

    Cardiac and Immune Cell Function in Preeclampsia

    Queen Mary University of London 86 participants Est. completion 2024-03-06 1 site
    Cardiovascular disease Other conditions: Preeclampsia, Hypertension, Pregnancy Induced Hypertension, Pregnancy Related, Cardiovascular Risk Factor, Heart Diseases
    View official trial listing →
  • Status unknown NCT NCT04513405

    Estrogens Levels and Receptors Status and Skin Tears

    Not yet reported University of Catanzaro 1200 participants Est. completion 2022-09-01 1 site
    Other conditions: Skin Tear, Estrogen Deficiency
    View official trial listing →
  • Active, not recruiting NCT NCT04524000

    Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer

    Not yet reported Novartis Pharmaceuticals 24 participants Est. completion 2027-02-27 15 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT04537078

    Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders

    Not yet reported El Shatby University Hospital for Obstetrics and Gynecology 90 participants Est. completion 2021-09-01 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Status unknown NCT NCT04539626

    Estrogen Therapy in Non-severe COVID-19 Patients

    Not yet reported CMN "20 de Noviembre" 44 participants Est. completion 2023-12-31 1 site
    Other conditions: Covid-19
    View official trial listing →
  • Active, not recruiting NCT NCT04544189

    Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer

    Not yet reported Novartis Pharmaceuticals 69 participants Est. completion 2027-01-29 24 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT04544475

    A Randomized, Single Center Pilot Study Comparing Hyaluronic Acid to Vaginal Estrogen for Treatment of Genitourinary Syndrome of Menopause

    Not yet reported NYU Langone Health 49 participants Est. completion 2022-10-03 1 site
    Other conditions: Genitourinary Syndrome of Menopause (GSM)
    View official trial listing →
  • Active, not recruiting NCT NCT04553133

    PF-07104091 as a Single Agent and in Combination Therapy

    Not yet reported Pfizer 157 participants Est. completion 2026-12-31 22 sites
    Other conditions: Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04567420

    DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)

    Not yet reported Criterium, Inc. 70 participants Est. completion 2028-12-31 19 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04572295

    A Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer

    Not yet reported Eisai Co., Ltd. 51 participants Est. completion 2026-06-18 11 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT04574999

    Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy.

    Not yet reported Italfarmaco S.A 167 participants Est. completion 2009-02-23 12 sites
    Other conditions: Vaginal Atrophy
    View official trial listing →
  • Active, not recruiting NCT NCT04576455

    A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)

    Not yet reported Hoffmann-La Roche 303 participants Est. completion 2027-08-25 81 sites
    Other conditions: Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04579380

    Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

    Not yet reported Seagen, a wholly owned subsidiary of Pfizer 217 participants Est. completion 2026-12-31 108 sites
    Other conditions: Uterine Neoplasms, Uterine Cervical Neoplasms, Biliary Tract Neoplasms, Urologic Neoplasms, Carcinoma, Non-Small-Cell Lung, HER2 Mutations Breast Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT04590417

    Assessment of Drug-drug Interactions Between Feminizing Hormone Therapy and Emtricitabine/Tenofovir Alafenamide Concomitantly for Pre-exposure Prophylaxis Among Transgender Women

    Not yet reported Thai Red Cross AIDS Research Centre 20 participants Est. completion 2025-10-01 1 site
    Other conditions: Drug Interaction
    View official trial listing →
  • Completed NCT NCT04603183

    ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL

    Not yet reported MedSIR 162 participants Est. completion 2025-06-30 31 sites
    Other conditions: Breast Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT04616417

    Investigational Oocyte Cryopreservation for Medical and Non Medical Indications

    Not yet reported University of Illinois Chicago 29 participants Est. completion 2023-03-20 1 site
    Other conditions: Infertility, Female, Deferred Childbearing
    View official trial listing →
  • Status unknown NCT NCT04616729

    DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation

    Not yet reported, Not yet reported Universitair Ziekenhuis Brussel 30 participants Est. completion 2025-12-31 2 sites
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Completed NCT NCT04641624

    sFlt- 1, PIGF, and Niacin Levels in Women With Premature Ovarian Insufficiency

    Cengiz Gokcek Women's and Children's Hospital 90 participants Est. completion 2021-08-30 1 site
    Other conditions: Premature Ovarian Insufficiency
    View official trial listing →
  • Active, not recruiting NCT NCT04650581

    Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor

    Not yet reported Canadian Cancer Trials Group 250 participants Est. completion 2026-12-31 39 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04714554

    A Study of the Effects of Erythromycin on the Pharmacokinetics of Relugolix, Estradiol, and Norethindrone in Healthy Postmenopausal Women and on the Pharmacokinetics of Relugolix in Healthy Adult Men

    Not yet reported Myovant Sciences GmbH 43 participants Est. completion 2021-03-29 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT04738292

    Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)

    Not yet reported University of Wisconsin, Madison 11 participants Est. completion 2023-05-15 2 sites
    Other conditions: ER-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Cancer
    View official trial listing →
  • Completed NCT NCT04746313

    Prevalence of Hyperprolactinemia in Systemic Scleroderma

    University Hospital, Lille 71 participants Est. completion 2021-05-12 1 site
    Other conditions: Sclerosis, Systemic, Scleroderma, Hyperprolactinemia
    View official trial listing →
  • Completed NCT NCT04760691

    Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGW

    Not yet reported Johns Hopkins University 13 participants Est. completion 2025-03-24 1 site
    Other conditions: HIV, Prophylaxis, Transgender
    View official trial listing →
  • Active, not recruiting NCT NCT04762979

    Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer

    Not yet reported Marina N Sharifi 44 participants Est. completion 2026-05 4 sites
    Other conditions: Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast Cancer, PIK3CA Mutant Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT04769401

    Effects of E2, P4 and LH Levels on the Day of Transfer and Endometrial Cavity Thickness on Implantation Success in Patients With Frozen-thawed Embryo Transfer Cycle

    Not yet reported Bezmialem Vakif University 238 participants Est. completion 2021-11-21 2 sites
    Other conditions: Infertility, IVF, Progesterone
    View official trial listing →
  • Completed NCT NCT04778514

    A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention

    Not yet reported Population Council 30 participants Est. completion 2023-09-11 1 site
    Other conditions: HIV Infections, Contraception
    View official trial listing →
  • Completed NCT NCT04796623

    A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast Cancer

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 122 participants Est. completion 2024-05-24 17 sites
    Other conditions: HR-positive, HER2-negative Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT04819906

    Effect of Estetrol Monohydrate (E4) on QTc Interval

    Not yet reported Estetra 32 participants Est. completion 2021-07-14 1 site
    Other conditions: Prolonged QTc Interval
    View official trial listing →
  • Completed NCT NCT04821375

    Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers

    Not yet reported Carol Fabian, MD 16 participants Est. completion 2024-12-31 1 site
    Other conditions: Increased Risk for Development of Breast Cancer
    View official trial listing →
  • Completed NCT NCT04822857

    The Impact of Menopause on the Development of Heart Failure and Organ Damage of Hypertension

    Polish Mother Memorial Hospital Research Institute 86 participants Est. completion 2020-12-30 1 site
    Other conditions: Hypertension, Menopause
    View official trial listing →
  • Completed NCT NCT04828824

    Premature Discontinuation of Contraceptive Implants

    Not yet reported University of Colorado, Denver 600 participants Est. completion 2025-11-12 1 site
    Other conditions: Contraception Behavior
    View official trial listing →
  • Completed NCT NCT04841499

    Effects of a Seven-day BASIS™ Supplementation on Menopausal Syndromes and Measurements of the Urinary Vitamin B3 and Estradiol Levels in Pre-, Peri- and Post-menopause

    Not yet reported University of South Alabama 40 participants Est. completion 2021-07-15 1 site
    Other conditions: Menopause
    View official trial listing →
  • Status unknown NCT NCT04852081

    Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.

    Blokhin's Russian Cancer Research Center 1000 participants Est. completion 2021-12-01 1 site
    Other conditions: Breast Cancer Stage IV
    View official trial listing →
  • Status unknown NCT NCT04853069

    Oestrogen Treatment for COVID-19 Symptoms

    Not yet reported Hamad Medical Corporation 2000 participants Est. completion 2022-03-31 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT04856306

    Myomectomy vs Uterine Artery Embolization vs GnRh Antagonist for AUB-L

    Medstar Health Research Institute 300 participants Est. completion 2025-08-30 1 site
    Other conditions: Heavy Menstrual Bleeding, Fibroid Uterus
    View official trial listing →
  • Terminated NCT NCT04862143

    Pilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combination With Fulvestrant

    Not yet reported Novartis Pharmaceuticals 2 participants Est. completion 2022-09-19 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04862663

    Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)

    Not yet reported AstraZeneca 893 participants Est. completion 2029-08-14 225 sites
    Other conditions: Locally Advanced (Inoperable) or Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT04865029

    Estradiol and Progesterone in Hospitalized COVID-19 Patients

    Not yet reported Tulane University 10 participants Est. completion 2022-01-25 1 site
    Other conditions: Covid19
    View official trial listing →
  • Terminated NCT NCT04899349

    Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant

    Not yet reported Novartis Pharmaceuticals 2 participants Est. completion 2023-05-10 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04899778

    Do Oral Contraceptives Protect Against ACL Injuries in Female Athletes

    Not yet reported Cedars-Sinai Medical Center 73 participants Est. completion 2024-06-30 1 site
    Other conditions: Ligament Injury
    View official trial listing →
  • Completed NCT NCT04901377

    A Study to Gather Information About User Satisfaction in Women in Russia Who Take Estradiol Valerate/Dienogest

    Bayer 255 participants Est. completion 2023-04-20 1 site
    Other conditions: Oral Contraception
    View official trial listing →
  • Completed NCT NCT04916509

    Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metastatic Breast Cancer in the Arabian Gulf Region

    Pfizer 258 participants Est. completion 2022-12-27 7 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT04920708

    Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression

    Not yet reported Royal Marsden NHS Foundation Trust 57 participants Est. completion 2027-06 13 sites
    Other conditions: Metastatic Breast Cancer, ER+ Breast Cancer, Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT04923867

    Suturable DuraGen™ PMCF Study

    Integra LifeSciences Corporation 106 participants Est. completion 2024-07-31 3 sites
    Other conditions: Cerebrospinal Fluid Leak
    View official trial listing →
  • Withdrawn NCT NCT04933240

    Tamoxifen Versus Estradiol for Unscheduled Bleeding in Etonogestrel Implant Users, a Randomized Pilot Trial

    Not yet reported Virginia Commonwealth University Est. completion 2024-12 2 sites
    Other conditions: Vaginal Bleeding
    View official trial listing →
  • Completed NCT NCT04934696

    A Study to Characterize the Drug Levels of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing Potential

    Not yet reported Bristol-Myers Squibb 25 participants Est. completion 2022-01-25 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Status unknown NCT NCT04936295

    Fulvestrant Plus Anlotinib in HR(+)/HER2(-) Metastatic Breast Cancer With FGFR Mutation

    Not yet reported Sun Yat-sen University 61 participants Est. completion 2025-06-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04942015

    Honghuaruyi Wan for Endometriosis Dysmenorrhea

    Not yet reported Beijing University of Chinese Medicine 164 participants Est. completion 2023-12-31
    Other conditions: Endometriosis, Dysmenorrhea
    View official trial listing →
  • Status unknown NCT NCT04962386

    Clinical Efficacy of Hormone Replacement Therapy in Treating Perimenopausal Women With MGD

    Second Affiliated Hospital, Zhejiang University, School of Medicine 30 participants Est. completion 2022-03-06 2 sites
    Other conditions: Meibomian Gland Dysfunction
    View official trial listing →
  • Terminated NCT NCT04967248

    A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women, and Men, With HR+,HER2- , Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation, After Disease Progression Following Endocrine Therapy as Monotherapy, in the Real-world Setting

    Novartis Pharmaceuticals 4 participants Est. completion 2024-10-18
    Other conditions: Hormone Receptor Positive HER2 Negative Breast Cancer With a PIK3CA Mutation
    View official trial listing →
  • Completed NCT NCT04972396

    Pemvidutide (ALT-801) DDI Study in Healthy Volunteers

    Not yet reported Altimmune, Inc. 40 participants Est. completion 2022-05-15 2 sites
    MASH
    View official trial listing →
  • Completed NCT NCT04979091

    Sex Hormone Dysregulations Are Associated With Critical Illness in COVID-19 Patients

    Universitätsklinikum Hamburg-Eppendorf 100 participants Est. completion 2021-05-31 1 site
    Other conditions: Covid19, Critical Illness
    View official trial listing →
  • Completed NCT NCT04989348

    Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol

    Not yet reported Shanghai First Maternity and Infant Hospital 240 participants Est. completion 2024-02-20 1 site
    Other conditions: IVF
    View official trial listing →
  • Completed NCT NCT04997525

    Estradiol and Progesterone Levels Following Frozen Embryo Transfer

    Not yet reported Copenhagen University Hospital at Herlev 305 participants Est. completion 2024-12-06 1 site
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT04999540

    Tucidinostat and Fulvestrant in Hormone-receptor Positive Advanced Breast Cancer

    Not yet reported Guangdong Women and Children Hospital 73 participants Est. completion 2024-12-30
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05002738

    Desogestrel-containing COCP Pharmacokinetic Validation Study

    Not yet reported University of Colorado, Denver 22 participants Est. completion 2022-11-28 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT05010707

    Transgender Estradiol Affirming Therapy

    Not yet reported Washington University School of Medicine 39 participants Est. completion 2024-01-01 1 site
    Other conditions: Transgenderism
    View official trial listing →
  • Status unknown NCT NCT05021094

    Clinical Observation on Kuntai Capsule in Treating Early-onset Ovarian Hypofunction

    Not yet reported Affiliated Hospital of Nantong University 120 participants Est. completion 2023-12-31 6 sites
    Other conditions: Primary Ovarian Insufficiency
    View official trial listing →
  • Status unknown NCT NCT05047848

    Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer

    Not yet reported Liaoning Cancer Hospital & Institute 82 participants Est. completion 2023-09-18 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT05054374

    A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 6 participants Est. completion 2023-10-26 4 sites
    Other conditions: Breast Cancer, Breast Cancer Stage IV, HER2-negative Breast Cancer, Solid Carcinoma, MEK1 Gene Mutation, MEK2 Gene Mutation, Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT05063786

    Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in PIK3CA-mutated HER2+ Advanced BC (ALPHABET)

    Not yet reported Spanish Breast Cancer Research Group 27 participants Est. completion 2025-12-23 106 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT05064332

    A Study To Estimate The Effect of PF-06650833 On The Pharmacokinetics (PK) of Oral Contraceptive (OC)

    Not yet reported Pfizer 10 participants Est. completion 2021-12-16 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT05065411

    Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer

    Not yet reported Veru Inc. 5 participants Est. completion 2024-01-09 30 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT05073237

    Effects of Novel Estrogens on Glucose and Lipids in Postmenopausal Prediabetic Women Veterans

    Not yet reported VA Office of Research and Development Est. completion 2024-04-08 1 site
    Prediabetes Other conditions: Menopause, Obesity
    View official trial listing →
  • Status unknown NCT NCT05076695

    Neoadjuvant With Trastuzumab, Pyrotinib Plus Palbociclib and Fulvestrant in HER2-positive, ER-positive Breast Cancer

    Not yet reported Fudan University 37 participants Est. completion 2024-10-15 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05077449

    A Study of XZP-3287 in Combination With Fulvestrant in Patients With Advanced Breast Cancer

    Not yet reported Xuanzhu Biopharmaceutical Co., Ltd. 300 participants Est. completion 2029-11 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Terminated NCT NCT05085002

    A Study of Lerociclib in Participants With Advanced Breast Cancer

    Not yet reported EQRx, Inc. 100 participants Est. completion 2023-11-29 21 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05090358

    Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 15 participants Est. completion 2027-10-08 9 sites
    Other conditions: Breast Cancer, Breast Cancer Stage IV, Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05096065

    Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis

    Not yet reported Enteris BioPharma Inc. 16 participants Est. completion 2022-05 4 sites
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT05098574

    Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder

    Not yet reported St. Joseph's Healthcare Hamilton 17 participants Est. completion 2024-04-11 1 site
    Other conditions: Premenstrual Dysphoric Disorder, Bipolar Disorder
    View official trial listing →
  • Status unknown NCT NCT05112692

    Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles

    Not yet reported Mansoura University 200 participants Est. completion 2023-12
    Other conditions: PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
    View official trial listing →
  • Status unknown NCT NCT05116371

    Control of Bleeding on Nexplanon in Latinx Patients

    University of Arizona 144 participants Est. completion 2024-12-01
    Other conditions: Contraception
    View official trial listing →
  • Status unknown NCT NCT05143723

    Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a

    Not yet reported Kuban State Medical University 102 participants Est. completion 2022-06-10 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT05153564

    A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause

    Not yet reported Novo Nordisk A/S 27 participants Est. completion 2022-09-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT05156879

    Aspirin for the Management of Endometriosis-associated Pelvic Pain

    Not yet reported Women's Hospital School Of Medicine Zhejiang University 220 participants Est. completion 2025-06 1 site
    Other conditions: Pelvic Pain
    View official trial listing →
  • Active, not recruiting NCT NCT05161195

    Roll-over Study to Allow Continued Access to Ribociclib

    Not yet reported Novartis Pharmaceuticals 134 participants Est. completion 2030-08-14 73 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT05161338

    Impact of Vaginal Microbiome on Vaginal Absorption of Exogenous Progesterone: a Pilot Study.

    Not yet reported Instituto Valenciano de Infertilidad, IVI VALENCIA 100 participants Est. completion 2023-04-30 1 site
    Other conditions: Infertility, Female
    View official trial listing →
  • Active, not recruiting NCT NCT05169567

    Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer

    Not yet reported Eli Lilly and Company 368 participants Est. completion 2027-12 138 sites
    Other conditions: Breast Neoplasm, Neoplasm Metastasis
    View official trial listing →
  • Completed NCT NCT05184777

    Evaluation of Salivary ELISA for Hormone Monitoring in IVF Patients

    Not yet reported Instituto Valenciano de Infertilidad, IVI VALENCIA 120 participants Est. completion 2023-02-20 1 site
    Other conditions: Infertility, Female, Reproductive Sterility
    View official trial listing →
  • Status unknown NCT NCT05186545

    An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer

    Not yet reported The First Affiliated Hospital of Zhengzhou University 63 participants Est. completion 2025-07 5 sites
    Other conditions: Breast Cancer, Breast Cancer Female
    View official trial listing →
  • Completed NCT NCT05189145

    Hormonal Monitoring and Progesterone Adjustment in Frozen Embryo Transfer Cycles

    Not yet reported Alexandria University 600 participants Est. completion 2021-10-01 1 site
    Other conditions: Female Infertility
    View official trial listing →
  • Completed NCT NCT05197374

    Effect of Estradiol Pretreatment on Antagonist ICSI Cycles

    Not yet reported Alexandria University 114 participants Est. completion 2021-11-15 1 site
    Other conditions: Female Infertility
    View official trial listing →
  • Terminated NCT NCT05207709

    Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype

    Not yet reported SOLTI Breast Cancer Research Group 61 participants Est. completion 2026-03-26 71 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05227391

    Live Birth After Letrozole-stimulated Cycles Versus Hormone Replacement Treatment Cycles for the First Frozen Embryo Transfer in Women With PCOS

    Not yet reported Reproductive & Genetic Hospital of CITIC-Xiangya 1078 participants Est. completion 2024-12-31 1 site
    Other conditions: PCOS
    View official trial listing →
  • Completed NCT NCT05243823

    Vaginal Estradiol Tablets (Vagifem®) and Endometrial Cancer Risk in the Treatment of Postmenopausal Vaginal Atrophy

    Novo Nordisk A/S 500000 participants Est. completion 2022-07-31 1 site
    Other conditions: Postmenopausal Vaginal Atrophy
    View official trial listing →
  • Terminated NCT NCT05252416

    (VELA) Study of BLU-222 in Advanced Solid Tumors

    Not yet reported Blueprint Medicines Corporation 50 participants Est. completion 2025-07-04 23 sites
    Obstructive sleep apnea Other conditions: Advanced Solid Tumors, HR+ Breast Cancer, CCNE1 Amplification, HER2-negative Breast Cancer, Ovarian Cancer, Endometrial Cancer, Gastric Cancer, Esophageal Adenocarcinoma
    View official trial listing →
  • Terminated NCT NCT05264506

    Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive

    Not yet reported Organon and Co 3055 participants Est. completion 2024-01-26 103 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT05282940

    Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product

    Not yet reported Laboratorios Andromaco S.A. 36 participants Est. completion 2022-04-08 1 site
    Other conditions: Therapeutic Equivalency
    View official trial listing →
  • Status unknown NCT NCT05300841

    The Effect of Pretreatment With Dydrogesterone Vs Combined Estradiol Valerate and Dydrogestrone on Clinical Pregnancy Outcome of ICSI in PCOS Patients"

    Not yet reported Sohag University 500 participants Est. completion 2023-05-01
    Other conditions: PCOS, ICSI
    View official trial listing →
  • Status unknown NCT NCT05302726

    Impact of Exogenous Estrogens on Cotisol Levels During Synacthen Stimulation

    Not yet reported Copenhagen University Hospital, Rigshospitalet 20 participants Est. completion 2023-06-01 1 site
    Other conditions: Adrenal Insufficiency, Hypogonadism Female
    View official trial listing →
  • Active, not recruiting NCT NCT05306340

    A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)

    Not yet reported Genentech, Inc. 373 participants Est. completion 2027-06-15 136 sites
    Other conditions: Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT05307133

    Oxytocin and Sleeve Gastrectomy

    Not yet reported Centre Hospitalier Universitaire de Nice 20 participants Est. completion 2025-03-04 1 site
    Other conditions: Obesity, Morbid
    View official trial listing →
  • Active, not recruiting NCT NCT05307705

    A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

    Not yet reported Eli Lilly and Company 260 participants Est. completion 2026-12 50 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT05317364

    Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery

    Not yet reported University of Alabama at Birmingham 38 participants Est. completion 2026-02-13 1 site
    Other conditions: Obstetric; Injury Pelvic Floor, Sexual Dysfunction, Anal Incontinence, Urinary Incontinence
    View official trial listing →
  • Active, not recruiting NCT NCT05319873

    Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer

    Not yet reported, Not yet reported Jonsson Comprehensive Cancer Center 18 participants Est. completion 2028-04-01 1 site
    Other conditions: Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Locally Advanced HER2-Positive Breast Carcinoma, Metastatic HER2-Positive Breast Carcinoma, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8
    View official trial listing →
  • Completed NCT NCT05360576

    An Open-label, Randomized, 2-Period, Crossover, Pharmacokinetics Study

    Not yet reported Lupin Research Inc 40 participants Est. completion 2022-07-04 1 site
    Other conditions: Pregnancy Prevention
    View official trial listing →
  • Terminated NCT NCT05384119

    Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer

    Not yet reported Tvardi Therapeutics, Incorporated 6 participants Est. completion 2024-05-06 6 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT05387577

    Coagulation and Fibrinolysis of Estradiol in Transwomen

    Not yet reported Medical College of Wisconsin 6 participants Est. completion 2022-11-23 1 site
    Other conditions: Transgenderism, Clotting Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT05392608

    SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)

    Not yet reported Borstkanker Onderzoek Groep 130 participants Est. completion 2028-03 25 sites
    Other conditions: Neoplasm, Breast, Congenital, Familial and Genetic Disorders
    View official trial listing →
  • Completed NCT NCT05418426

    A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women

    Not yet reported Daré Bioscience, Inc. 34 participants Est. completion 2022-01-27 2 sites
    Other conditions: Vulvovaginal Atrophy, Vasomotor Symptoms
    View official trial listing →
  • Completed NCT NCT05427617

    Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer

    Hunan Cancer Hospital 223 participants Est. completion 2021-06-30
    Other conditions: Metastatic Breast Cancer, Circulating Tumor DNA, Gene Abnormality
    View official trial listing →
  • Terminated NCT NCT05428215

    Comparison of PKs of 17-Beta-Estradiol Via Sublingual Placement Versus Swallowing in Male-to-Female Transgender Patients

    Not yet reported MaineHealth 2 participants Est. completion 2023-07-20 1 site
    Other conditions: Gender Dysphoria
    View official trial listing →
  • Active, not recruiting NCT NCT05463601

    Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast Cancer

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 132 participants Est. completion 2026-12-31 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT05469204

    Effect of Estrogen Treatment on Drug Metabolism and Transport

    Not yet reported University of Washington 22 participants Est. completion 2025-07-30 1 site
    Other conditions: Transgender Persons
    View official trial listing →
  • Completed NCT NCT05472779

    Periurethral vs Intravaginal Estrogen for Prevention of Recurrent Urinary Tract Infections

    Not yet reported Stephanie Wang Zuo 114 participants Est. completion 2025-06-25 4 sites
    Other conditions: Recurrent Urinary Tract Infection
    View official trial listing →
  • Completed NCT NCT05505162

    Assessing the Effect of Multiple Doses of Zibotentan on the Pharmacokinetics of Single Doses of Combined Oral Contraceptives in Healthy Female Participants of Non-childbearing Potential.

    Not yet reported AstraZeneca 24 participants Est. completion 2023-01-10 1 site
    Other conditions: Healthy Female Participants
    View official trial listing →
  • Status unknown NCT NCT05545592

    Reduced Oestrogen Dosage to Improve the Outcome of Frozen-thawed Embryo Transfer

    Not yet reported Nanjing University 660 participants Est. completion 2026-06-01 1 site
    Other conditions: FET
    View official trial listing →
  • Completed NCT NCT05551949

    Preventing Recurrent UTI With Vaginal Estrogen

    Not yet reported Johns Hopkins University 27 participants Est. completion 2025-08-31 1 site
    Other conditions: Recurrent Urinary Tract Infection, Urinary Tract Infections, Cystitis Recurrent
    View official trial listing →
  • Status unknown NCT NCT05574881

    Dalpiciclib, Fulvestrant, Trastuzumab and Pertuzumab in HR Positive, HER2 Positive Metastatic Breast Cancer

    Not yet reported, Not yet reported Fudan University 72 participants Est. completion 2025-01-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05577923

    Exploring Whether Disease-free Intervals Can Guide Endocrine Combined Targeted Therapy for ER+/HER2+ Advanced Breast Cancer (T-sunflower)

    Not yet reported Fudan University 126 participants Est. completion 2026-03-01 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT05579574

    A Study to Investigate the Interaction of BMS-986322 and a Combined Oral Hormonal Contraceptive (Ethinyl Estradiol [EE]/Norethindrone [NET]) in Healthy Female Participants

    Not yet reported Bristol-Myers Squibb 42 participants Est. completion 2023-06-01 2 sites
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT05586711

    Local DHEA and Estradiol on Dyspareunia in Postmenopausal Women

    Not yet reported Angelica Lindén Hirschberg 170 participants Est. completion 2024-12-15 1 site
    Other conditions: Vulvovaginal Atrophy, Genitourinary Syndrome of Menopause
    View official trial listing →
  • Completed NCT NCT05613777

    A Study in Healthy Women to Test Whether BI 425809 Influences the Amount of a Contraceptive in the Blood

    Not yet reported Boehringer Ingelheim 19 participants Est. completion 2023-10-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT05620355

    Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids.

    Not yet reported Bio Genuine (Shanghai) Biotech Co., Ltd. 312 participants Est. completion 2025-03 29 sites
    Other conditions: Uterine Fibroids, Heavy Menstrual Bleeding
    View official trial listing →
  • Active, not recruiting NCT NCT05654623

    A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer

    Not yet reported Pfizer 624 participants Est. completion 2028-05-15 312 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT05657171

    "Effect of CPA/EE Drug on Periodontal Tissue and hsCRP Levels in PCOS Patients With Gingivitis

    Postgraduate Institute of Dental Sciences Rohtak 47 participants Est. completion 2023-12-30 1 site
    Other conditions: Periodontal Diseases
    View official trial listing →
  • Completed NCT NCT05678192

    Effect of Menopausal Hormone Therapy on Immune System Parameters

    Not yet reported Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare 40 participants Est. completion 2023-03-01 1 site
    Other conditions: Last Period Not Earlier Than 6 Months Ago
    View official trial listing →
  • Status unknown NCT NCT05683119

    The Effect of Menstrual Cycle and Oral Contraceptive Pill Phase on Aspects of Exercise Physiology

    Not yet reported Western University, Canada 20 participants Est. completion 2024-12 1 site
    Other conditions: Menstrual Cycle, Oral Contraceptives
    View official trial listing →
  • Completed NCT NCT05706753

    A Study of Milvexian in Healthy Adult Females

    Not yet reported Janssen Pharmaceutica N.V., Belgium 20 participants Est. completion 2023-07-20 1 site
    Other conditions: Healthy Female
    View official trial listing →
  • Terminated NCT NCT05716139

    Natural Cycle vs Programmed Cycle Frozen Embryo Transfer

    Not yet reported Indira IVF Hospital Pvt Ltd 172 participants Est. completion 2024-03-26 1 site
    Other conditions: Infertility, Frozen Embryo Transfer, Preeclampsia and Eclampsia
    View official trial listing →
  • Status unknown NCT NCT05716152

    Hormonal Associations in Male Patients With Psoriasis Vulgaris

    Sohag University 102 participants Est. completion 2024-08-01
    Other conditions: Psoriasis Vulgaris
    View official trial listing →
  • Active, not recruiting NCT NCT05723601

    Preference of Women With Recurrent Urinary Tract Infection for Vaginal Estradiol Tablet vs Cream

    Not yet reported Wake Forest University Health Sciences 21 participants Est. completion 2027-01 1 site
    Other conditions: Recurrent Urinary Tract Infection
    View official trial listing →
  • Active, not recruiting NCT NCT05738213

    Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine

    Not yet reported Washington University School of Medicine 100 participants Est. completion 2028-01-01 1 site
    Other conditions: Migraine
    View official trial listing →
  • Active, not recruiting NCT NCT05739136

    MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy

    Sumitomo Pharma Switzerland GmbH 530 participants Est. completion 2027-05 1 site
    Other conditions: Pregnancy Related, Pregnancy Complications, Pregnancy, High Risk
    View official trial listing →
  • Completed NCT NCT05753098

    Effect of Sildenafil Citrate Compared to Estrogen as Adjuvant Therapy for Unexplained Infertility

    Not yet reported Beni-Suef University 148 participants Est. completion 2023-01-31 1 site
    Other conditions: Subfertility, Female
    View official trial listing →
  • Completed NCT NCT05759949

    First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors

    Not yet reported Relay Therapeutics, Inc. 41 participants Est. completion 2025-04-11 7 sites
    Other conditions: PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer, Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer, Unresectable Solid Tumor, Hormone Receptor Positive Tumor
    View official trial listing →
  • Completed NCT NCT05774405

    Short-term Effects of Transdermal Estradiol on Female COVID-19 Patients

    Not yet reported Istanbul University - Cerrahpasa 9169 participants Est. completion 2021-07-31 1 site Stand-alone
    Other conditions: COVID-19, Hormone Replacement Therapy
    View official trial listing →
  • Status unknown NCT NCT05780489

    Evaluation of Salivary ELISA for Hormone Monitoring in Donors

    Not yet reported Instituto Valenciano de Infertilidad, IVI VALENCIA 200 participants Est. completion 2024-12 2 sites
    Other conditions: Infertility, Female, Reproductive Sterility
    View official trial listing →
  • Status unknown NCT NCT05792410

    A Phase Ⅰb/Ⅱ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer.

    Not yet reported, Not yet reported Jiangsu HengRui Medicine Co., Ltd. 300 participants Est. completion 2025-02-27
    Other conditions: HER2 Low Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT05802303

    Estrogen (Gel)Transdermal vs Oral Estrogen for Endometrial Preparation

    Not yet reported Indira IVF Hospital Pvt Ltd 172 participants Est. completion 2024-03-26 1 site
    Other conditions: Frozen Embryo Transfer, Infertility, Female
    View official trial listing →
  • Status unknown NCT NCT05806047

    Combination of Chidamide and Fulvestrant for HR+/HER2- Breast Cancer That Has Failed Previous CDK4/6 i Adjuvant Therapy

    Not yet reported Fudan University 23 participants Est. completion 2024-11-01
    Other conditions: Hormone Receptor-positive Advanced Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05806671

    Dalpiciclib Plus Fulvestrant With Pyrotinib in Hormone Receptor-positive, HER2-low Advanced Breast Cancer That Progressed on Previous CDK4/6i Plus AI Therapy

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 30 participants Est. completion 2025-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05835089

    Evaluation of Some Puberty-related Hormones Among Children and Adolescents With Chronic Kidney Diseases

    Sohag University 50 participants Est. completion 2024-05 1 site
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT05894954

    Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment

    Not yet reported Alzheimer's Prevention and Reversal Project, Inc. 73 participants Est. completion 2026-02-09 6 sites
    Other conditions: Mild Cognitive Impairment, Dementia, Mild
    View official trial listing →
  • Status unknown NCT NCT05903716

    The Effects of Systemic Isotretinoin Treatment on Adrenal Steroid and Sex Hormones Level in Severe Acne Vulgaris

    Marmara University 40 participants Est. completion 2023-06-30 1 site
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Completed NCT NCT05903820

    Rhythmic Estradiol and Bone Health

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 48 participants Est. completion 2024-10-28 1 site
    Other conditions: Osteoporosis Risk, Menopause
    View official trial listing →
  • Terminated NCT NCT05932667

    Milademetan and Fulvestrant in GATA3-mutant, ER+HER- Advanced or Metastatic Breast Cancer

    Not yet reported Institut Curie 1 participants Est. completion 2023-11-30 6 sites
    Other conditions: Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT05966584

    A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 1 participants Est. completion 2024-08-02 7 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05985590

    A Study to Investigate the Effects of BMS-986278 on Drospirenone and Ethinyl Estradiol Drug Levels in Healthy Female Participants

    Not yet reported Bristol-Myers Squibb 37 participants Est. completion 2023-12-11 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT05994599

    Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring

    Not yet reported Evestra Inc. 36 participants Est. completion 2023-12-11 1 site
    Other conditions: Healthy Women, Female, Contraception
    View official trial listing →
  • Terminated NCT NCT06005610

    Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 93 participants Est. completion 2025-08-21 18 sites
    Other conditions: HIV I Infection
    View official trial listing →
  • Status unknown NCT NCT06026553

    Assessing Ketorolac (Toradol) at Oocyte Retrieval

    Not yet reported Shady Grove Fertility Reproductive Science Center 400 participants Est. completion 2025-01 2 sites
    Other conditions: Infertility, Infertility, Female, Oocyte Retrieval, Postoperative Pain, Embryo Transfer
    View official trial listing →
  • Completed NCT NCT06039826

    A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese

    Not yet reported Eli Lilly and Company 46 participants Est. completion 2024-07-11 2 sites
    Other conditions: Overweight
    View official trial listing →
  • Active, not recruiting NCT NCT06065748

    A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

    Not yet reported Hoffmann-La Roche 1050 participants Est. completion 2029-02-12 311 sites
    Other conditions: Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06110793

    A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 56 participants Est. completion 2027-11 7 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT06132620

    Clinical Efficacy of Qingxin Zishen Decoction in Treating Menopausal Syndrome and Neuroendocrine Mechanism of Regulating KNDy Neurons

    Not yet reported Yun Chen 60 participants Est. completion 2018-06-30 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT06136208

    Pharmacokinetic Aspects of 25-mg Estradiol Pellet in Climacteric Women

    Not yet reported Science Valley Research Institute 20 participants Est. completion 2025-07-30 1 site
    Other conditions: Climacteric Syndrome, Menopause, Hypoestrogenism
    View official trial listing →
  • Completed NCT NCT06144814

    A Comparison of Hyaluronic Acid and Estradiol Treatment in Vulvovaginal Atrophy.

    Not yet reported Koru Health Groups 300 participants Est. completion 2023-09-30 1 site
    Other conditions: Vulvovaginal Atrophy
    View official trial listing →
  • Terminated NCT NCT06191289

    Neurocognitive Mechanisms of Perimenstrual Estrogen Effects on Suicidality

    Not yet reported University of Illinois Chicago 11 participants Est. completion 2024-12-01 1 site Stand-alone
    Other conditions: Suicide
    View official trial listing →
  • Status unknown NCT NCT06204016

    Estradiol and Stress Reactivity in Women

    International Research Training Group 2804 74 participants Est. completion 2025-12 1 site
    Other conditions: Stress vs. Control, Estradiol vs. Placebo
    View official trial listing →
  • Status unknown NCT NCT06233071

    Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®

    Not yet reported Bio-innova Co., Ltd 32 participants Est. completion 2024-05-02 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT06250205

    Evaluate the Pharmacokinetics of a Combined Oral Contraceptive (COC) With and Without Obicetrapib

    Not yet reported NewAmsterdam Pharma 30 participants Est. completion 2024-04-26 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06253195

    BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

    Not yet reported BeOne Medicines 33 participants Est. completion 2026-04-23 7 sites
    Other conditions: Advanced Solid Tumor, Metastatic Solid Tumor, Hormone-receptor-positive Breast Cancer, Breast Cancer, Metastatic Breast Cancer, Hormone Receptor Positive Malignant Neoplasm of Breast, HER2-negative Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06257264

    A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

    Not yet reported BeiGene 103 participants Est. completion 2027-08-27 24 sites
    Other conditions: Breast Cancer, Small Cell Lung Cancer, Ovarian Cancer, Gastric Cancer, Hormone-receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Advanced Solid Tumor, Endometrial Cancer, Prostate Cancer, TNBC - Triple-Negative Breast Cancer, GastroEsophageal Cancer, Bladder Cancer
    View official trial listing →
  • Withdrawn NCT NCT06279195

    Phenotyping of Idiopathic Pelvic Pain With Real-time Uterine Imaging and Relugolix-Combination Therapy Treatment

    Not yet reported Endeavor Health Est. completion 2025-11-02 1 site
    Other conditions: Pelvic Pain
    View official trial listing →
  • Not yet recruiting NCT NCT06306404

    Sleeping Through Menopause

    Not yet reported VU University of Amsterdam 222 participants Est. completion 2030-01-01
    Other conditions: Menopause, Insomnia
    View official trial listing →
  • Completed NCT NCT06308614

    Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

    Not yet reported Estetra 82 participants Est. completion 2025-04-21 24 sites
    Other conditions: Sexual Dysfunction, Physiological
    View official trial listing →
  • Completed NCT NCT06310616

    A Study to Investigate the Potential Drug-Drug Interaction Between VH4524184 and Oral Contraceptive (Loestrin) in Healthy Adult Female Participants

    Not yet reported ViiV Healthcare 26 participants Est. completion 2024-08-15 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT06312033

    Estradiol's Effect on Brain Volume and Connectivity

    Not yet reported International Research Training Group 2804 32 participants Est. completion 2021-12-31 1 site
    Other conditions: Emotion Regulation, Estradiol
    View official trial listing →
  • Completed NCT NCT06316219

    The Use of Nomegestrol Acetate/Estradiol in Random Start Rapid Endometrial Preparation

    Not yet reported University of Palermo 80 participants Est. completion 2024-03-01 2 sites
    Other conditions: Endometrial Polyp, Endometrial Diseases
    View official trial listing →
  • Not yet recruiting NCT NCT06318403

    Estradiol Supplementation and Rotator Cuff Repair

    Not yet reported University of Utah 58 participants Est. completion 2030-12 Stand-alone
    Other conditions: Rotator Cuff Tears, Rotator Cuff Injuries, Rotator Cuff Syndrome, Menopause Related Conditions, Menopause
    View official trial listing →
  • Active, not recruiting NCT NCT06353269

    Adherence to Vaginal Estrogen Therapy in Hypoestrogenic Women With Recurrent Urinary Tract Infections

    Not yet reported University of California, Irvine 111 participants Est. completion 2027-09 1 site
    Other conditions: Recurrent Urinary Tract Infection, Hypoestrogenism
    View official trial listing →
  • Completed NCT NCT06354257

    A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age

    Not yet reported GlaxoSmithKline 20 participants Est. completion 2024-07-01 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Not yet recruiting NCT NCT06369363

    Estrogen Deficiency on Cardiovascular Risk

    Not yet reported Milton S. Hershey Medical Center 20 participants Est. completion 2028-11 Stand-alone
    Cardiovascular disease Other conditions: Postmenopausal Symptoms
    View official trial listing →
  • Completed NCT NCT06375707

    First-Line Ribociclib Plus Endocrine Therapy Versus Chemotherapy With or Without Subsequent Endocrine Therapy in Patients With Rapidly Progressive HR-Positive/HER2-Negative Advanced Breast Cancer

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 74 participants Est. completion 2026-05-30 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT06396208

    "Quick-starting" of a Quadriphasic Contraceptive Pills, 1 - 3 mg Estradiol Valerate/ 2 - 3 mg Dienogest VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition

    Not yet reported Chulalongkorn University 40 participants Est. completion 2024-10-20 1 site
    Other conditions: Ultrasound Finding: Ovulation Inhibition, Ovarian Activities, Cervical Mucus, Serum Hormonal Profile
    View official trial listing →
  • Completed NCT NCT06396221

    "Quick-starting" of a New Combined Hormonal Contraceptive Pills, 15 mg Estetrol/3 mg Drospirenone VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition

    Not yet reported Chulalongkorn University 36 participants Est. completion 2024-09-30 1 site
    Other conditions: Ultrasound Finding: Ovulation Inhibition, Ovarian Activities, Cervical Mucus, Serum Hormonal Profile
    View official trial listing →
  • Terminated NCT NCT06408168

    Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial)

    Not yet reported M.D. Anderson Cancer Center 6 participants Est. completion 2025-12-08 1 site
    Other conditions: Hormone Receptor-positive Human Epidermal Growth Factor 2-negative, Metastatic Invasive LObular Carcinoma
    View official trial listing →
  • Completed NCT NCT06426771

    Effect of Antimullerian Hormone Levels on the Inflammatory Index, Phytochemical Index and NRF Nutrient Density

    Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital 90 participants Est. completion 2024-11-10 1 site
    Other conditions: AMH, Diet Habit, Ovarian Failure, Polycystic Ovary Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT06428396

    Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)

    Not yet reported Merck Sharp & Dohme LLC 120 participants Est. completion 2028-12-25 41 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06447623

    Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer

    Not yet reported Fudan University 184 participants Est. completion 2029-02-01 1 site
    Other conditions: Advanced Breast Cancer, HR+/HER2- Breast Cancer
    View official trial listing →
  • Completed NCT NCT06461039

    A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant

    Not yet reported Novo Nordisk A/S 43 participants Est. completion 2025-04-04 1 site
    Other conditions: Obesity
    View official trial listing →
  • Not yet recruiting NCT NCT06480682

    Relative Energy Deficiency in Sport and Dance

    University of Wolverhampton 200 participants Est. completion 2029-07-30 1 site
    Other conditions: Relative Energy Deficiency in Sport, Bone Stress Reaction
    View official trial listing →
  • Active, not recruiting NCT NCT06494150

    Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)

    Not yet reported University of Oklahoma 37 participants Est. completion 2029-09 1 site
    Other conditions: Low Grade Ovarian Serous Adenocarcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT06506955

    Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.

    Not yet reported, Not yet reported Taiho Oncology, Inc. 15 participants Est. completion 2027-04-30 9 sites
    Other conditions: Advanced/Metastatic Cancer
    View official trial listing →
  • Completed NCT NCT06525675

    Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)

    MedSIR 419 participants Est. completion 2024-09-02 36 sites
    Other conditions: Metastatic Breast Cancer, Advanced Breast Cancer, Luminal Breast Cancer, HER2-negative Breast Cancer, ER-positive Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06546397

    Study on the Effect of Combined Estrogen and Progestogen Therapy on Endometrial Repair After Induced Abortion

    Not yet reported Women's Hospital School Of Medicine Zhejiang University 200 participants Est. completion 2025-12-31 1 site
    Other conditions: Pregnancy Complications
    View official trial listing →
  • Status unknown NCT NCT06577974

    Role of Medical Treatment in Endometriosis Patients Undergoing ICSI

    Not yet reported Cairo University 129 participants Est. completion 2025-03-01 2 sites
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT06654570

    Effects of Vaginal Estrogen on Serum Estradiol During Aromatase Inhibitor Therapy in Breast Cancer Patients with Vulvovaginal Atrophy: a Prospective Trial

    Not yet reported Helsinki University Central Hospital 20 participants Est. completion 2024-10-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT06671405

    An Open-label Study in Healthy Participants to Evaluate AZD0780 as an Object or Precipitant of CYP3A4-mediated Drug-drug Interactions

    Not yet reported AstraZeneca 59 participants Est. completion 2025-02-17 1 site
    Other conditions: Dyslipidaemia
    View official trial listing →
  • Active, not recruiting NCT NCT06680921

    A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)

    Not yet reported Jiangsu Simcere Pharmaceutical Co., Ltd. 482 participants Est. completion 2028-08-31 57 sites
    Other conditions: Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06691815

    Triptorelin for Early Diagnosis of Hypogonadotrophic Hypogonadism

    Not yet reported Hospital de Niños R. Gutierrez de Buenos Aires 48 participants Est. completion 2026-09 1 site
    Other conditions: Pubertal Delay, Hypogonadism, Hypogonadotropic, Constitutional Delay in Growth and Puberty (CDGP)
    View official trial listing →
  • Completed NCT NCT06773429

    Estradiol and Brain Age

    International Research Training Group 2804 32 participants Est. completion 2019-07-31 1 site
    Other conditions: Estradiol (E2) Vs. Placebo (PLAC), Estradiol
    View official trial listing →
  • Completed NCT NCT06778733

    Effectiveness of Low Dose Gonadotropin Stimulation Protocol Vs High Dose Gonadotropin Protocol in Poor Responders

    Not yet reported University of Athens 22 participants Est. completion 2024-04-30 2 sites
    Other conditions: Female Infertility
    View official trial listing →
  • Completed NCT NCT06780163

    Effect of Vaginal Estrogen on Alterations in the Urine Microbiome of Menopausal Women With Overactive Bladder

    Not yet reported Mahidol University 30 participants Est. completion 2025-11-11 1 site
    Other conditions: Overactive Bladder (OAB), Menopause, Microbiome
    View official trial listing →
  • Completed NCT NCT06799884

    A Drug-drug Interaction Trial in Healthy Female Participants to Investigate the Effect of Aprocitentan on Combined Hormonal Contraceptives

    Not yet reported Idorsia Pharmaceuticals Ltd. 19 participants Est. completion 2025-02-21 1 site
    Other conditions: Drug Drug Interaction
    View official trial listing →
  • Completed NCT NCT06820307

    Evaluation of the Effect of Suzetrigine (SUZ) on the Pharmacokinetics of Oral Contraceptives in Healthy Female Participants

    Not yet reported Vertex Pharmaceuticals Incorporated 50 participants Est. completion 2025-04-29 1 site
    Other conditions: Pain
    View official trial listing →
  • Completed NCT NCT06942936

    A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female Participants

    Not yet reported AstraZeneca 51 participants Est. completion 2026-01-28 2 sites
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT07007416

    Impact of Supraphysiological Estradiol on ECG in IVF Patients

    Konya City Hospital 62 participants Est. completion 2025-01-31 1 site
    Other conditions: In Vitro Fertilization, Estradiol, Cardiac Electrophysiology, Electrocardiography (ECG), Reproductive Endocrinology
    View official trial listing →
  • Active, not recruiting NCT NCT07013643

    A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity

    Not yet reported AstraZeneca 100 participants Est. completion 2027-07-09 2 sites
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT07027332

    Liver Stiffness And Steatosis Assessment In Women With Polycystic Ovary Syndrome Using Fibroscan

    Bezmialem Vakif University 36 participants Est. completion 2025-03-08 1 site
    Other conditions: Polycystic Ovary Syndrome, Non-Alcoholic Fatty Liver Disease
    View official trial listing →
  • Active, not recruiting NCT NCT07038369

    A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

    Not yet reported Atavistik Bio, Inc 134 participants Est. completion 2029-01-31 8 sites
    Other conditions: Advanced Solid Tumors, Breast Cancer, Breast Carcinoma, Breast Neoplasms, ER Positive Breast Cancer, Cervical Cancers, Cervical Neoplasms, Cervical Carcinoma, Triple Negative Breast Cancer, Gynecologic Cancers, Gynecologic Neoplasm, Endometrial Cancer, Endometrial Neoplasm, Endometrial Carcinoma (EC), Fallopian Cancer, Ovarian Carcinoma, Ovarian Cancer, Ovarian Neoplasms, Prostate Cancers, Prostate Carcinoma, Solid Tumors, Neoplasms, Neoplasms by Site, Breast Diseases, Uterine Neoplasms, Genital Neoplasms, Female, Urogenital Neoplasms
    View official trial listing →
  • Not yet recruiting NCT NCT07041814

    A Study Comparing Different Treatment Approaches for the Initiation of Puberty in Girls With Turner Syndrome Using a TRIFECTA-DARED Approach for Rare Diseases

    Not yet reported Universiti Kebangsaan Malaysia Medical Centre 24 participants Est. completion 2029-10-31 1 site
    Other conditions: Turner Syndrome
    View official trial listing →
  • Completed NCT NCT07074327

    Effects of VX-407 on the Pharmacokinetics of Oral Contraceptives in Healthy Participants

    Not yet reported Vertex Pharmaceuticals Incorporated 74 participants Est. completion 2026-02-27 1 site
    Other conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
    View official trial listing →
  • Completed NCT NCT07096024

    A Study to Understand About the Study Medicine Palbociclib in Breast Cancer Patients After it is Out in the Japanese Market

    Pfizer 95637 participants Est. completion 2025-02-07 1 site
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT07103603

    MHT and Liver Function in Postmenopausal Women

    Not yet reported Ipek B. Ozcivit Erkan, MD 44 participants Est. completion 2025-12-30 1 site
    Other conditions: Menopause, Non Alcholic Fatty Liver Disease, Hepatic Steatosis
    View official trial listing →
  • Completed NCT NCT07145281

    Comparing the Effects of Sublingual Estradiol Treatment Versus Oral Estradiol With Cyproterone Acetate (CPA) Treatment on The Coagulation System in Transgender Women: A Prospective, Controlled Cohort Study

    Not yet reported Tel-Aviv Sourasky Medical Center 30 participants Est. completion 2024-11-10 1 site
    Other conditions: Gender Dysphoria, Adult, Blood Coagulation, Coagulation Factors, Transgender Persons, M01.777.500, Hemostasis, Transgender Women
    View official trial listing →
  • Not yet recruiting NCT NCT07179939

    Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study

    Not yet reported Fudan University 288 participants Est. completion 2031-12-30 1 site
    Other conditions: HER2-positive Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT07204093

    Ultra-Safe Hormonal Strategy: Transdermal Estradiol Added to Progestins for Endometriosis

    Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 138 participants Est. completion 2026-02 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT07215806

    Effect of Evobrutinib on Pharmacokinetics of a Combined Oral Contraceptive

    Not yet reported Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 20 participants Est. completion 2022-11-25 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT07229209

    Oral Contraceptive Pills Versus Levonorgestrel-Releasing Intrauterine System for Niche-Related Abnormal Uterine Bleeding

    Not yet reported Benha University 166 participants Est. completion 2025-11-01 1 site
    Other conditions: Abnormal Uterine Bleeding, Cesarean Section Complications, Uterine Scar
    View official trial listing →
  • Not yet recruiting NCT NCT07235618

    A Study of Entinostat in Combination With Fulvestrant for the Treatment of Locally Advanced or Metastatic Breast Cancer

    Not yet reported Sun Yat-sen University 50 participants Est. completion 2028-12-30 1 site
    Other conditions: Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT07235774

    A Drug-drug Interaction Study of Vorasidenib and a Combined Oral Contraceptive in Healthy Female Participants

    Not yet reported Institut de Recherches Internationales Servier (I.R.I.S.) 28 participants Est. completion 2026-03-13 1 site
    Other conditions: Healthy Adult Female Participants
    View official trial listing →
  • Not yet recruiting NCT NCT07260825

    Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial

    Not yet reported, Not yet reported TriHealth Inc. 44 participants Est. completion 2026-08 2 sites
    Other conditions: Vulvodynia, Dyspareunia, Lichen Sclerosus of Vulva
    View official trial listing →
  • Completed NCT NCT07269327

    An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin

    Not yet reported Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 24 participants Est. completion 2026-03-09 1 site
    Other conditions: Fertility
    View official trial listing →
  • Completed NCT NCT07272889

    Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)

    Not yet reported Atea Pharmaceuticals, Inc. 24 participants Est. completion 2026-02-17 1 site
    Other conditions: Healthy Volunteer Study
    View official trial listing →
  • Not yet recruiting NCT NCT07288190

    Phase 2b, Open Label, Multisite, Randomized Crossover Study of DPP Versus 2PR

    Not yet reported HIV Prevention Trials Network 300 participants Est. completion 2028-05-15 3 sites
    Other conditions: Pregnancy, HIV Infections
    View official trial listing →
  • Completed NCT NCT07318337

    Effect of Drospirenone-Ethinyl Estradiol (20microgram vs 30 Microgram) on Free Androgen Index in PCOS

    Not yet reported Mst.Sumyara Khatun 60 participants Est. completion 2025-06-30 1 site
    Other conditions: PCOS (Polycystic Ovary Syndrome)
    View official trial listing →
  • Not yet recruiting NCT NCT07328789

    Factors Influencing Cardiac Rehabilitation Success

    Pomeranian Medical University Szczecin 150 participants Est. completion 2029-07-01
    Other conditions: Rehabilitation
    View official trial listing →
  • Not yet recruiting NCT NCT07340619

    Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.

    Not yet reported UNICANCER 51 participants Est. completion 2029-11-18 8 sites
    Other conditions: Metastatic (Stage IV) Melanoma
    View official trial listing →
  • Not yet recruiting NCT NCT07366632

    A Study of Single Dose of BL0175 in Postmenopausal Women

    Not yet reported Shanghai Best-Link Bioscience, LLC 27 participants Est. completion 2026-12-21
    Other conditions: Postmenopausal Women
    View official trial listing →
  • Not yet recruiting NCT NCT07393321

    A Phase III Clinical Trial of NTQ1062 in Combination With Fulvestrant for the Treatment of Advanced or Metastatic HR+/HER2- Breast Cancer

    Not yet reported Nanjing Chia-tai Tianqing Pharmaceutical 210 participants Est. completion 2031-08-31
    Other conditions: HR Positive/HER2 Negative Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT07408089

    Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer

    Not yet reported Boundless Bio, Inc. 8 participants Est. completion 2026-07-28 8 sites
    Other conditions: Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT07414784

    A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives

    Not yet reported AbbVie 20 participants Est. completion 2026-08-04 2 sites
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Not yet recruiting NCT NCT07480681

    Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HLX97 (a KAT6A/B Inhibitor) in Patients With Advanced/Metastatic Solid Tumor

    Not yet reported Shanghai Henlius Biotech 138 participants Est. completion 2028-06
    Other conditions: Advanced/Metastatic Solid Tumors
    View official trial listing →
  • Not yet recruiting NCT NCT07496294

    Comparison of Oral Dydrogesterone and Vaginal Progesterone in Menopausal Hormone Therapy

    Not yet reported Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital 200 participants Est. completion 2027-10 1 site Stand-alone
    Other conditions: Menopausal Women, Menopausal Symptom Relief, Hormone Therapy, Menopausal Hormone Therapy
    View official trial listing →
  • Completed NCT NCT07509411

    Anti-TNFα Therapy for Improving Pregnancy Rates in Endometriosis Patients With Failed ICSI

    Not yet reported Benha University 145 participants Est. completion 2026-08-07 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Active, not recruiting NCT NCT07523711

    Effect of Maridebart Cafraglutide on How Oral Contraceptives Are Absorbed and Processed in the Body in Postmenopausal Female Participants Living With Overweight or Obesity

    Not yet reported Amgen 49 participants Est. completion 2026-11-18 2 sites
    Other conditions: Overweight, Obesity
    View official trial listing →
  • Active, not recruiting NCT NCT07525791

    A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight

    Not yet reported Novo Nordisk A/S 41 participants Est. completion 2027-06-18 1 site
    Other conditions: Overweight, Obesity
    View official trial listing →
  • Completed NCT NCT07526207

    Estradiol 8 vs 12 mg for Endometrial Preparation in HRT-FET

    Not yet reported Cairo University 850 participants Est. completion 2026-02-26 2 sites
    Other conditions: Infertility (IVF Patients), Infertility Assisted Reproductive Technology, Frozen Embryo Transfer (FET), Endometrial Preparation, Clinical Pregnancy Rates
    View official trial listing →
  • Not yet recruiting NCT NCT07526948

    Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV

    Not yet reported Albert Einstein College of Medicine 62 participants Est. completion 2029-10-14 1 site
    Other conditions: Menopausal Complaints, Vaginal Atrophy, Genitourinary Symptoms, HIV (Human Immunodeficiency Virus), Menopause Related Conditions, Vaginitis, Perimenopause
    View official trial listing →
  • Completed NCT NCT07539090

    Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel)

    Not yet reported Deciphera Pharmaceuticals, LLC 27 participants Est. completion 2026-10-08 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Not yet recruiting NCT NCT07544966

    Teen Vulnerability to Irritability: Brain and Estrogen Changes

    Not yet reported University of North Carolina, Chapel Hill 50 participants Est. completion 2029-04 2 sites
    Other conditions: Depression - Major Depressive Disorder, Irritability
    View official trial listing →
  • Not yet recruiting NCT NCT07618390

    A Phase ll, Interventional, Single-arm Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib and Fulvestrant in Chinese Patients With PIK3CA-mutant, HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer.

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 160 participants Est. completion 2028-12
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT07656792

    A Study in Japanese Healthy Men to Test How Well Different Doses of BI 3031185 Are Tolerated and a Study in Japanese Healthy Women to Test Whether BI 3031185 Influences the Amount of a Contraceptive in the Blood

    Not yet reported Boehringer Ingelheim 8 participants Est. completion 2026-09-23 1 site
    Other conditions: Healthy
    View official trial listing →
  • Not yet recruiting NCT NCT07679269

    Roll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety.

    Not yet reported Novartis Pharmaceuticals 51 participants Est. completion 2032-04-20
    Other conditions: PIK3CA-Related Overgrowth Spectrum (PROS), Breast Neoplasms (Including Advanced or Metastatic Breast Cancer With PIK3CA Mutation)
    View official trial listing →
  • Not yet recruiting NCT NCT07714616

    Evaluation of the Contraceptive Efficacy and Safety of a New Concentration of an Antiandrogenic Progestogen Combined With a Reduced-Dose Estrogen (LUNA)

    Not yet reported Eurofarma Laboratorios S.A. 1600 participants Est. completion 2030-05-31 1 site
    Other conditions: Contraception
    View official trial listing →
  • Not yet recruiting NCT NCT07724145

    Association Between Female Hormonal Profile and Wound Healing

    University Hospital, Geneva 84 participants Est. completion 2028-12 1 site
    Other conditions: Wound Healing, Wound Healing Complication, Estradiol
    View official trial listing →
  • Not yet recruiting NCT NCT07729046

    Neu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast Cancer

    Not yet reported University of California, San Diego 150 participants Est. completion 2035-06 1 site
    Other conditions: Metastatic Invasive Breast Cancer, Resistant Breast Cancer, ER+, HER2-, Metastatic Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07732452

    Hormone thERapy Effects on BRAin-HEART Health During the Menopausal Transition

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 100 participants Est. completion 2029-01 Stand-alone
    Cardiovascular disease Other conditions: Menopause, Perimenopause, Vasomotor Symptoms, Menopausal Hormone Therapy, Cardiac Remodeling, Myocardial Fibrosis, Microvascular Dysfunction, Cognitive Function Assessment
    View official trial listing →
  • Not yet recruiting NCT NCT07737613

    Acute Effects of Estradiol Administration on Brain Function During Fear Learning

    Not yet reported University of Arizona 30 participants Est. completion 2027-12
    Other conditions: PTSD and Trauma-related Symptoms, Cognitive Decline in Older Adults, Post Menopausal Women
    View official trial listing →
  • Active, not recruiting NCT NCT07754630

    Analysis of the Hormonal Implant and Transdermal Estradiol Gel in Climacteric Women

    Not yet reported Nutrindo Ideais Research Center 50 participants Est. completion 2027-10-01 1 site
    Other conditions: Menopause, Hypoestrogenism, Hormonal Therapy
    View official trial listing →
  • Completed NCT NCT07763847

    Effect of Elagolix in Symptomatic Endometrioma in Comparison to Combined Oral Contraceptive Pill.

    Not yet reported Mst.Sumyara Khatun 60 participants Est. completion 2026-04-16 1 site
    Other conditions: Endometrioma
    View official trial listing →
  • Completed NCT NCT07770594

    Effect of Dienogest in Symptomatic Endometrioma in Comparison to Combined Oral Contraceptive Pill.

    Not yet reported Mst.Sumyara Khatun 60 participants Est. completion 2026-04-16 1 site
    Other conditions: Endometrioma
    View official trial listing →
  • Not yet recruiting NCT NCT07784036

    JYP0035 Capsules Plus Fulvestrant in PIK3CA-Mutant HR+/HER2- Advanced Breast Cancer

    Not yet reported Chengdu JOYO pharma Co., Ltd. 171 participants Est. completion 2029-06-30
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07787520

    A Study of LAE118 as Monotherapy and in Combination With Antitumor Agents in Advanced Solid Tumors

    Not yet reported Laekna Limited 150 participants Est. completion 2029-12 6 sites
    Other conditions: Patients With Advanced Solid Tumors
    View official trial listing →
  • Not yet recruiting NCT NCT07811232

    A Study of AL58805 in Advanced, Metastatic GYN, STS or Breast Cancers

    Not yet reported, Not yet reported Advenchen Pharmaceuticals, LLC. 138 participants Est. completion 2031-09-01 1 site
    Other conditions: Endometrial Neoplasms, Soft Tissue Sarcoma (STS), Breast Neoplasms
    View official trial listing →
  • Not yet recruiting NCT NCT07818278

    Cycle-to-cycle Variability of Progesterone in the Endometrium in Patients Undergoing an Euploid Blastocyst Transfer in a Hormone Replacement Therapy (HRT) Cycle (PROMICOFET)

    Not yet reported University Hospital, Ghent 70 participants Est. completion 2029-08-31 1 site Stand-alone
    Other conditions: Fertility, Implantation, Embryo
    View official trial listing →
  • Completed NCT NCT07821086

    Effects of Estrogen Therapy on Lipid Metabolism and Insulin Sensitivity in Hypogonadal Women

    Not yet reported Khyber Medical University Peshawar 30 participants Est. completion 2026-09-20 1 site
    Other conditions: Female Hypogonadism
    View official trial listing →
  • Completed NCT NCT07851649

    A Study to Assess the Bioavailability and Adhesion of Estradiol/Levonorgestrel TDS in Healthy Post-Menopausal Female Participants

    Not yet reported Corium Innovations, Inc. 68 participants Est. completion 2026-09-29 1 site Stand-alone
    Other conditions: Healthy Female Participants, Postmenopause
    View official trial listing →
  • Completed NCT NCT07854873

    Vaginal Prasterone Versus Estriol in Women With Pelvic Floor Disorders

    Not yet reported Poznan University of Medical Sciences 74 participants Est. completion 2026-01-31 1 site
    Other conditions: Pelvic Organ Prolapse (POP), Stress Urinary Incontinence (SUI)
    View official trial listing →
  • Not yet recruiting NCT NCT07857226

    Trastuzumab/Pertuzumab With Fulvestrant and Culmerciclib in HR+/HER2+ Early Breast Cancer

    Not yet reported Hebei Medical University Fourth Hospital 31 participants Est. completion 2028-12
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07867262

    A Study to Evaluate the Effects of GDC-4198 in Combination With Letrozole, Fulvestrant, or Giredestrant in Participants With Locally Advanced or Metastatic Hormone Receptor-Positive, HER2-Negatve Breast Cancer

    Not yet reported Genentech, Inc. 165 participants Est. completion 2030-08-15
    Other conditions: Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07868536

    Post-traumatic Estradiol Administration and Care Evaluation (PEACE)

    Not yet reported University of North Carolina, Chapel Hill 30 participants Est. completion 2028-07-31
    Other conditions: Chronic Musculoskeletal Pain, Sexual Assault, Posttraumatic Stress Disorder (PTSD)
    View official trial listing →
  • Completed NCT NCT07891793

    Late-Start Corifollitropin Alfa in Mild Ovarian Stimulation

    Not yet reported Assisting Nature 180 participants Est. completion 2026-06-30 1 site
    Other conditions: Infertile Patient Undergoing ICSI Procedure
    View official trial listing →
  • Not yet recruiting NCT NCT07897721

    A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid Tumors

    Not yet reported Pfizer 268 participants Est. completion 2032-03-21 5 sites
    Other conditions: Advanced Breast Cancer, Advanced or Metastatic Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-), Metastatic Colorectal Adenocarcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT07908901

    Integrated Care Pathway for Hormonally Mediated Vestibulodynia: a Feasibility and Acceptability Pilot

    Not yet reported HerAccess ApS 35 participants Est. completion 2027-12 2 sites
    Other conditions: Vestibulodynia, Vulvodynia, Vulvar Vestibulitis
    View official trial listing →
  • Completed NCT NCT07911709

    Effect of Combined Hormonal Contraceptiveson Free Androgen Index (FAI) in Polycystic Ovary Syndrome:Drospirenone-Ethinyl Estradiol (DRSP-EE) Versus Cyproterone Acetate-Ethinyl Estradiol (CPA-EE)

    Not yet reported Mst.Sumyara Khatun 60 participants Est. completion 2024-12-31 1 site
    Other conditions: PCOS (Polycystic Ovary Syndrome)
    View official trial listing →
  • Not yet recruiting NCT NCT07919054

    Serum Estradiol and Endometrial Thickness After Bariatric Surgery in Postmenopausal Women With Obesity

    Kasr El Aini Hospital 78 participants Est. completion 2028-04-30 1 site
    Other conditions: Obesity, Morbid, Postmenopause, Endometrial Thickening
    View official trial listing →
  • Completed NCT NCT07922512

    Letrozole in Oligospermia With Eugonadotropic-Hypogonadism and Low Testosterone Estradiol Ratio

    Not yet reported Mst.Sumyara Khatun 60 participants Est. completion 2024-12-31 1 site
    Other conditions: Oligospermia
    View official trial listing →
  • Completed NCT NCT07932990

    Halova Vaginal Ovules Versus Vaginal Estriol for Genitourinary Symptoms in Postmenopausal Women

    Not yet reported Perfect Care Distribution 252 participants Est. completion 2026-06-22 1 site
    Other conditions: Genitourinary Syndrome of Menopause (GSM), Vaginal Dryness, Vulvo Vaginal Atrophy (VVA)
    View official trial listing →
  • Not yet recruiting NCT NCT07937605

    KC1086 in Combination With Fulvestrant for HR-Positive, HER2-Negative Advanced Breast Cancer

    Not yet reported Beijing Konruns Pharmaceutical Co., Ltd. 168 participants Est. completion 2030-11
    Other conditions: HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Transdermal estrogen, Transdermal estradiol, Climara

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.